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Stellingen 
1. Met behulp van de nieuwe in vitro en in vivo reporter gen assays, die kunnen worden 
ingezet voor het snel determineren van de aanwezigheid van biologisch-actieve 
oestrogene stoffen, is aangetoond dat op enkele plaatsen in het Nederlandse 
aquatische milieu al niveaus van (xeno) oestrogenen voorkomen, die zeer 
waarschijnlijk ongewenste effecten op de voortplanting van vissen zouden kunnen 
veroorzaken. (dit proefsckrift) 
2. Terwijl persistente stoffen in vivo hogere oestrogene activiteit vertonen dan voorspeld 
wordt met in vitro bioassays, kan de oestrogene potentie van snel metaboliseerbare 
stoffen mogelijk overschat worden door in vitro bioassays. (ditproefschrift) 
3. De synergistische effecten van gecombineerde blootstelling aan de pesticiden 
paraquat en maneb op het dopamine systeem in de hersenen van de rat kan betekenen, 
dat blootstelling aan mengsels van pesticiden een bijdrage zou kunnen leveren aan het 
ontstaan van de ziekte van Parkinson. (Thiruchelvam, M. et al. (2000) J. Neuroscience, 20, 
9207-9214) 
4. Subtiele ecologische-relevante effecten, zoals verlengde metamorfose bij kikkers 
door PCB-blootstelling, worden niet aangetoond met klassieke toxicologische 
toetsten. (now: Gutleb, A.C. etal. (1999) Environ. Toxicol. Pharmacol. 8, 1-14) 
5. De aanwezigheid van lage niveaus van farmaceutica in het milieu is zorgwekkend, 
omdat deze stoffen continu terechtkomen in oppervlaktewater via rioolwaterzuivering 
effluenten en bovendien zeer weinig bekend is over de aquatische toxiciteit van deze 
stoffen. (Daughton, C.G. and Terms, T.A. (1999) Environ. Health Perspect, 107, 907-938) 
6. Met haar plannen om de fok van zogenaamde "agressieve" hondensoorten te 
verbieden legt de Nederlandse overheid de verantwoordelijkheid voor deze 
problematiek bij de hond in plaats van bij de eigenaar. 
7. De werkelijke morele beproeving van de mens, de meest essentiele (zo diep 
opgeborgen dat die zich aan onze blik onttrekt), berust op zijn verhouding tot wie aan 
hem zijn overgeleverd: de dieren. (Kundera, M. (1983) "De ondraaglijke lichtheidvan het 
bestaan ") 
8. Buitenlanders zouden het beste in Nederland kunnen integreren door drie dingen te 
leren: de Nederlandse taal, fietsen en vergaderen. (naar: Van Vree, W. (1994) 
"Nederland als vergaderland") 
Stellingen behorend bij het proefschrift "Development and application of in vitro and in vivo reporter 
gene assays for the assessment of (xeno-)estrogenic compounds in the aquatic environment" door 
Juliette Legler, Wageningen, 27 februari 2001. 
Propositions 
1. Application of the newly developed in vitro and in vivo reporter gene assays, which 
can be used to rapidly determine the presence of biologically-active estrogenic 
compounds, has shown that in some localised areas in the Dutch aquatic environment, 
fish may be exposed to (xeno-)estrogens at levels that may impact their reproductive 
success, (this dissertation) 
2. While persistent compounds may be more estrogenic in vivo than predicted by in 
vitro assays, the estrogenic potency of rapidly metabolised compounds may be 
overestimated by in vitro assays, (this dissertation) 
3. The synergistic effects of combined exposure to the pesticides paraquat and maneb on 
the brain dopaminergic system in the rat suggests that exposure to mixtures of 
pesticides may play a role in the development of Parkinson's disease. (Thiruchelvam, 
M. et al. (2000) J. Neuroscience, 20, 9207-9214) 
4. Subtle, ecologically relevant effects, such as prolonged metamorphosis in PCB-
exposed frogs, are not detected with classical toxicological tests, (based on: Gutleb, 
A.C. etal. (1999) Environ. Toxicol. Pharmacol. 8, 1-14) 
5. The presence of low levels of pharmaceuticals in the environment is alarming, as 
these compounds are continually introduced to surface waters via sewage treatment 
effluent and very little is known of their aquatic toxicity. (Daughton, C.G. and Terms, 
T.A. (1999) Environ. Health Perspect, 107, 907-938) 
6. By outlawing the breeding of so-called "aggressive" dog-breeds, the Dutch 
government is placing the burden of responsibility for this issue upon the dog instead 
of the owner. 
7. Mankind's true moral test, its fundamental test (which lies deeply buried from view), 
consists of its attitude towards those who are at its mercy: animals. (Kundera, M. 
(1983) "The unbearable lightness of being") 
8. Foreigners would integrate best in The Netherlands by learning three things: the 
Dutch language, bicycling, and "meeting" skills, (based on: Van Vree, W. (1994) "The 
Netherlands as a meeting-place ") 
Propositions belonging to the PhD dissertation "Development and application of in vitro and in vivo 
reporter gene assays for the assessment of (xeno-)estrogenic compounds in the aquatic environment" 
by Juliette Legler, Wageningen, February 27,2001. 
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Chapter 1 
General Introduction 
The research presented in this thesis describes the development of new bioassays to determine 
the exposure to and early effects of substances with an estrogenic mode of action. An in vitro 
reporter gene assay using a human breast cancer cell line, and an in vivo reporter gene assay 
using stably transformed (transgenic) zebrafish, were developed. Special emphasis was placed 
on application of the assays to environmental mixtures to monitor levels of biologically active 
estrogenic substances in the aquatic ecosystem. 
Chapter 1 
Endocrine disruption: a "stolen future"for humans and wildlife? 
In 1992, Carlsen, Skakkebaek and colleagues published a controversial study 
reporting that a significant, worldwide decrease in sperm quality has occurred over the past 50 
years. In addition to decreased sperm counts, increased incidence of testicular cancer and 
cryptorchidism were reported (Giwercman et al., 1993). Evidence in wildlife species that 
deleterious effects on male reproductive health were occurring also mounted. In Florida 
panthers, males were found with low sperm counts and cryptorchidism (Facemire et al., 
1995). Male alligators in Lake Apopka in Florida demonstrated an array of reproductive 
abnormalities, including reduced penis size, abnormal testis morphology and abnormal 
testicular steroidogenesis (Guillette et al., 1994). In seagulls, altered sex ratio and 
feminization of sexual behaviour in males was observed (Fry and Toone, 1981). Wild male 
fish captured in waters receiving sewage effluents showed feminized gonads and production 
of a yolk protein, which normally is produced in females (see below). These alarming reports 
lead to the hypothesis that declines in sperm counts and related disorders of the male 
reproductive system in both humans and wildlife could have arisen because of exposure of the 
developing fetus or during neonatal life to estrogens (Sharpe and Skakkebebaek, 1993; 
Colborn et al., 1993). One potential source of increased estrogen exposure was via chemicals 
in the environment that can mimic natural estrogens, the so-called xeno-estrogens. The term 
"endocrine disruption" was born. Endocrine disruption has been officially defined as process 
by which an exogenous substance "causes adverse health effects in an intact organism or its 
progeny consequent to changes in endocrine function" (European Commission, 1996). This 
wide definition includes not only the estrogenic substances, but also all substances that can 
effect endocrine function via interference with hormone (e.g. androgen, thyroid, retinoid or 
progesterone) pathways. 
The reports of endocrine disruption in humans and wildlife (recently reviewed by 
Golden et al., 1998; Tyler et al, 1998; Vos et al, 1999) did not go unnoticed by the media 
and resulted in a shock-wave of concern in the general public. Numerous newspaper articles 
as well as television reports (e.g. the BBC documentary "Assault on the Male" in 1993) raised 
public awareness, culminating in 1996 with the publication of the book "Our Stolen Future" 
by Colborn and colleagues. In response to the heightened public concern, research efforts 
were launched internationally to test the hypothesis that environmental chemicals can disrupt 
male reproductive function. In fact, very little evidence actually existed to unequivocally 
demonstrate that environmental substances can interfere with endocrine processes, with the 
exception of the effects of DES on male offspring (reviewed by Cheek and Maclachan, 1998). 
Regulatory agencies worldwide, including the European Chemical Industry Council (CEFIC), 
the Organization of Economic Cooperation and Development (OECD) and the U.S. 
Environmental Protection Agency, launched ambitious programs to test existing and new 
chemicals for their potential to disrupt endocrine systems. In The Netherlands, The Health 
Council published advisory reports on the effects of endocrine-disrupting chemicals in 
humans (Health Council, 1997) and ecosystems (Health Council, 1999), and a Netherlands 
Research Platform on Endocrine-Disrupting Compounds (Vethaak et al, 2000a) was initiated. 
One general theme has arisen from these regulatory initiatives; there is a definite need for the 
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development of rapid new biologically relevant methods to test chemicals for endocrine-
disrupting potential (see below). 
Evidence of estrogenic substances in the aquatic environment 
One of the most convincing lines of evidence for endocrine disruption stems from 
effects observed in the aquatic environment. In wild fish populations, intersex (defined as the 
simultaneous presence of both male and female gonadal characteristics) and testis 
abnormalities have been found in a high proportion of male fish sampled in rivers, estuaries 
and coastal waters in the U.K. (Jobling et al., 1998; Lye et al., 1997; Allen et al, 1999) as 
well as in localized freshwater sites in The Netherlands (Vethaak, 2000). The observed effects 
on male fish gonads have been associated with exposure to environmental levels of natural, 
synthetic and xenobiotic chemicals (collectively, "(xeno-)estrogens") in the aquatic 
environment that can mimic the action of the female hormone estrogen, thereby disturbing 
endocrine balance and causing feminising effects in the developing male gonads. 
Accordingly, male rainbow trout maintained in waters receiving wastewater treatment plant 
(WTP) effluents synthesized high levels of the estrogen-inducible yolk precursor protein 
vitellogenin (VTG) (Purdom et al., 1994; Harries et al., 1996) and had smaller testis than 
those of fish collected from reference sites (Harries et al., 1997). Laboratory exposure to 
(xeno-)estrogenic compounds has resulted in induced VTG (Jobling et al., 1996; Routledge et 
al, 1998), inhibited testicular growth (Jobling et al., 1996; Panter et al, 1998), testis 
abnormalities (Miles-Richardson et al, 1999) and formation of intersex gonads (Gimeno et 
al, 1996; Gray and Metcalfe 1997), suggesting that indeed feminization offish in the wild 
may be caused by (xeno-)estrogens. 
Role of estrogens in mammalian and fish physiology 
Estrogens are steroid hormones made primarily in the female ovaries. Estrogens are 
found in greater amounts in females than males and are thus referred to as the female 
hormones. In all vertebrates, estrogens play an important role in many reproductive and 
developmental processes as they influence growth, development and behaviour (puberty), 
regulate reproductive cycles (menstruation, pregnancy) and affect many other body parts 
(bones, skin, arteries, the brain). Recently, estrogens have been shown to be essential for male 
fertility as well (Hess et al, 1997). 17(3-estradiol (E2; structure pictured in Figure 1) is the 
major endogenous estrogen. 
In fish, steroid hormones are important for the sexual differentiation of the gonads, 
though the mechanisms by which sexual development is controlled have not been clearly 
elucidated. The critical role of steroids is suggested by the observation that the expected 
sexual phenotype (based on genotype) can be reversed by the administration of exogenous 
androgens or estrogens during the labile period of sexual development. Indeed, the 
administration of estrogens during the sexual differentiation of male fish results in varying 
degrees of intersex in a variety of fish species (Yamamoto, 1969; Hunter and Donaldson, 
1983). In addition to their role in influencing sexual differentiation, estrogens play a crucial 
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role in the synthesis of the yolk-precursor protein vitellogenin in fish. Increasing E2 
concentrations during sexual maturation of female fish stimulates the synthesis of vitellogenin 
by the liver, which in turn is take up growing ooctyes and stored as yolk (Sumpter and 
Jobling, 1995). 
17P-estradiol 17a-ethynylestradiol 
4-nonylphenol o.p'DDT 
Di(2-Ethylhexyl) phthalate Bisphenol A 
Figure 1: Structures of natural, synthetic and xenobiotic estrogenic chemicals. 
Cellular mechanism of action of estrogens 
Estrogens are transported through the blood mainly bound to sex hormone binding 
globulins. Free, non-bound estrogens can exert their action through diffusing through cell 
membranes and binding estrogen receptors (ER). In addition to the two known ER subtypes 
(ERa and ERP), recently a third form was identified in the marine fish Atlantic croaker (ERy; 
Hawkins et al., 2000). These three ER subtypes differ in amino acid sequence, as well as 
tissue distribution, ligand binding affinities and transactivation properties. ERs are found in 
many tissues, including reproductive organs and accessory sex organs, brain, bone and liver. 
Inactive ERs exist in large complexes associated with heat shock proteins (Figure 2). Upon 
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binding of estrogens to the ER, the heat shock proteins disassociate, inducing a 
conformational change that activates the receptor. Following dimerization of two ER-ligand 
complexes, binding to estrogen response elements (ERE) of genes in the nucleus takes place. 
This binding stabilises the binding of transcription factors involved in gene activation and 
transcription (Figure 2). Gene transcription can be modified by cellular coactivators, 
repressors and modulators (Stoney, 1996). Following transcription, mRNA is translated into 
protein by ribosomes. By inducing the synthesis of new proteins that alter cellular functions, 
estrogens can have profound effects on cell function and physiology (Ing and O'Malley, 
1995). 
hormone 
Binding to DNA 
£&-
HRE | TATA 
Transactivation 
Transcription 
NUCLEUS 
Figure 2: The mechanism of steroid hormone receptor action in the cell. Inactive 
receptors are associated with heat shock proteins (hsp). Hormones freely enter the cell and 
bind to inactive receptor, inducing hsp dissociation and conformational change. Activated 
dimers bind to hormone response elements (HRE) of genes in the nucleus. Transcriptional 
factors (B,D,E,F) and RNA polymerase II (Pol II) are recruited for transcription. Messenger 
RNA is subsequently translated into proteins. These new proteins may alter cell function and 
physiology (adapted from Ing and O'Malley, 1995). 
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Natural, synthetic and xeno-estrogens 
In addition to the endogenous estrogens such as estradiol, estrone and estriol, other 
compounds found in the environment can mimic estrogens by binding to estrogen receptors 
and influence estrogen signalling pathways. These compounds include natural chemicals such 
as the mycoestrogens and phytoestrogens, as well as synthetic estrogens such as the anti-
conception pill component ethynylestradiol (pictured in Figure 1) and a number of xenobiotic 
chemicals (xeno-estrogens). Some examples of xeno-estrogenic compounds are given in 
Figure 1, and include the organochlorine pesticide o.p'DDT, the industrial surfactant 4-
nonylphenol, plasticizers such as di-(2-ethylhexyl)phthalate (DEHP) and Bisphenol A, a 
compound used in the manufacture of polycarbonate. Some compounds have also been 
identified with an anti-estrogenic mode of action; that is, they can block, prevent and/or alter 
binding to estrogen receptors. More detailed lists of phyto- and mycoestrogens, as well as 
suspected xeno-estrogenic chemicals are provided in Colborn et ah, 1993 and Tyler et al, 
1998. Recently, the Health Council of The Netherlands reported 34 groups of (xeno-) 
estrogenic chemicals as potential hormone disruptors which may form a risk for ecosystem 
health in the Netherlands (Health Council, 1999). 
Bioassays for the detection of biologically active (xeno-)estrogens 
The large difference in chemical structures of xeno-estrogenic compounds makes 
prediction of estrogenic activity based on structure difficult. However, xeno-estrogens share a 
common mechanism of action, namely binding to the estrogen receptor and induction of the 
ER signal transduction pathway. They also share a common estrogen-mediated biological 
effect in an intact organism, such as feminization of male gonads or effects on reproduction. 
Biological test systems or "bioassays" which make use of this common mechanism of action 
can provide a very useful means of measuring the biological potency of a suspected (xeno-) 
estrogen or mixture of xeno-estrogens. 
A number of in vitro bioassays have been developed to screen substances for (anti-) 
estrogenicity, including competitive ligand binding assays, cell proliferation assays, 
recombinant receptor/reporter gene assays (see review by Zacharewski, 1997). However, 
most of these assays suffer from a number of drawbacks that limit their usefulness as a screen 
for (anti-)estrogenic activity (Zacharewski, 1997). However, recombinant reporter gene 
assays based on stably transfected cell lines can provide one of the most specific, responsive 
and biologically relevant means to screen substances for potential anti-estrogenic as well as 
estrogenic effects with a high throughput potential. This type of assay is based on the 
receptor-mediated mechanism of action of estrogens and reporter gene expression is a 
culmination of the molecular cascade of events involved in receptor transactivation. The 
stably transfected Ah receptor-mediated CALUX (chemical activated luciferase gene 
expression) assay is an example of an in vitro reporter gene assay that has been developed as 
a sensitive and rapid method to determine the potency of individual congeners and mixtures 
of dioxin-like compounds in environmental matrices (Murk et ah, 1996). 
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Despite the usefulness of in vitro reporter gene assays as tools to rapidly identify 
(mixtures of) substances with estrogenic potency, prediction of effects of a suspected estrogen 
in an intact organism is difficult. This is a consequence of the lack of toxicokinetics in the in 
vitro system. For this reason, the use of in vivo bioassays has been widely recommended to 
determine the biological effects of (xeno-)estrogenic compounds (Kavlock et al., 1996; 
Ankley et al, 1998). To assess effects of (xeno-)estrogenic compounds in the aquatic 
ecosystems, the use of bioassays with fish are warranted. In vivo bioassays with teleost fish, 
including short-term lethality, early life-stage and partial and full life-cycle studies, are 
already required for regulation purposes by various national and international regulatory 
agencies, such as the Organization of Economic Cooperation and Development. Because 
these bioassays can be relatively non-specific in terms of an estrogenic mechanism of action, 
a number of test systems have been developed to more specifically detect estrogen disrupting 
chemicals. These included vitellogenin induction, binding of chemicals to fish receptors, or 
alterations in sexual differentiation (reviewed by Ankley et al., 1998). Some of the 
disadvantages of these estrogen-specific assays is that they require species-specific antibody 
development (in the case of vitellogenin), long term exposure regimes, or histopathological 
expertise. No in vivo bioassays exist to rapidly determine the exposure and effects of (xeno-) 
estrogens in sensitive target tissues and critical life stages of fish. 
Outline of thesis 
The aim of the research described in this thesis is to develop and apply novel 
bioassays to rapidly detect chemicals with an estrogenic mode of action. These bioassays 
were developed to determine the presence of biologically active (xeno-)estrogens in the 
environment and the estrogenic effects of such exposure on aquatic organisms. Two new 
bioassays were developed: an in vitro estrogen receptor-mediated chemical activated 
luciferase gene expression (ER-CALUX) assay; and an in vivo reporter gene assay using 
transgenic zebrafish. In both assays, an estrogen-responsive luciferase reporter gene has been 
stably introduced. Exposure of cells or transgenic zebrafish to (xeno-)estrogens which have 
an estrogenic mode of action results in reporter gene induction which can be easily measured 
in cell/tissue lysates. 
The development of the ER-CALUX assay is described in Chapter 2. The 
characterization of the ER-CALUX assay using a range of natural, synthetic and xeno-
estrogens is shown in Chapter 2-4. Complex mixtures of (xeno-)estrogens as present in 
sediments (Chapter 3 and 4), water and biota (Chapter 4) and WTP effluent (Chapter 6) from 
various locations in The Netherlands were tested for total biologically active estrogenic 
potency. In addition, the ER-CALUX assay was applied to determine estrogenic potency of 
(metabolites of) human urine and male fish bile as a possible biomarker for internal dose of 
(xeno-)estrogens (Chapter 4). 
The development of the transgenic zebrafish assay as a rapid in vivo test system for 
(xeno-)estrogens is described in Chapter 5. The zebrafish, Danio rerio, was chosen as a model 
fish species because it has been widely used for toxicological research for decades (reviewed 
in Laane et al., 1977; Lele and Krone, 1996). This small tropical cyprinid was ideal for this 
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study because it has a short life cycle and provides large number of eggs. In addition, the 
genetics underlying zebrafish development and reproduction have been well documented 
(reviewed by Haffter and Nusslein-Volhard, 1996). Transgenic zebrafish had been already 
produced at the moment of start of this project (Stuart et al., 1988, reviewed in Lele and 
Krone, 1996; for recent reviews, see Jowett, 1999, Meng et al., 1999), although the technique 
was still poorly developed. In order to determine critical life stages and sensitive target tissues 
in (xeno-)estrogen responsive transgenic zebrafish, luciferase reporter gene induction was 
studied in various stages of development as well as in tissues of adult zebrafish following 
short term (xeno-)estrogenic exposure (Chapter 5). In addition, the expression of ER a and P 
mRNA during developmental stages and in various tissues was studied and related to 
luciferase induction (Chapter 5). 
In Chapter 6, both the ER-CALUX assay and transgenic zebrafish assay were applied 
to determine estrogenic potency in WTP effluents, as well as a small panel of (xeno-) 
estrogens. The differences in response to (mixtures of) (xeno-)estrogens between the in vitro 
and in vivo assay were elucidated and discussed (Chapter 6). 
In Chapter 7, the perspectives for the use of the newly developed bioassays in the 
field of environmental toxicology are discussed. The possible impacts of current levels of 
(xeno-)estrogens in the Dutch aquatic environment as measured with the newly developed 
bioassays are also discussed. 
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Development of a stably transfected 
estrogen receptor-mediated 
luciferase reporter gene assay 
in the human T47D breast cancer cell line 
Toxicological Sciences 48,55-66, 1999 
Juliette Legler1, Christine E. van den Brink2, Abraham Brouwer1, Albertinka J. Murk1, Paul T. 
van der Saag2, A. Dick Vethaak3 and Bart van der Burg2 
'Division of Toxicology, Wageningen University, The Netherlands, 2Hubrecht Laboratory, Netherlands 
Institute for Developmental Biology, Utrecht, The Netherlands, 'Ministry of Transport, Public Works 
and Water Management, National Institute for Coastal and Marine Management, Middelburg, The 
Netherlands 
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Abstract 
Development of an estrogen receptor-mediated chemical activated luciferase reporter gene 
expression (ER-CALUX) assay was attempted by stable transfection of luciferase reporter 
genes in a number of cell lines. Stable transfection of the chimeric Gal4 estrogen receptor and 
luciferase gene constructs in MCF-7 breast cancer and Hepa.lclc7 mouse hepatoma cell 
lines, as well as transfection of a newly constructed luciferase reporter gene pEREtata-Luc in 
the ECC-1 human endometrial cell line, resulted in constitutive, non-estradiol inducible 
clones. Stable transfection of pEREtata-Luc in the T47D breast cancer cell line, however, 
resulted in an extremely sensitive, highly responsive cell line. Following 24 hour exposure to 
estradiol (E2), stably transfected T47D.Luc cells demonstrated a detection limit of 0.5 pM, an 
EC50 of 6 pM and a maximum induction of 100-fold relative to solvent controls. No clear 
reduction in responsiveness has been found over extended culture periods (50 passages). Anti-
estrogens ICI 182,780, TCDD and tamoxifen inhibited the estradiol-mediated luciferase 
induction. Genistein, nonylphenol and o.p'DDT were the most potent (pseudo-)estrogens 
tested in this system (EC50 100, 260 and 620 nM, resp.). Determination of interactive effects 
of the (pseudo-)estrogens nonylphenol, o,p'DDT, chlordane, endosulfan, dieldrin and 
methoxychlor revealed that, in combination with 3 pM E2, pseudo-estrogens were additive. 
Slightly more than additive effects (less than 2-fold) were found for combinations of dieldrin 
and endosulfan tested in the range of 3 to 6 uM. At these concentrations, the combination of 
endosulfan and chlordane demonstrated additive interaction. The ER-CALUX assay with 
T47D cells can provide a sensitive, responsive and rapid in vitro system to detect and measure 
substances with potential (anti-)estrogenic activity. 
Introduction 
An increasing number of reports that chemicals in the environment may mimic the natural 
hormone estrogen, thereby disrupting normal endocrine function, have raised public concern 
and resulted in a rapidly growing research effort. It has been hypothesized that increased 
incidence of hormone-sensitive cancers, decreased sperm counts in humans and compromised 
gonadal functionality in wildlife may be due to exposure to substances possessing estrogenic 
activity (reviewed by Colborn et al., 1993). An ever-growing list of environmental, industrial, 
natural and pharmaceutical chemicals have been identified as potentially estrogenic. Many of 
these chemicals, defined as "estrogenic", have structures that deviate considerably from the 
natural steroid hormone 17[3-estradiol, but can nevertheless evoke effects via the estrogen 
receptor signal transduction pathway. The effects of estrogens are mediated via binding with 
high affinity to a specific estrogen receptor (ER), a member of the nuclear receptor 
superfamily (Evans, 1988). In addition to the "classical" ERcc form, recently a second ER 
form (ER(3) has been identified that has high homology with ERa but shows a different tissue 
distribution, ligand binding potential and trancriptional activity (Mosselman et al., 1996; 
Kuiper et al., 1996; 1997; 1998). Estrogen freely enters the cell and binds to the ER, inducing 
heat shock protein 90 dissociation and homodimerization (Figure 1). The homodi'mer complex 
binds to specific DNA sequences called estrogen response elements (ERE) within regulatory 
Development ofER-CALUX assay 
regions of estrogen-responsive genes. Transcription is induced and messenger RNA is 
translated into protein. The synthesis of these new proteins can alter cellular functions and 
result in profound effects on physiology (Ing and O'Malley, 1995). In females, estrogen is 
essential for the development of secondary sex characteristics, the reproductive cycle, fertility 
and maintenance of pregnancy. Recently, estrogens have been shown to be essential for male 
fertility as well (Hess et al., 1997). 
estrogens CELL 
\ _ 
Estrogen Receptor 
o 
(§)-— @|D , 
Activated Dirrjerization 
Receptor 
NUCLEUS 
Translocation 
ERE gene 
Binding to DNA 
rranscriptior)) 
pERE-tata-Luc ^ C ™ ^ > 
O o Luciferase 
altered cell functions/physiology 
Figure 1: Mechanism of estrogen action in stably transfected T47D.Luc cells. (Pseudo-) 
estrogens enter the cell and bind to and activate the estrogen receptor (ER). Following 
dimerization, the ER-ligand dimer translocates to the cell nucleus and binds to estrogen 
response elements (ERE) upstream of genes or present on pEREtata-Luc construct. 
Transcription and translation of proteins (including luciferase) is induced. 
A number of in vitro assays have been developed to screen substances for (anti-)estrogeni-
city (see review by Zacharewski, 1997). These assays include competitive ligand binding 
assays (Korach et al., 1978; Berthois et al., 1986; Migliaccio et al., 1992), cell proliferation 
assays (Soto et al., 1995), recombinant receptor/reporter gene assays (Pons et al., 1990; 
Jausons-Loffreda et al., 1994) and yeast-based screens for estrogens (Connor et al., 1995; 
Arnold et al., 1996; Routledge and Sumpter, 1997). However, most of these assays suffer 
from a number of drawbacks that limit their usefulness as a screen for (anti-)estrogenicity. 
Competitive ligand binding assays for the estrogen receptor are limited because they cannot 
distinguish between estrogenic and anti-estrogenic substances and do not provide insight into 
a substance's ability to initiate the molecular cascade of events leading to altered gene expres-
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sion. Cell proliferation assays are limited by a lack of specificity as mitogens other than 
estrogens are able to influence the proliferation of human breast cancer cells (van der Burg et 
al, 1988; Dickson and Lippman, 1995). Yeast-based assays are simple and sensitive, however 
drawbacks include lack of responsiveness to anti-estrogens (Lyttle et al., 1992; Kohno et al., 
1994) as well as possible differences in permeability of compounds through the yeast cell wall 
relative to mammalian cell membranes. 
In comparison to other existing in vitro assays, we believe recombinant receptor and 
reporter gene assays based on stably transfected cell lines can provide one of the most speci-
fic, responsive and biologically relevant means to screen substances for potential anti-estro-
genic as well as estrogenic effects with a high throughput potential. This type of assay is 
based on the receptor-mediated mechanism of action of estrogens and reporter gene expres-
sion is a culmination of molecular cascade of events involved in receptor transactivation. To 
our knowledge, only two estrogen-responsive cell lines stably transfected with recombinant 
receptor and/or reporter genes have previously been developed. Pons and coworkers devel-
oped a MCF-7 cell line stably transfected with the pVit-tk-Luc construct which consists of the 
Xenopus laevis vitellogenin A2 promoter region containing one estrogen response element 
upstream of the Herpes simplex virus thymidine kinase promoter controlling expression of the 
firefly luciferase gene (Pons et al, 1990). A HeLa cell line stably transfected with a Gal4-
regulated chimeric estrogen receptor and luciferase reporter gene constructs has also been 
developed (Jausons-Loffreda et al., 1994). In both stably transfected cell lines, however, only 
modest sensitivity and responsiveness to estradiol has been reported. 
Recently in our laboratories, stably transfected CALUX (chemical activated luciferase 
gene expression) cell line assays have been developed as a sensitive and rapid method to 
determine the potency of individual congeners and mixtures of dioxin-like compounds (Aarts 
et al, 1995; Garrison et al., 1996; Murk et al., 1996). These cell lines express endogenous 
aryl hydrocarbon (Ah) receptor and are stably transfected with a dioxin-responsive luciferase 
reporter gene. In the present study we attempted to develop new, highly responsive stably 
transfected estrogen receptor-mediated ER-CALUX cell lines for the assessment of (anti-
estrogenic substances. ECC-1 human endometrial carcinoma and T47D human breast adeno-
carcinoma cells expressing endogenous estrogen receptor were stably transfected with a 
newly constructed estrogen-responsive luciferase reporter gene, pEREtata-Luc. This construct 
consists of three estrogen response elements upstream of a TATA box regulating expression 
of an enhanced luciferase reporter gene construct. Hepa.lclc7 mouse hepatoma and MCF-7 
human breast adenocarcinoma cells were stably transfected with the chimeric receptor and 
reporter gene constructs Gal4-HEGO and 17m5-G-Luc. Stable transfection of pEREtata-Luc 
in T47D cells resulted in a sensitive, highly responsive clone which was further characterized 
in dose-response studies with estradiol as well as some known estrogenic and anti-estrogenic 
substances. 
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Materials and Methods 
Chemicals 
17P-estradiol (E2, 99%), methoxychlor (95%), tamoxifen (99%), genistein (99%), al-trans 
retinoic acid and ethanol (100%, p.a.) were purchased from Sigma Chemicals Co. 4-
nonylphenol (92.7%) was purchased from Fluka. Bisphenol A (99%) was purchased from 
Aldrich. Chlordane (97.7%), endosulfan (99%) and dieldrin (98.5%) were purchased from 
Riedel-de Haan, The Netherlands. ICI 182, 780 was a kind gift from Dr. A. Wakeling, 
Zeneca Pharmaceuticals, U.K. o,p'DDT and tetrachlorodibenzo-p-dioxin (TCDD) were 
kindly provided by the Dutch State Institute for Quality Control of Agricultural Products 
(RIKILT-DLO). The synthetic progestin Org 2058 was a gift from Organon 3.V., Oss, The 
Netherlands. The synthetic androgen R1881 (methyltrienolone) was purchased from NEN 
(Boston, U.S.A.) and kindly provided by Dr. A. Brinkman, Erasmus University, Rotterdam. 
For exposure of cells, all chemicals were dissolved in ethanol or dimethyl sulfoxide (DMSO, 
99.9%, spectrophotometric grade, Acros). Antibiotics used for selection of stable clones 
(puromycin, hygromycin and G418) were purchased from Duchefa, The Netherlands. 
Cell culture 
The T47D human breast adenocarcinoma cell line was kindly provided by Dr. R.L. Suther-
land (Garvan Institute of Medical Research, Sydney, Australia). The T47D cells were cult-
ured in a 1:1 mixture of Dulbeccos's modified Eagle's medium and Ham's F12 medium (DF, 
Gibco) supplemented with sodium bicarbonate, non-essential amino acids, sodium pyruvate 
and 7.5% fetal calf serum (FCS, Integro, Austria). T47D cells were cultured at 37°C, 7.5% 
CO2. The ECC-1 human endometrial carcinoma cell line was a kind gift from Dr. P.G. 
Stayaswaroop (Pennsylvania State University, U.S.A). ECC-1 cells were cultured in RPMI 
(Gibco) supplemented with 1 ng/ml insulin and 5% FCS (Sigma). The MCF-7 human breast 
cancer cell line was acquired from the American Type Culture Collection (ATCC, USA). The 
Hepa lclc7 mouse hepatoma cell line was kindly provided by Dr. J.P. Whitlock, Jr. (Stanford 
University, U.S.A.) The MCF-7 and Hepa cell lines were cultured according to Zacharewski 
et ai, 1995 in phenol red-free Dulbecco's minimal essential medium (DMEM, Gibco) supple-
mented with 10% FCS. ECC-1, MCF-7 and Hepa cells were cultured at 37°C, 5% C02. 
For ER-CALUX assays, T47D, MCF-7 and Hepa cells were maintained in assay medium 
without phenol red supplemented with 5% dextran-coated charcoal treated FCS (DCC-FCS). 
DCC-FCS was prepared by heat inactivation (30 minutes at 56°C) of FCS followed by two 
45-minute DCC treatments at 45°C as described by Horwitz and McGuire, 1978. ECC-1 cells 
were assayed in RPMI with phenol red supplemented with 5% DCC-FCS. 
Receptor and reporter gene constructs 
The reporter gene pEREtata-Luc was constructed using the enhanced luciferase reporter 
gene pGL3-basic (Promega, U.S.A.). Three tandem repeats of the consensus ERE oligo 
(GAGCTTAGGTCACTGTGACCT) upstream of the minimal human E,B TATA promoter 
sequence (GGGTATATAAT) were inserted in the Smal-Bgl II site of the multiple cloning 
site of pGL3-basic (Figure 2). 
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The Gal4-HEGO chimeric receptor and Gal4-regulated luciferase reporter gene 17m5-G-
Luc were kindly provided by Prof. P. Chambon, INSERM U184, Strasbourg, France. Gal4-
HEGO consists of the ligand binding domain of the ER linked to the DNA binding domain (1-
147) of the yeast transcription factor Gal4 (Green et al, 1988). The plasmid 17m5-G-Luc 
consists of luciferase cDNA regulated by the rabbit P-globin basal promoter and five tandem 
consensus Gal4 17-mer response elements (Jausons-Loffreda et al, 1994). For stable trans-
fection, a second 17m5 luciferase reporter gene (pl7m5-G-neo-Luc) was constructed by 
cloning the Pvul-EcoRV fragment of pMAMneo-Luc (ClonTech, U.S.A.) containing the 
sequence for neomycin (G418) resistance in the Pvul- EcoRV sites of pl7m5-G-Luc. 
Figure 2: Schematic representation of the pEREtata-Luc construct. Three estrogen 
response elements (ERE) upstream of a minimal E,B TATA promoter were inserted in the 
multiple cloning site (MCS) of the enhanced luciferase (luc+) vector pGL3-basic. 
For selection of stable transfected clones, the following selection plasmids were used: for 
puromycin selection, pPur (ClonTech, U.S.A.); for hygromycin selection. pGK-Hyg (Te Riele 
et al, 1990); and for G418 selection, pS V2-Neo (Hoglund et al., 1992). 
Stable transfection 
ECC-1, MCF-7andHepa.lclc7 cell lines 
Six-sixteen hours prior to transfection, ECC-1, MCF-7 and Hepa.lclc7 cells were seeded 
at 50% confluency in three wells of a 6-well plate in 3 ml culture medium per well. 
Transfection was carried out according to the calcium phosphate precipitation method 
(Sambrook et al, 1989). In ECC-1 cells, 4.65 mg pEREtata-Luc and 4.65 mg pPur was 
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transfected per well, using 250 ml Hepes-buffered solution (HBS, consisting of 42 mM 
Hepes, 275 mM NaCl, 10 mM K.C1, 1.4 mM Na2HP04, pH 7.05) and 250 ml 250 mM CaCl2 
per well. For MCF-7 and Hepa cells, cells were transfected with either 0.6 mg pGal4HEGO, 3 
mg pl7m5-G-Luc and 1.5 mg pSV2Neo or 0.6 mg pGaWHEGO and 3 mg pl7m5-G-neo-Luc. 
After 24 hours, the cells were trypsinized and per well distributed over five 100 mm petri 
dishes. Medium was replaced every three days with culture medium containing 1 mg/ml 
puromycin (ECC-1 cells) or 1000 mg/ml G418 (MCF-7 and Hepa cells) until clones formed 
which were large enough to isolate (about two to three weeks). 
Luciferase positive clones were screened using a single photon detecting camera 
(Argus 50, Hatamatsu) according to the method described by Pons et ai, 1990. Briefly, clones 
in 100 mm dishes were exposed for 24 hours to 10 nM E2. Luciferin (0.3 mM) was added to 
the culture medium and dishes were immediately introduced into the dark room of the single-
photon counting camera for luminescence measurement. Light intensity was monitored for 5 
to 10 minutes per dish. The image of the luminescent cells was superimposed on to the light 
field image of the dishes, enabling identification of positive clones. Positive clones were 
isolated using cloning rings and further cultured in 24 well plates. 
To test for luciferase induction, clones were trypsinized and seeded over 3 wells in a white 
96-well viewplate (Packard) in assay medium. Following 24 hour incubation, cells were 
exposed for 24 hours to control (0.5% DMSO), 10 nM E2 and 10 nM ICI 182,780. Cells 
were rinsed twice with 50 ml 0.5x phosphate buffered saline (PBS). Low salt (LS) buffer 
containing 10 mM Tris pH 7.8, 2 mM DTT, 2 mM 1,2 diaminocyclohexane-N,N,N',N'-
tetraacetic acid was added at a volume of 20 ml per well. Following 10 minute incubation on 
ice, 96 well plates were frozen at -80°C for a minimum of 30 minutes to lyse cells. The plates 
were thawed on ice and shaken for 5 minutes at room temperature. Luciferase activity was 
measured in 96 well viewplates in a luminometer (Labsystems Luminoscan RS) with 
automatic injection of 100 ml luciferin "flashmix" containing 470 mM luciferin, 20 mM 
tricine, 1.07 mM (MgCO3)4Mg(OH)2.5H20, 2.67 MgS04, 0.1 mM EDTA, 5 mM ATP, 2 
mM DTT, pH 7.8 per well. 
pEREtata-Luc in T47D cell line 
Two days prior to transfection, T47D cells were plated at a density of 250 000 cells in 5 
cm petridishes in 5 ml culture medium. Per dish, 18 mg pEREtata-Luc and 2 mg pGK-Hyg 
was transfected using the calcium phosphate precipitation method described above. Cells 
were incubated with transfection mixture for 8 hours, after which the medium was renewed. 
The following day, the cells were trypsinized and plated over four 5 cm dishes per dish in 
culture medium supplemented with 100 mg/ml hygromycin (selection medium). Clones were 
allowed to grow for 10 days, during which time the selection medium was renewed every two 
to three days. Dishes containing 10-15 large colonies were trypsinized for 1-3 minutes at 
room temperature. Individual clones were resuspended in 2 ml medium and added to 24 well 
plates containing 2 ml selection medium. Smaller clones were left an extra 2 weeks to grow 
and isolated in the same manner. To test for luciferase induction, confluent 24 wells were 
trypsinized and one 96 well per clone was seeded in culture medium and incubated for 24 
hours. Non-transfected T47D cells were used as control. Medium was removed and cells were 
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lysed in 55 ml triton-lysis buffer containing 1% triton X-100, 25 mM glycylglycin, 15 mM 
MgS04, 4 mM EGTA (pH 7.8) and 1 mM DTT. A 50 ml portion of cell lysate was 
transferred to a black 96 well plate (Packard) to which 50 ml luciferine substrate (LucLite 
reporter gene assay kit, Packard) was added. Luciferase activity was measured in a 
scintillation counter (Packard Top Count) for 0.1 minute per well. 
ER-CAL UK assay procedure 
T47D cells stably transfected with pEREtata-Luc from the most responsive clone were 
plated in 24 well plates at a density of 50 000 cells in 0.8 ml DF without phenol red + 5% 
DCC-FCS (assay medium) per well or in black 96 well viewplates (Packard) at a density of 
5000 cells per well in 0.1 ml assay medium. Following 24 hours incubation, cells were 
approximately 50% confluent. Assay medium was renewed and the cells were incubated 
another 24 hours. The medium was then renewed again and the cells were dosed in triplicate 
in 24 well plates by direct addition of the chemical to be tested dissolved in ethanol or DMSO 
to the medium above cells. For 96 wells plates, assay medium containing chemicals was first 
prepared in 0.8 ml assay medium in 48 well plates, mixed well, and transferred to the 
microtiter plate at a volume of 0.1 ml per well. In addition to one E2 standard curve in 
triplicate per experiment, control wells, solvent control wells and E2 calibration points (6 pM 
and 30 pM) were included in triplicate on each plate. The maximum solvent concentration 
used was 0.2%. Cells were dosed for 24 hours prior to luciferase measurement. For 24 well 
plates, medium was removed, and the cells were lysed in 100 ml triton-lysis buffer. Lysis was 
carried out by gentle shaking at 4CC for a minimum of one hour. A 50 ml sample of the cell 
lysate was then transferred to a black 96-well plate, 50 ml luciferin substrate was added and 
the luciferase activity was assayed in a scintillation counter for 0.1 minute per well. For 96 
well viewplates, 50 ml LucLite was added directly to the medium above cells and the plates 
were shaken gently for 10 minutes at room temperature to stimulate cell lysis. The transparent 
bottom of the viewplates was covered by a black sticker prior to luciferase measurement in a 
scintillation counter (Packard Top Count). 
Potential cytotoxicity of pseudo-estrogens was controlled by microscopic visualization of 
the cells. In addition, a "CytoLite" (Packard) luminescent, non-separation assay kit for the 
determination of viable cell numbers was used according to manufacturer's specifications in 
black 96-well viewplates. T47D.Luc cells were seeded and exposed to pseudo-estrogens in 
the same manner as outlined in the ER-CALUX assay procedure. 
Data and statistical analysis 
To determine the EC50 and detection limit of E2 in the ER-CALUX assay, a complete 
standard curve was included in each assay. The standard curve was fitted (sigmoidal fit, 
function: y=ao+ai/(l+exp(-(x-a2)/a3)) using SlideWrite 3.0 for Windows, which determines 
the fitting coefficients by an iterative process minimizing the c2 merit function (least squares 
criterion). The EC50 for E2 and pseudo-estrogens was calculated by determining the concen-
tration at which 50% of the maximum luciferase activity was reached using the sigmoidal fit 
equation. The detection limit was calculated as the luciferase activity elicited by the solvent 
control plus three times the standard deviation. 
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In order to determine estradiol equivalents (EEQs), the luciferase response by (combinati-
ons of) pseudo-estrogens was interpolated in the linear range of the corresponding E2 
standard curve for the same assay. Data shown are representative of a minimum of two 
independent assays. Statistical analysis was performed on luciferase activity by combinations 
of pseudo-estrogens as compared to the arithmetic sum of luciferase activity by individual 
compounds using ANOVA (oc=0.01) in SPSS Version 6.0 for Windows. Standard deviation 
around the arithmetic sum was calculated by taking the square root of the pooled variance of 
the luciferase activity by the two individual compounds. 
Results 
Stable transfection of reporter genes in ECC-1, MCF-7 and Hepa cell lines 
Following transfection of the pEREtata-Luc reporter gene plasmid in ECC-1 cells and 
selection with puromycin, 23 luminescent clones were identified using the single photon 
counting camera. However, exposure of these clones to 10 nM E2 resulted in no inducible 
luciferase activity. Luciferase expression in the clones appeared to be constitutive. Similar 
results were obtained with Hepa.lclc7 cells transfected with the chimeric receptor and 
reporter gene constructs pGal4-HEGO and pl7m5-G-Luc and selected with G418. Fifteen 
luminescent clones were identified with the photon-counting camera, of which only one 
demonstrated estradiol-inducible luciferase expression. This clone showed a 5-fold increase in 
luciferase activity relative to background following 24 hour exposure to 10 nM E2. In subse-
quent assays, however, luciferase activity decreased to three times control levels, suggesting 
that integration was unstable (data not shown). In Hepa cells transfected with pGal-HEGO 
and pl7m5-G-neo-Luc, all 12 luminescent clones showed constitutive, estradiol-independent 
luciferase expression. Three separate attempts to stably transfect the chimeric constructs in 
MCF-7 cells with different concentrations of G418 selection resulted in the formation of 
unstable clones which ultimately died. 
Stable transfection of pEREtata-Luc in T47D cells 
A total of 72 T47D clones were isolated and tested for luciferase expression by 
comparison of activity (without estradiol stimulation) relative to non-transfected cells. Using 
this method, 28 clones were identified with luciferase expression more than 10-fold induction 
relative to non-transfected cells. Of these 28 clones, 22 were further characterized according 
to the ER-CALUX assay method in 24 well plates with exposure to 1 nM estradiol. Nine 
clones were found with greater than 10-fold induction relative to control. Clone ERE.Luc 
number 42 showed the highest induction and was used for further experiments with the ER-
CALUX method. 
ER-CALUX assay with stably transfected T47D cells 
Stable transfection of the pEREtata-Luc contract in T47D cells resulted in a sensitive, 
highly responsive cell line for the assessment of compounds with (anti-)estrogenic activity. 
As illustrated in Figure 1, using the ER-CALUX assay with T47D.Luc cells, substances can 
be tested for (anti-)estrogenicity based on their specific estrogen receptor mediated mecha-
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nism of action. Upon entering the T47D.Luc cell, substances with estrogenic activity will bind 
to the endogenous estrogen receptor and activate the receptor. The activated receptor dimer 
subsequently binds to estrogen response elements (EREs) upstream of the luciferase gene, 
leading to recruitment of transcription factors to the promoter and ultimately to luciferase 
gene expression (Figure 1). 
Response to estradiol 
The sensitivity and responsiveness of the ER-CALUX assay with the stably transfected 
T47D ERE.Luc 42 clone (T47D.Luc cells) was assessed by measuring the luciferase activity 
induced by E2 compared to solvent control over a period of 9 months in cells ranging from 
passage 9 to 48. Exposure of T47D.Luc cells to estradiol for 24 hours resulted in dose-respon-
se related luciferase induction as measured in both 24 well plates and 96 well plates (Figure 
3). In 24 well plates, averaged over 15 assays, 102 (±76) fold maximum induction relative to 
control was reached at 30 pM E2. A detection limit of 0.5 (±0.1) pM and an EC50 of 5.5 
(±1.8) pM was calculated. Using 96 wells plates, a similar EC50 and detection limit was 
measured in 6 experiments, though maximum induction at 30 pM E2 relative to control was 
less than in 24 well plates (average 76 (± 31) fold). No clear reduction in luciferase activity 
over prolonged periods of cell culture was found, demonstrating stable integration of the 
luciferase gene. 
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Figure 3: Luciferase induction by estradiol relative to solvent control in the ER-CALUX 
assay with T47D cells stably transfected with pEREtata-Luc plated in 24 (solid circles) or 96 
(open circles) well plates. Cells were treated with estradiol for 24 hours (n=3, avg ± std). 
26 
Development of ER-CALUXassay 
Response to other steroids and retinoic acid 
Because the T47D cell line expresses other hormone receptors, such as progesterone, 
androgen and retinoic acid receptors, we determined the potential effects of other endogenous 
ligands on the estrogen receptor mediated luciferase response. Luciferase activity in 
T47D.Luc cells was determined following 24 hour treatment with a synthetic progestin (Org 
2058), synthetic androgen (R1881) and retinoic acid. No luciferase activity was found by 
these ligands when tested in concentrations ranging from 1 pM to 10 nM (data not shown). 
Response to anti-estrogens 
Exposure of T47D.Luc cells to the pure anti-estrogen ICI 182,780 and the Ah receptor 
agonist TCDD at concentrations ranging from 0.01 to 1000 nM resulted in luciferase activity 
equal to or slightly less than control values (Figure 4). When tested in combination with the 
EC50 value (6 pM E2), ICI 182,780 completely inhibited luciferase activity at concentrations 
at or above 1 nM. TCDD was a potent antagonist when co-administered with 6 pM E2, as a 
concentration as low as 10 pM inhibited luciferase activity by 50% (Figure 4). Exposure of 
cells to tamoxifen alone at lower concentrations (< 100 nM) resulted in no luciferase activity, 
though tamoxifen was slightly estrogenic at 100 and 1000 nM (about 10% activity relative to 
6 pM E2) (Figure 4). Tamoxifen was far less anti-estrogenic when tested in combination with 
E2 than ICI 182, 780, as concentrations above 100 nM were necessary to inhibit the E2-
induced luciferase response by about 90%. 
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Figure 4: Luciferase activity (%) of anti-estrogens relative to estradiol (E2, 6 pNI) in the 
ER-CALUX assay. T47D.Luc cells were treated for 24 hours with tamoxifen (triangles), ICI 
182,780 (circles) and TCDD (diamonds). Anti-estrogens were tested with (solid lines) or 
without (dashed lines) co-administration of 6 pM E2 (n=3, avg ± std). 
27 
Chapter 2 
Response to pseudo-estrogenic compounds 
The specificity of the ER-CALUX assay was determined by testing the luciferase activity 
induced by a number of compounds previously shown in other in vitro assays to be estro-
genic. These compounds were also estrogenic when tested in T47D.Luc cells (Table 1). 
Genistein, nonylphenol and o,p'DDT were the most potent pseudo-estrogens tested (EC50 
100, 260 and 660 nM, resp.) (Table 1). With the exception of dieldrin and methoxychlor, all 
compounds tested at concentrations above 30 uM demonstrated cytotoxic effects (data not 
shown). The organochlorine pesticides tested induced luciferase in a dose-response related 
manner (Figure 5). A number of compounds, including nonylphenol, genistein, o,p'DDT, 
methoxychlor and bisphenol A, showed maximum luciferase activity exceeding that of 
estradiol at 30 pM, though at concentrations 3000 - 300000 times that of estradiol (Table 1). 
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Figure 5; Luciferase induction (%) of pesticides relative to 30 pM estradiol (E2) in 
the ER-CALUX assay. T47D.Luc cells were treated for 24 hours with o.p'DDT (DD), 
chlordane (CH), endosulfan (EN), dieldrin (DL) and methoxychlor (MX) (n=3, avg ± std). 
Combination effects of pseudo-estrogens 
Pseudo-estrogenic compounds were tested in combination with a low concentration of E2 
(3 pM) in order to determine potential interactive effects when tested in mixtures (Figure 6). 
All combinations tested showed additive luciferase activity, i.e. not significantly different 
than the arithmetic sum of the compounds tested individually. To determine interactive 
effects, the pseudo-estrogens endosulfan, dieldrin and chlordane were also tested together at 
concentrations eliciting luciferase activity within the lower linear range of the estradiol 
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Table 1: Potency of (pseudo-)estrogens relative to estradiol following 24 hour treatment 
in the ER-CALUX assay with T47D.Luc cells 
Natural hormone: 
Estradiol 
Pesticides: 
o,p'-DDT 
Methoxychlor 
Dieldrin 
Endosulfan 
Chlordane 
Industrial 
chemicals: 
4-nonylphenol 
bisphenol A 
Phytoestrogen: 
genistein 
LOEC 
(nM) 
0.0005 
100 
600 
1000 
1000 
1000 
100 
100 
100 
Relative 
potencyb 
(LOEC) 
5E-6 
8E-7 
5E-7 
5E-7 
5E-7 
5E-6 
5E-6 
5E-6 
EC50C 
(nM) 
0.006 
660 
5720 
24490 
5920 
6240 
260 
770 
100 
Relative 
potencyd 
(EC50) 
1 
9.1 E-6 
1.0 E-6 
2.4 E-7 
1.0 E-6 
9.6 E-7 
2.3 E-5 
7.8 E-6 
6.0 E-5 
Max. 
effect 
cone. 
(nM)c 
0.030 
10000 
30000 
60000 
10000 
10000 
1000 
10000 
1000 
% effect 
rel. to 
estradiol' 
100 
168 (2.0) 
167(12.9) 
104(11.8) 
59 (2.6) 
52 (4.5) 
135(1.3) 
153(2.3) 
127 (2.4) 
a
 low effect concentration; test concentration at which estrogenic effect is detected 
b
 ratio between dose of compound and that of estradiol needed to achieve an estrogenic effect 
' concentration at which 50% of maximum luciferase activity is reached 
d
 ratio between EC50 of compound and EC50 of estradiol 
e
 concentration at which maximum estrogenic effect is detected 
f
 Per cent luciferase activity (standard deviation) at concentration eliciting maximum estrogenic effect 
relative to 30 pM estradiol 
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standard curve (between 1 and 6 pM E2 equivalents). The combination of endosulfan with 
dieldrin at concentrations between 3 and 6 uM resulted in luciferase activity showing more 
than additive interaction. The luciferase activity elicited by these combinations significantly 
exceeded the arithmethic sum of their individual luciferase activity, though by a factor of less 
than 2 (Figure 7). At 7 and 8uM, the interaction between endosulfan and dieldrin was additive 
or slightly less than additive (Figure 7). The combination of endosulfan and chlordane tested 
at concentrations between 3 and 5uM resulted in additive luciferase activity (Figure 8). When 
combined at concentrations higher than their individual EC50 values (6 to 8 uM), luciferase 
activity was less than additive (Figure 8). 
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Figure 6: Interactive estrogenic activity of environmental chemicals with estradiol (E2) 
in the ER-CALUX assay. T47D.Luc cells were exposed for 24 hours to environmental 
chemicals with (striped bars) or without (open bars) co-administration of 3 pM E2. Double-
striped bars show the arithmetic sum of luciferase activity obtained by adding the induction by 
the individual compound with induction elicited by 3 pM E2. o.p'DDT (DDT) and 4-
nonylphenol (NP) were tested at a concentration of 200 nM. Methoxychlor (MX) was tested at 
a concentration of 2 nM. Chlordane (CH), dieldrin (DL) and endosulfan (EN) were tested at a 
concentration of 4 uM (n=6, avg ± std). 
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Figure 7: Interactive effects of mixtures of the pseudo-estrogens endosulfan (END) and 
dieldrin (DLD) in the ER-CALUX assay. T47D.Luc cells were treated with individual and 
combinations (COMB) of environmental estrogens. Double-striped bars on the right show the 
arithmetic sum (SUM) of luciferase activity obtained by adding the induction elicited by the 
individual compounds. (n=6, avg ± std, 'significantly higher than arithmetic sum, p<0.01). 
Discussion 
Stable transfection in ECC-1, MCF-7 andHepa cell lines 
Attempts to stably transfect the pEREtata-Luc construct in ECC-1 cells, as well as the 
chimeric Gal4-HEGO/17m5-G-Luc constructs in Hepa.lclc7 and MCF-7 cells resulted in 
constitutive, non-estradiol-inducible luciferase expression. Jausons-Loffreda and co-workers 
also reported some hormone-independent luminescent clones after stable tranfection of 
chimeric Gal4 constructs in HeLa cells (Jausons-Loffreda et al., 1994). The reasons for these 
constitutive clones are not clear, but may be due to events during integration resulting in a 
mutation in the promoter region of the luciferase gene, or influence of promoters around the 
integration site, causing constitutive, E2-independent luciferase expression. Only one Hepa 
clone stably transfected with Gal4HEGO/17m5-G-Luc demonstrated estradiol-inducible 
luciferase activity, though this induction decreased in subsequent assays, indicating instability 
of the clone. Subculturing of this clone could result in clones with a more homogeneous 
population of luciferase-expressing cells. 
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Figure 8: Interactive effects of mixtures of the pseudo-estrogens endosulfan (END) and 
chlordane (CHL) in the ER-CALUX assay. T47D.Luc cells were treated with individual and 
combinations (COMB) of environmental estrogens. Double-striped bars on the right show the 
arithmetic sum (SUM) of luciferase activity obtained by adding the induction elicited by the 
individual compounds (n=6, avg ± std, EC50 endosulfan: 5920 nM; EC50 chlordane: 6240 
nM). 
ER-CALUX assay in stably transfected T47D cell line 
Stable transfection of the pEREtataLuc construct in T47D cells resulted in a sensitive, 
highly responsive cell line for the screening of compounds with (anti-)estrogenic activity. 
Estradiol concentrations as low as 0.5 pM were detected and an EC50 of 6 pM was found 
following 24 hour exposure to estradiol. The assay is also highly responsive, as luciferase 
induction in 24 well plates by 30 pM E2 resulted in about 100 fold relative to solvent controls. 
The assay appears also to be specific for estrogens, as other endogenous ligands tested, such 
as a synthetic progestin and androgen, and retinoic acid, did not induce luciferase activity. 
Anti-estrogenicity of substances such as ICI 182,780 and tamoxifen could be demonstrated by 
measuring inhibition of luciferase induction with co-administration of estradiol. The 
prototypical Ah receptor agonist TCDD was also a potent anti-estrogen when measured in the 
ER-CALUX assay. These results are consistent with previous studies which demonstrate the 
anti-estrogenicity of TCDD in breast cancer cell lines, likely due to the complex cross talk 
between the AhR and ER signal transduction pathways (reviewed by Safe, 1995/ 
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Response of pseudo-estrogens 
A number of (pseudo-)estrogenic compounds were tested individually and in combination 
in order to determine their potency in the ER-CALUX assay. The phyto-estrogen genistein, 
nonylphenol and the pesticide o,p'DDT were the most potent of the pseudo-estrogens tested. 
The environmental estrogens demonstrating induced luciferase activity in the ER-CALUX 
assays have also been previously shown to be estrogenic in both in vivo and in vitro assays: 4-
nonylphenol (Soto et al, 1991; Jobling and Sumpter, 1993; White et al., 1994), o.p'DDT 
(Bitman, 1969, Fry and Toone, 1981, Klotz et al., 1996), methoxychlor (Gray et al., 1989, 
Schlenk et al., 1997), endosulfan (Arnold et al., 1996), dieldrin (Haake et al., 1987) and 
chlordane (Cranmer et al., 1984). Comparison of the potency values relative to estradiol 
shows that in general, lower potency values for environmental estrogens are calculated in the 
ER-CALUX than demonstrated with other ER-mediated reporter gene assays, such as trans-
ient transfections of ERE-reporter genes in HeLa and MCF-7 cells (Table 2). However, this 
factor 10-100 fold difference in potency could be explained by the differences in estradiol 
concentrations required to produce a maximal response. For the ER-CALUX assay, maximum 
luciferase induction is reached at 30 pM E2. For other assays, estradiol concentrations ranging 
from 1 nM (Shelby et al., 1996) to 10 nM (White et al., 1994) are used for calculation of 
relative potency. ER-CALUX relative potency values correlate well with those reported in 
MCF-7 cell proliferation assays, in which a maximum E2 effect concentration of 10-30 pM is 
also found (Soto etal., 1992; 1994; 1995). 
Interestingly, when tested at high concentrations (> 1000 nM), a number of compounds 
such as genistein, nonylphenol, bisphenol A, o,p' DDT and methoxychlor elicited luciferase 
induction higher than that of the maximum induction by estradiol (Table 1). In a screening of 
estrogenic compounds using a recombinant yeast strain, Routledge and Sumpter also reported 
that exposure to both the genistein and the alkylphenol 4-tert-octylphenol resulted in higher 
reporter gene activity than by estradiol (Routledge and Sumpter, 1997). The mechanism of 
this super-agonism is not clear, but may be due to stimulated receptor and/or co-activation 
factor renewal by pseudo-estrogens, or effects on luciferase stability. 
When tested in combination with 3 pM E2 in the ER-CALUX assay, all test compounds 
showed additive luciferase activity (Figure 6). However, when the pseudo-estrogens 
endosulfan, dieldrin and chlordane were tested in combination in the ER-CALUX assay, the 
resulting interaction was not consistently additive. The combination of dieldrin with 
endosulfan resulted in luciferase activity slightly more than additive, though significantly 
higher, than the arithmetic sum of the individual compounds (Figure 7). The combination of 
endosulfan and chlordane was additive at the lower concentrations tested (3 to 6 |iM). Gaido 
and coworkers have also reported the additive effects of endosulfan and chlordane when 
tested in combination in a yeast estrogen screen (Gaido et al., 1997). Less than additive 
luciferase induction by the combination of endosulfan and chlordane was observed at higher 
concentrations (7 and 8 uM) (Figure 8). However, these concentrations were higher than the 
EC50 level of the individual compounds, so it is not surprising that the arithmetic sum of their 
individual activities was higher than activity elicited by the combination. These results 
indicate that weak environmental estrogens may act cumulatively and further research is 
warranted in the in vivo effects of mixtures of pseudo-estrogens. 
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Table 2: Potency values for maximum effect concentrations of (pseudo-)estrogens rela-
tive to estradiol according to in vitro assays for estrogenicity 
Compound 
o,p'DDT 
methoxychlor 
dieldrin 
Endosulfan 
4-nonyl-
phenol 
genistein 
Assay 
ER-CALUX 
transient transfection MCF-7 
E-SCREEN 
ER-CALUX 
transient transfection HeLa cells 
ER-CALUX 
E-SCREEN 
ER-CALUX 
transient transfection HeLa cells 
E-SCREEN 
ER-CALUX 
transient transfection HeLa cells 
transient transfection MCF-7 
E-SCREEN 
ER-CALUX 
E-SCREEN 
Relative 
Potency 
3E-6 
1E-4 
1E-6 
1E-6 
0 
5E-7 
1E-6 
3E-6 
0 
1E-6 
3E-5 
1E-3 
1E-3 
3E-6 
3E-5 
1E-4 
Reference 
Klotz et al, 1996 
Soto era/., 1994 
Shelby et al., 1996 
Soto etal, 1994 
Shelby et al., 1996 
Soto et al., 1994 
Shelby etal, 1996 
White etal., 1994 
Soto etal., 1992 
Msyxetal, 1992 
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Comparison ER-CALUX with other in vitro assays 
To our knowledge, in comparison to other recombinant receptor and/or reporter gene 
assays using stably or transiently transfected mammalian cells, the ER-CALUX assay is the 
most sensitive and responsive stably transfected estrogen-responsive cell line in existence 
(Table 3). The sensitivity and specificity of the ER-CALUX assay may be explained in part 
by the use of a minimal EiB promoter (TATA box only) in the pEREtata-Luc construct. 
Enhancer and promoter regions are absent in this minimal promoter. Other promoters used in 
response element-regulated reporter genes generally consist of several hundred base pairs of 
5' flanking regions which may cause higher background activation levels (Cavailles et al., 
1988; 1989). Also, the vigorous serum stripping method used may contribute to the low 
background levels in the ER-CALUX assay. The presence of serum-borne estrogens can 
result in high constitutive reporter gene activity and can be demonstrated by assessing the 
ability of anti-estrogens to reduce background levels (Bondy and Zacharewski, 1993). In the 
ER-CALUX assay, ICI 182,780 at concentrations up to 100 nM did not significantly 
antagonize bacground luciferase activity, demonstrating that serum-borne estrogens were very 
low. The ER-CALUX assay procedure was also optimized to ensure the lowest possible 
background levels. Cells are plated 2 days prior to exposure with a medium renewal step on 
the second and third day. These medium renewal steps reduced background levels of serum-
borne estrogens by a factor of 2 (data not shown). 
The high responsiveness of the ER-CALUX assay may be due in part to the choice of the 
cell line. The T47D cell line appears to provide the cellular environment, such as high estro-
gen receptor levels and the availability of transcription factors, necessary for gene transcrip-
tion. The presence of both ERa and ERP subtypes in T47D cells has been confirmed using 
RT-PCR (Dotzlaw et al., 1996). Estrogen receptor levels in the cytosol of T47D cells have 
been reported to be 67.6 ± 6.2 fmol/mg cytosol protein (Watanabe et al., 1990). The use of an 
enhanced luciferase reporter gene which was modified for optimal transcriptional activity in 
transfected eukaryotic cells (Sherf and Wood, 1994) may also have contributed to higher 
induction values. Comparison of EREtata constructs with enhanced vs normal luciferase in 
transient transfections in the 293 human embryonic kidney cell line showed a factor 5 
increase in fold induction (data not shown). 
The use of the ER-CALUX assay in stably transfected T47D.Luc cells offers many advan-
tages in comparison to other in vitro bioassays for assessing estrogenic substances, such as 
transient transfections of reporter gene constructs, yeast based assays and cell proliferation 
assays. The ER-CALUX assay is rapid and simple, and detection in microtiter volumes is 
possible, allowing for qualitative and quantitative assessment of luciferase induction in a high 
throughput setup. Compared to transient transfections of estrogen-responsive reporter genes, 
the ER-CALUX assay is less cumbersome and time consuming, as it is not necessary to 
transfect DNA for each experiment. Problems with differences in quality of DNA and 
changes in luciferase activity due to cell culture conditions found with transient transfections 
(Zacharewski, 1997) are therefore avoided. A number of yeast-based assays have been 
developed to assess estrogenic substances which are very sensitive and responsive (Arnold et 
al., 1996; Routledge and Sumpter, 1997). Unlike the ER-CALUX assay, however, lack of 
antagonism of ER-mediated reporter gene expression by anti-estrogens has been demonstrated 
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in yeast-based assays (Lyttle et al., 1992; Kohno et al., 1994). Permeability of compounds 
through yeast cell wall may also be a problem not encountered in the ER-CALUX assay 
(Legler, in prep.). In comparison to cell proliferation assays with estrogen responsive cell 
lines like MCF-7, such as the E-SCREEN (Soto et al., 1995), the ER-CALUX assay is more 
specific, rapid, sensitive and responsive. 
Table 3: Comparison of detection limit (d.L), EC50 and responsiveness to estradiol (fold 
induction) in recombinant receptor/reporter gene assays with stable or transient 
transfection of estrogen-receptor mediated reporter genes in mammalian cell lines 
d.L EC50 Induc-
Transfection DNA construct Cell line (pM) (pM) tion Reference 
this study stable pEREtata-Luc T47-D 0.5 100 
Ponsetal, 1990 stable pVit-tk-Luc MCF-7 n.s. 20 
Kramer et al., 1997 stable pVit-tk-Luc MCF-7 n.s. 1.5 2.2 
Balaguer et al., 1996 stable pGal4HEGO/ HeLa 
pl7m5-G-Luc 
18 40 
Zacharewski et al., transient 
1995 
pGal4HEGO/ MCF-7 n.s. 
pl7m5-G-Luc 
20 50 
White etal., 1994 transient pEREBLCAT MCF-7 n.s. 
Jobling et al., 1995 transient pERE-tk-Luc MCF-7 n.s. 50 10 
n.s. = data not shown 
We believe that the ER-CALUX assay can form a valuable contribution to a careful 
selection of in vitro and in vivo assays used to identify and determine the (anti-)estrogenicity 
of compounds. The ER-CALUX assay is also currently being used to identify (anti-
estrogenic substances in complex environmental mixtures, such as sediment and water 
extracts (Legler, in prep.). Of course, the in vitro ER-CALUX assay cannot completely reflect 
complex in vivo events, such as the pharmacokinetics, metabolism and accumulation of a 
compound. T47D.Luc cells possess some metabolic capabilities, such as the cytochrome P450 
enyzmes involved in the hydroxylation of estrogens and xenobiotics. For example, P450IA 
(data not shown, Kuil et al., 1998, Spink et al., 1998); P4501B (Spink et al., 1998) and 17P-
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hydroxysteroid dehydrogenase (Piao et al., 1997) activity has been reported in T47D cells. In 
an in vitro assay, cross-talk with other mechanisms not directly involving interaction with the 
ER signal transduction pathway may be also missed. In addition, caution should be exercised 
when using a breast cancer cell line expressing both ERa and ER(3 subtypes for the prediction 
of tissue-specific effects. Tissues such as prostrate and ovary have been found to contain 
prominent ER(3 expression (Kuiper et al., 1997). Differences in the binding affinities of 
compounds, such as phytoestrogens, as well as in the transcriptional activity for both ER 
subtypes have been demonstrated (Kuiper et al., 1998). Further research can determine 
whether estrogenic potency predicted in the ER-CALUX assay using human T47D.Luc cells 
may be extrapolated to other species, such as fish, birds and reptiles. If not, recombinant 
reporter gene assays should be developed using species specific estrogen receptors in 
estrogen-sensitive cell lines from various species. To address many of these questions, 
biological validation is currently underway in fish to compare the reproductive effects of 
(mixtures of) estrogens in vivo to effects measured by the ER-CALUX assay. 
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Abstract 
Sediments may be the ultimate sink for (xeno-)estrogenic compounds in the aquatic 
environment. In vitro reporter gene assays can provide useful and rapid means to assess the 
total estrogenic activity in complex mixtures such as sediment extracts. To determine a 
suitable assay to test environmental mixtures for estrogenic potency, a recently developed 
estrogen receptor-mediated luciferase reporter gene (ER-CALUX) assay in stably transfected 
T47D human breast cancer cells was compared with a recombinant yeast screen. Following 
exposure to the (xeno-)estrogens 17(3-estradiol (E2), nonylphenol and o,p'DDT, the ER-
CALUX assay was more sensitive than the recombinant yeast screen, with an EC50 of 6 pM 
E2 compared to 100 pM in the yeast screen. In addition, recombinant yeast cells were unable 
to distinguish substances with an anti-estrogenic mode of action, as the anti-estrogens IC1 
182,780, hydroxytamoxifen and tamoxifen were agonistic in the yeast. Complex mixtures of 
compounds present in sediments from various marine locations in The Netherlands were 
tested for estrogenic activity in the ER-CALUX assay. Acetone-soluble polar extracts of 
sediments showed higher estrogenic potency than hexane-soluble non-polar extracts. Polar 
extracts from sediments obtained from industrialized areas such as the Port of Rotterdam 
showed the highest estrogenic potency of the sediments tested (up to 40 pmol estradiol 
equivalents per gram sediment). The estrogenic activity of individual chemicals that may be 
found in sediments, including alkylphenols ethoxylates and carboxylates, phthalates, and 
pesticides, was tested. Increasing sidechain length of various nonylphenol ethoxylates resulted 
in decreased estrogenic activity. Of the phthalates tested, butylbenzylphthalate was the most 
estrogenic, though with a potency approximately 100,000 times less than E2. Though 
o,p'DDT and o,p'DDE were estrogenic in the ER-CALUX assay, the organochlorine 
herbicides atrazine and simazine were not estrogenic. As metabolic activation may be 
required to induce estrogenic activity in some sediment-associated compounds, a metabolic 
transformation step was added to the ER-CALUX assay. Parent compounds were incubated 
with liver microsomes obtained from PCB-treated rats and metabolites were extracted and 
tested in the ER-CALUX assay. Results indicated that metabolites of E2, NP and Bisphenol A 
were less active, while metabolites of methoxychlor were more estrogenic than the parent 
compound following microsomal incubations. 
Introduction 
In the aquatic environment, exposure of organisms to substances with an estrogenic 
mode of action has been linked to endocrine effects observed in wild populations of male fish, 
such as vitellogenin induction and feminized reproductive organs (reviewed by Tyler et al., 
1998). Chemical analysis has revealed the presence of various substances that possess 
estrogenic activity in wastewater treatment plant (WTP) discharges, which may form a main 
source of estrogenic substances in the aquatic environment. These include natural estrogens, 
such as 17p-estradiol (E2), synthetic estrogens such as the contraceptive pill component, 17a-
ethynylestradiol (EE2), as well as estrogenic chemicals of anthropogenic origin ("xeno-
estrogens"), such as alkylphenols (Shore et al, 1993, Desbrow et al., 1998, Belfroid et al., 
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1999a, Snyder et al., 1999). The use of chemical analysis is essential to determine the 
exposure concentrations of (xeno-)estrogens to organisms and help to assess the potential risk 
of (xeno-)estrogens in the environment. This type of analysis, however, is limited in that only 
known substances are analysed, mixture interaction is not taken into account, and the 
biological effects of the (xeno-)estrogen or mixtures can not be predicted. 
The use of in vitro bioassays based on the mechanism of action of estrogens can be 
very useful to rapidly and inexpensively determine the total biological potency of individual 
substances as well as mixtures of chemicals. Two examples of in vitro reporter gene bioassays 
for determining estrogenic effects include the recently developed estrogen receptor (ER)-
mediated Chemical Activated Luciferase gene expression (ER-CALUX) assay (Legler et al., 
1999) and the recombinant yeast screen (Routledge and Sumpter, 1996). The ER-CALUX 
assay uses T47-D human breast adenocarcinoma cells expressing endogenous ER a and p, 
which are stably transfected with an estrogen-responsive luciferase reporter gene. Exposure of 
stably transfected T47-D cells to (xeno-)estrogens results in transactivation of the ER and 
consequent induction of the luciferase gene, which is easily assayed by lysing cells and 
adding the substrate luciferin, and measuring light output. In the recombinant yeast screen, 
yeast cells have been stably transformed with human ER-cc cDNA and an ERE-regulated 
expression plasmid (lac-Z). Interaction of an estrogenic compound with the ER results in 
expression of the reporter gene lac-Z and secretion of the enzyme [3-galactosidase in the yeast 
medium. Both the ER-CALUX assay and recombinant yeast screen are rapid and easy to 
perform in a microtiter, high-throughput manner. 
Mixtures of (xeno-)estrogens released in the environment via domestic and industrial 
effluents, as well as from agricultural runoff, may accumulate in sediments. Sediments may 
be the ultimate sink for many persistent chemicals released in aquatic systems, and may form 
a source of exposure to aquatic organisms. This may be particularly important for the 
Netherlands, which forms the sedimentation basin for major European rivers such as the 
Rhine, Meuse and Scheldt. Therefore, the aim of this study was to determine the in vitro 
estrogenic activity in sediments sampled from various locations along the Dutch coast. In 
order to choose the most suitable in vitro assay for this purpose, the ER-CALUX assay was 
first compared with the recombinant yeast screen for responses to estrogens and anti-
estrogens. In addition, a number of alkylphenol ethoxylates and phthalates detected in Dutch 
sediments (Belfroid et al, 2000), as well as persistent organochlorine pesticides which may be 
found in sediments (DDT derivatives and chloro-s-triazine-derived herbicides) were tested for 
estrogenic potency in the ER-CALUX assay. Because sediment-associated compounds may 
also only be estrogenic following metabolic activation, an additional goal of this study was to 
include a metabolic transformation step in the ER-CALUX assay in order to determine the 
estrogenic potential of metabolites as well as parent compounds. The model (xeno-)estrogens 
estradiol, bisphenol A, nonylphenol and methoxychlor were pre-incubated with liver 
microsomes from rats treated with the PCB mixture Aroclor 1254, which induces a broad 
spectrum of liver enzymes (especially CYP 1A), and tested in the ER-CALUX assay. Our 
results indicate that a simple metabolism step can be added to the ER-CALUX assay, 
allowing for the measurement of the impact of metabolic transformation on the estrogenic 
activity of (xeno-)estrogens. 
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Materials and Methods 
Chemicals 
17P-estradiol (E2, 99%), methoxychlor (95%), tamoxifen (99%), and ethanol (100%, p.a.) 
were purchased from Sigma Chemicals. 4-nonylphenol (92.7%) was purchased from Fluka. 
Bisphenol A (99%) was from Aldrich. The nonylphenol ethoxylates (NpnEO), nonylphenol 
carboxylates (NpnEC) and octylphenol ethoxylates (OP 8/9EO) were kindly provided by Dr. 
P. de Voogt, University of Amsterdam, The Netherlands. ICI 182,780 and 4-hydroxy-
tamoxifen (OHT) were a kind gift from Dr. A. Wakeling, Zeneca Pharmaceuticals, U.K. The 
organochlorine pesticide o,p'-dichlorodiphenyl trichloroethane (o,p'DDT) was kindly 
provided by the Dutch State Institute for Quality Control of Agricultural Products (RIKILT-
DLO). Simazine, atrazine, desethylatrazine, deisopropylatrazine and o,p'DDE were a kind 
gift from E. van der Velde, National Institute of Public Health and the Environment, 
Bilthoven, The Netherlands. Dimethylphthalate (DMP, 99.5%), di-ethylhyexyl phthalate 
(DEHP; 98%), 4-octylphenol (OP, 99%) and dimethyl sulfoxide (DMSO, 99.9%, spectrop-
hotometric grade) were purchased from Acros. Diethyl phthalate (DEP, 99%) was from Alfa. 
Dibutyl phthalate (DBP; 99%) and butylbenzyl phthalate (BBP, 98%) were purchased from 
TCI. Solvents used for extractions (hexane, acetone, dichlormethane, methanol and 
diisopropyl ether; Merck) were of p.a. or HPLC quality. 
ER-CAL UX assay procedure 
Culture of the T47D cell line which is stably transfected with the ER-regulated 
pEREtata-Luc DNA construct (T47D.Luc cells) is described elsewhere (Legler et al., 1999). 
For the ER-CALUX assay, T47D.Luc cells were plated in clear plastic 96 well plates 
(Nucleon, Denmark) at a density of 5000 cells in 0.1 ml Dulbeccos's modified Eagle's 
medium and Ham's F12 (DF) medium without phenol red with 5% dextran-coated charcoal 
treated fetal calf serum FCS (DCC-FCS) per well. Following 24 hours incubation, medium 
was renewed and the cells incubated for another 24 hours. The medium was then removed and 
the cells were dosed in triplicate by addition of the dosing medium containing the chemical or 
extract to be tested dissolved in ethanol or DMSO (max. 0.2%). Control wells, solvent control 
wells and E2 calibration points (6 pM and 30 pM) were included in triplicate on each plate. 
Following 24 hours treatment, medium was removed and cells were lysed in 50 ul triton-lysis 
buffer, pH. 7.8 (containing 1% triton X-100, 25 mM glycylglycin, 15 mM MgS04, 4 mM 
EGTA and 1 mM DTT) for a minimum of 1 hour with gentle shaking at 4°C. A sample of 25 
(xl lysate was then transferred to a black 96 well plate (Costar) and 25 ul of luciferin solution 
(Luclite, Packard) was added per well. Luciferase activity was assayed in a scintillation 
counter (Top Count, Hewlett-Packard) for 0.1 minute per well. 
Recombinant yeast screen 
Yeast cells stably expressing the human ER and ERE-lacZ expression plasmid were 
kindly provided by Glaxo Group Research Ltd, United Kingdom. Yeast culture and galactosi-
dase measurement was carried out mainly according to the assay procedure of Routledge and 
Sumpter, 1996. Growth and assay media were prepared as described previously (Routledge 
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and Sumpter, 1996). Briefly, 0.25 ml of a concentrated recombinant yeast stock was added to 
45 ml growth medium and incubated overnight at 28°C in a shaking incubator (250 rpm) until 
an optical density (OD) of 1.0 (640 nm) was reached. Assay medium was prepared by adding 
0.5 ml of the substrate chlorophenol red-B-D-galactospyranoside (CPRG, Boeringer 
Mannheim) to 50 ml fresh growth medium, and adding 2 ml yeast from the overnight culture. 
Clear plastic 96 well plates (Costar) were seeded with 200 u.1 per well of the assay medium 
containing yeast, using a 8-well multichannel pipettor, in a laminar air flow cabinet. Stock 
solutions and dilutions of test compounds were prepared in DMSO and added directly to the 
wells containing the yeast, to a maximum concentration of 2% DMSO (i.e. 4 ul in 200 u.1). 
Each dilution was tested in triplicate. Each assay included a standard curve for E2 (1 to 10000 
pM) and each plate contained triplicate solvent control and E2 calibration points (100 and 
1000 pM). For experiments involving co-treatment of compounds (e.g. E2 with anti-
estrogens), test compounds were added together so that the final solvent concentration did not 
exceed 2%. Plates were then covered with a lid, and shaken vigorously on a plate shaker for 5 
minutes. Plates were incubated for 3 days at 32°C, with daily 5 minute shaking of plates. 
Substrate conversion (color development) was measured at 540 nm and cell growth at 640 nm 
in a 96 well plate spectrophotometer (Spectromax). As neglible absorbance was measured in 
blank wells containing medium alone, the formula used to calculate absorbance per well was 
OD540-OD640. 
Sediment extraction 
A preliminary study was carried out to determine if estrogenic activity was found in 
non-polar or polar extracts of sediments. A sediment sample from a relatively polluted area 
located in the Dutch Wadden Sea near a freshwater outlet was dried overnight at 30°C. A 
dried sediment sample of 14.05 g was extracted with hexane:acetone (1:1) for 2 hours in a 
Soxtec apparatus (miniaturized Soxhlet, Tecator, The Netherlands). The hexane/acetone 
fraction was then evaporated to approximately 2 ml. After sulphur removal using tetrabutyl 
ammonium sulfite (TBA) (De Voogt et al., 1990), the extract was transferred to hexane 
resulting in a precipitate of acetone soluble components. The hexane fraction was then split in 
two equal portions. One portion was filtered over a 1 g Na2S04 column, evaporated and taken 
up in 50 ul DMSO, resulting in a non-polar fraction. The other portion was subjected to 
further clean-up over a multilayer acid-base silica column to remove labile components (Murk 
et al., 1996), evaporated and taken up in 100 ul DMSO. This extraction procedure resulted in 
a stable non-polar fraction. The precipitate of acetone soluble components mentioned above 
was redissolved in acetone. This acetone fraction was filtered over a 1 g Na2S04 column, 
evaporated and taken up in 100 ul ethanol, resulting in a polar fraction. 
To determine estrogenic potency in polar fractions of a number of field samples, 
sediment was sampled from 12 marine locations in the Netherlands (De Boer et al, 2000). 
Dried sediment samples of 5 g were extracted with hexane:acetone (1:1) for 2 hours in a 
Soxtec apparatus (Tecator, The Netherlands). After sulphur removal as described above, the 
extract was transferred to hexane resulting in a precipitate of acetone soluble components. 
This precipitate (representing the polar fraction) was redissolved in acetone, filtered over a 1 
g Na2S04 column, evaporated and taken up in 50 ul DMSO. Stocks were diluted 100 times 
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in DMSO and tested in the ER-CALUX assay according to the procedure described above. 
These extract dilutions demonstrated no toxicity, determined by microscopic observations of 
the cells. 
Microsomal biotransformation studies 
For in vitro microsomal biotransformation studies, parent compounds were incubated 
with rat liver microsomes according to the method of Morse et al., 1995. Microsomes were 
collected as described in Morse et al, 1993, from rats treated with two daily interperitoneal 
injections of 100 mg/kg Aroclor 1254. Microsomal incubation mixtures were prepared in 
glass tubes on ice and contained 10 jxl of a 10 mM stock concentration of E2, methoxychlor, 
nonylphenol or bisphenol A (final concentration 100 uM) in a total volume of 900 ul of 0.1 M 
Tris-HCl buffer, pH 7.5. Microsomal protein concentration in the incubation mixture was 1 
mg/ml. The incubation mixtures were vortexed and pre-incubated for 2 minutes at 37°C. The 
reaction was initiated by the addition of 100 ul NADPH (Boeringer Mannheim) in Tris-HCL 
buffer to a final concentration of 1 mM NADPH. In parent compound controls, only 100 jul of 
Tric-HCl buffer was added. Following 1-hour incubation at 37°C in a shaking water bath, 
reactions were stopped by the addition of 2 ml ice-cold methanol and vortexing for 10 sec. 
The tubes were then centrifuged 5 min. at 3000 rpm and the supernatant was transferred to a 
clean tube. Parent compounds and metabolites were extracted three times with 2 ml 
diisopropyl ether by vortexing 1 minute, centrifuging 3 min. at 2000 rpm and transferal of the 
diisopropyl fraction. The ether extracts were pooled and dried at room temperature under a 
gentle N2 stream, transferred to glass conical vials, and taken up in 25 ul ethanol. Extracts 
were diluted and tested in the ER-CALUX assay as described above. 
Data analysis 
To determine the EC 10 and EC50 of E2 in the ER-CALUX and recombinant yeast assay, a 
complete standard curve was included in each assay. The standard curve was fitted using a 
cumulative fit function using SlideWrite 4.0 for Windows. The EC50 for E2 and xeno-
estrogens was calculated by determining the concentration at which 50% of the maximum 
reporter gene activity was reached using the cumulative fit equation. In some cases, an EC50 
value could not be calculated, as a plateau in reporter gene activity was not reached. In this 
case, an EC 10 was calculated by determining the reporter gene induction by E2 at 10% the 
maximum response, and the concentration of the (xeno-)estrogen at this induction level was 
interpolated in the curve. The detection limit was calculated as the reporter gene activity 
elicited by the solvent control plus three times the standard deviation. 
Estradiol equivalency factors (EEFs) were calculated by dividing the EC50 or EC 10 of E2 
by that of the xeno-estrogen. In order to determine estradiol equivalents (EEQs) in mixtures, 
the reporter gene response by sediment extracts was interpolated in the lower linear range 
(between 1 and 6 pM) of the corresponding E2 standard curve for the same assay. Data shown 
are representative of a minimum of three independent assays. Compounds were tested in 
triplicate; error bars represent standard deviation of the mean. 
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Results 
Comparison ER-CAL UX and recombinant yeast screen 
Comparison of the E2 standard lines in the ER-CALUX and recombinant yeast screen 
demonstrated that the ER-CALUX is about a factor 20 more sensitive (Figure 1). The 
calculated detection limit and EC50 for the ER-CALUX was 0.5 and 6 pM, respectively, and 
for the yeast screen 10 pM and 100 pM, resp. The maximum fold induction in the yeast screen 
(at 1000 nM) was 8-16 fold relative to solvent controls. In the ER-CALUX, maximum fold 
induction was found at 30 pM and was 75 to 100 fold (Figure 1). The reporter gene induction 
by two known xeno-estrogens, 4-nonylphenol (NP) and o,p'DDT, was tested in the ER-
CALUX and yeast screen assays. The EC50 in the ER-CALUX for NP and o.p'DDT is 260 
and 660 nM, respectively (Legler et al., 1999). In the yeast recombinant screen, however, 
EC50s for these compounds were about 6 to 10 times higher, with NP demonstrating an EC50 
of 2000 nM and o.p'DDT 3600 nM (data not shown). 
Reporter gene induction by the anti-estrogens ICI 182,780, tamoxifen and 4-
hydroxytamoxifen (OHT) was tested with and without co-administration of E2 at the EC50 
level (Table 1; Figure 1). In the ER-CALUX assay, OHT and ICI 182,780 alone showed no 
reporter gene induction (Table 3). Tamoxifen was weakly estrogenic at high concentrations in 
the ER-CALUX assay, as a concentration of 1000 nM resulted in luciferase induction about 
11% that of 6 pM E2 (Table 1). In the recombinant yeast screen, the three anti-estrogens 
induced reporter gene activity when tested alone without co-treatment with E2. At 
concentrations of 1000 nM, OHT and tamoxifen induced (3-galactosidase activity over 300% 
that of activity elicited by 100 pM E2. When tested at 10000 nM, the estrogenic activity of 
OHT decreased, though it still induced reporter gene induction to about 60% that of 100 pM 
E2, or about 5 fold above solvent controls (Figure 1). ICI 182,780 demonstrated dose-
response related agonistic activity in the yeast screen, with 10000 nM resulting in reporter 
gene activity of 770% that of 100 pM E2. In experiments in which cells were co-treated with 
6 pM E2 in the ER-CALUX assay, OHT and ICI 182,780 at 10 nM already completely 
abolished the luciferase induction by E2 (Table 1). Tamoxifen demonstrated anti-estrogenic 
working at concentrations at or above 100 nM in the ER-CALUX assay. In the recombinant 
yeast screens, none of the anti-estrogens tested could antagonize the reporter gene induction 
by 100 pM E2. With the exception of OHT at the highest concentrations (10,000 nM), 
treatment of E2 with anti-estrogens suggested that these compounds worked as agonists rather 
than antagonists in the recombinant yeast screen (Table 1). 
Because of the differences in sensitivity to (xeno-)estrogens and anti-estrogens 
between the ER-CALUX and recombinant yeast assays, further studies were carried out with 
the ER-CALUX assay. 
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Figure 1: Effects of estrogen and anti-estrogens in the ER-CALUX assay (ERC) and 
recombinant yeast screen (RYS). T47D.Luc cells were exposed for 24 hours and yeast cells 
for 72 hours to estradiol (E2) and 4-hydroxytamoxifen (HT). Response is given as reporter 
gene induction relative to solvent controls (fold induction). 
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Figure 2: Estrogenic activity (fold induction relative to control) of estradiol (E2), 
nonylphenol (NP) and nonylphenol ethoxylates (NPnEO) in the ER-CALUX assay using 
T47D.Luc cells (24 hour exposure). 
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Table 1: Response of anti-estrogens in the ER-CALUX and recombinant yeast screen 
assays. Anti-estrogens were tested alone or with co-treatment with estradiol at the EC50 level 
of E2 (6 pM for ER-CALUX, 100 pM for yeast). Reporter gene induction is expressed at 
average percentage relative to E2 (standard deviation bracketed) 
Cone. (nM) 
4-hydroxy-
tamoxifen 
10 
100 
1000 
10000 
ICI 182,780 
10 
100 
1000 
10000 
Tamoxifen 
10 
100 
1000 
10000 
Reporter Gene Induction (%) 
ER-CALUX 
0.5 (0) 
0.4 (0) 
0.4 (0) 
0.0 (0) 
0.0 
0.0 
0.7 (0) 
0.0 (0) 
0.2 (0.0) 
7 (0.3) 
11(0.1) 
* 
Yeast screen 
72(2) 
290 (83) 
339(10) 
59(19) 
4(0.2) 
13(1.0) 
33 (6.1) 
773(11.2) 
7 (0.2) 
13(1.4) 
397 (20.1) 
* 
Co-treatment with Estradiol 
Reporter Gene Induction (%) 
ER-CALUX 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
52(2) 
5 (0.6) 
8 (0.4) 
* 
Yeast screen 
317(40) 
353 (26) 
347 (13) 
102 (21) 
103(11) 
202 (2) 
319(18) 
774 (8) 
193 (25) 
261 (14) 
606 (5) 
* 
•cell lysis observed 
Estrogenic potency of mixtures of estrogenic compounds in sediments 
Sediment sampled from a contaminated sight in the Dutch Wadden Sea was chosen as 
a model sediment to determine suitable extraction procedure for sediment samples as. Polar 
acetone-soluble extracts from this sediment demonstrated higher estrogenic potency in the 
ER-CALUX assay than non-polar hexane extracts. The polar extract contained 5 pmol EEQ/g 
sediment, whereas the both the total non-polar and stable non-polar extracts from this 
sediment contained considerably less estrogen equivalents (0.3 and 0.4 pmol EEQ/g sediment, 
respectively). Further determination of estrogenic potency in sediments sampled from 12 
locations along the Dutch coast was therefore carried out in polar extracts. Sediment samples 
taken from the port of Rotterdam and one location along the Dutch coast (IJmuiden Harbour) 
showed the highest estrogenic activity ranging from 22-38 pmol/g sediment in comparison to 
locations in the port of Amsterdam and two relatively unpolluted 'reference' areas (5-7 pmol 
EEQ/g sediment) (Table 2). 
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Table 2: Estradiol equivalents (EEQ) following 24 hour treatment of T47D.Luc cells 
with polar acetone-soluble extracts of sediments collected from marine locations in the 
Netherlands 
Location EEQ' Location EEQ 
Port of Rotterdam: 
Nieuwewaterweg Benelux Tunnel 38.4 (9.5) 
Nieuwewaterweg Splitsingdam 
Dutch Coast: 
Loswal North km 53 
Loswal North km 12 
Noordwijk km 2 
Ijmuiden Harbour (outer) 
.  .  
22.0 (4.5) 
6.4(1.5) 
4.5 (0.6) 
15.0(5.7) 
27.1(10.1) 
Port of Amsterdam: 
IJmuiden Harbour (inner) 
North Sea Canal km 10 
North Sea Canal km 18 
North Sea Canal km 29 
"Reference" areas: 
Lake IJssel 
Eastern Scheldt 
7.3 (0.5) 
5.4(1.5) 
7.1 (2.9) 
6.0(1.2) 
7.5 (0.6) 
4.9 (0.8) 
pmol/g sediment, average ± std 
Estrogenic potency of xeno-estrogenic substances in ER-CALUX 
The ER-CALUX was further characterized in this study for response by xeno-
estrogens that have been detected in sediments in the Netherlands such as alkylphenols and 
phthalates (Belfroid et al., 2000). In addition, a number of persistent organochlorine 
pesticides that may be found in sediments were tested. When testing nonylphenol, 
octylphenol, nonylphenol- and octylphenol ethoxylates in the ER-CALUX, increasing size of 
the ethoxylate sidechain resulted in a decrease in estrogenic activity, with luciferase induction 
decreasing from 80-fold for NP1EO to 9-fold for NP4EO and no induction by NP10E0 
(Figure 2). Estrogenic potency of the nonylphenol exothylates was about 10"* to 10"7 that of 
E2 (Table 3). The final alkylphenol degradation products, NP and OP, demonstrated highest 
estrogenic potency, with an EEF between 10"5 to 10"6 resp. relative to E2 (Table 3). The 
nonylphenol carboxylates (NP1EC and NP2EC) tested, as well as the octylphenol ethoxylates 
(OP 8/9EO) failed to induce luciferase activity (Table 3). Compounds tested at concentrations 
exceeding 10 uM were cytotoxic. Of the phthalates tested, only butylbenzylphthalate (BBP) 
showed a complete dose-response curve, though at concentrations 100,000 higher than E2 
(Figure 3, Table 3). Diethyphthalate (DEP) and dibutylphthalate (DBP) were weakly 
estrogenic, demonstrating slight luciferase activity (about 10-fold induction) at concentrations 
of 10 uM (Figure 3). Dimethylphthalate (DMP) and diethylhexylphtalate (DEHP) showed no 
estrogenic actitivity in the ER-CALUX assay. Of the pesticides tested, only o,p'DDE and 
o.p'DDT showed estrogenic activity whereas the chloro-s-triazine-derived herbicides 
simazine, atrazine, desethylatrazine, and deisopropylatrazine failed to induce luciferase 
activity (Table 3). 
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Figure 3: Estrogenic activity (fold induction relative to control) in T47D.Luc cells 
exposed for 24 hours to estradiol (E2), and phthalates: diethylphthalate (DEP), 
butylbenzylphthalate (BBP), dibutylphthalate (DBP), dimethylphthalate (DMP) and 
diethylhexylphthalate (DEHP). 
Microsomal biotransformation in ER-CALUX assay 
In an attempt to determine the estrogenic potential of metabolites as well as 
parent compounds, a microsomal biotransformation step was included in the ER-CALUX 
assay. The biotransformation step involved in vitro metabolism of parent compounds using 
liver microsomes from rats pre-treated with the PCB mixture Aroclor 1254, which induces a 
broad range of metabolic enzymes in rat liver, including hepatic P450 1A and 2B enzymes 
(Safe, 1984). Following 24-hour exposure, metabolites of estradiol, (Figure 4a), nonylphenol 
and bisphenol A (data not shown) obtained by microsomal incubations showed less estrogenic 
potency than parent compounds. Metabolites of methoxychlor, however, microsomes showed 
about two to three times higher estrogenic potency than the parent compound (Figure 4b). 
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Table 3: Estradiol equivalence factors (EEF) calculated for xeno-estrogens in the ER-
CALUX assay. EEFS are ratio ECSOpp^ imdioiiECSOcmpou,,,!, unless indicated otherwise. 
Compound 
17|3-estradiol 
Alkylphenols: 
4-nonylphenol 
4-octylphenol 
NP1E0 
NP2E0 
NP4E0 
NP10E0 
NP1EC 
NP2EC 
OP8/9EO 
Pesticides: 
Op'DDT 
0,pDDE 
Simazine 
Atrazine 
Desethylatrazine 
Deisopropylatrazine 
EEF 
1 
2.3* 10"5 
1.4*10"6 
3.8* 106 
1.1*10"* 
u*io-7" 
n.c* 
n.c. 
n.c. 
n.c. 
si.mo-6 
2.3*10"* 
n.c. 
n.c. 
n.c. 
n.c. 
Compound 
Phthalates: 
Dimethylphthalate 
Diethylphthalate 
Dibutylphthalate 
Butylbenzylphthalate 
di(2-ethylhexyl)phthalate 
Dioctylphthalate 
EEF 
n.c. 
3.2* 108" 
1.8*10"8" 
1.4* 10"6 
n.c. 
n.c 
not calculated; no luciferase induction to the EC 10 level observed 
"calculated based on EC 10 
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Figure 4: Luciferase activity in T47D.Luc cells exposed for 24 hours to dilutions of (A) 
estradiol and (B) methoxychlor without (open circles; -NADPH) or with (closed circles; 
+NADPH) in vitro biotransformation. Compounds were pre-incubated with liver microsomes 
from Aroclor 1254 treated rats and extracted. 
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Discussion 
Comparison ER-CALUXassay and recombinant yeast screen 
Both the ER-CALUX and recombinant yeast screen assays provide a simple and rapid 
means to screen substances for their ER transcriptional activity in vitro. The recombinant 
yeast screen has a number of advantages, including the absence of other endogenous receptors 
and consequent lack of complex interaction between the ER and other receptors (Routlegde 
and Sumpter, 1996). The yeast cells grow in a medium devoid of hormones, thereby ensuring 
low background levels. The ease of use of the recombinant yeast screen is another definite 
advantage, as the product of the reporter gene is secreted in the medium and no cell lysis is 
necessary. In comparing the recombinant yeast screen with the ER-CALUX assay, however, 
differences in responses to (xeno-)estrogens and anti-estrogens are evident. Firstly, a 
difference in the sensitivity was found between the ER-CALUX and recombinant yeast 
screen, demonstrating that the ER-CALUX can detect estrogens at lower concentrations. For 
E2, nonylphenol and o,p'DDT, a difference of about 6 to 20 fold was found between the 
EC50 in the ER-CALUX and the yeast screen. Other yeast-based estrogen screens have also 
reported different ligand potencies when compared to mammalian in vitro assays 
(Zacharewski, 1997). There may be a number of explanations for this difference in sensitivity 
between the two assays. One explanation is that permeability may considerably differ 
between the yeast and mammalian cell membranes, with the yeast cell wall allowing fewer 
substances to passively diffuse or exhibiting selective uptake of some compounds. Lyttle and 
coworkers (1992) developed a hyperpermeable strain of yeast by selecting the yeast on 
increasing concentrations of the antibiotic nystatin, which forms a trans-membrane canal with 
cholesterol, thereby producing a "leaky" membrane through which more ligands can pass. 
Using this hyperpermeable strain of yeast, they showed that less hydrophilic estrogen 
conjugate E2-valerate was more "estrogenic" than in wild type strains transformed with hER 
and hER-regulated reporter genes (Lyttle et al., 1992). Other mechanisms that may be 
involved in the difference in sensitivity between the yeast- and mammalian-based assays 
include differences in cellular transcription factors (Tora et al., 1989; Halachmi et al., 1994), 
multiple drug resistance (Dexter et al, 1994) and endogenous yeast estrogen binding proteins 
(Feldman et al, 1982). Another possibility is a difference in the solubility and availability of 
compounds in the assays. In the ER-CALUX assay, cells are exposed in medium containing 
5% serum. Proteins in serum may act as carriers for ligands, thereby increasing their 
bioavailability. No such carrier molecules are present in the water-based recombinant yeast 
medium. Arnold and colleagues (1996) demonstrated that addition of albumin, sex hormone 
binding globulins, or serum to yeast medium induced greater reporter gene activity by the 
synthetic estrogen diethylstilbestrol and xeno-estrogens o,p'DDT and octylphenol. 
The difference in response to anti-estrogens in the ER-CALUX assay and 
recombinant yeast screen forms another important distinction between the two assays. While 
classical anti-estrogens such as ICI 182,780 and tamoxifen are potent inhibitors of E2-
mediated reporter gene induction in the ER-CALUX assay, these compounds showed 
agonistic, rather than antagonistic, effects in the recombinant yeast screen (Table 3). Other 
studies have also reported the agonistic effects of ICI 182,780 and/or tamoxifen in yeast 
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(Lyttle et al, 1992; Shiau et al, 1996; Beresford et al, 2000; Dudley et al, 2000). In another 
study with the recombinant yeast screen, hydroxytamoxifen has also been shown to be a weak 
estrogen agonist (Beresford et al, 2000). However, in contrast to the results present in our 
study, OHT was able to antagonize E2-mediated (3-galactosidase activity, either partially 
(Beresford et al, 2000) or completely in dose-response related manner (Sohoni and Sumpter, 
1998). The reason why OHT did not demonstrate antagonistic effects in our study is unclear 
and may be due to differences in yeast cell culture or administration of test compounds. 
However, the fact that contradicting results have been reported for OHT in the recombinant 
yeast screen suggests that OHT is not a clear anti-estrogen in the yeast screen. A number of 
hypotheses have been offered to explain the lack of anti-estrogenic effects in yeast, including 
reduced permeability of the yeast cell wall to these compounds (Zysk et al., 1995) or lack of 
appropriate repressor compounds in yeast necessary for antagonism (Gaido et al., 1997). Data 
presented in a recent study favor the hypothesis that anti-estrogens work in mammalian 
systems by inducing ER down-regulation (Dudley et al., 2000), which is not attained in the 
yeast system. The difference in ability to differentiate between estrogen agonists and 
antagonists between the ER-CALUX and yeast recombinant screen should be kept in mind, 
particularly when testing complex mixtures for total estrogenic potency. Importantly, because 
the yeast screen is less sensitive to some (xeno-)estrogens than the ER-CALUX assay, larger 
samples would have to be processed when testing environmental matrices. Accordingly, when 
testing estrogenic potency in water and effluent, it was shown that considerably more material 
was needed in the yeast screen to elicit an estrogenic response than in the ER-CALUX assay 
(Murk et al, 2000). 
In vitro estrogenic potency of sediment extracts 
The ER-CALUX assay can be successfully applied to provide an indication of the 
estrogenic potency in complex mixtures, such as extracts from environmental matrices. Polar 
(acetone-soluble) extracts of sediments contained higher estrogenic activity than non-polar 
(hexane-soluble) extracts, demonstrating that biologically active estrogenic compounds may 
be of a more hydrophilic nature. Polar extracts of sediments sampled from Rotterdam Harbour 
showed the highest estrogenic activity of the twelve locations tested (Table 1). Though 
detailed chemical analysis of the levels of (xeno-)estrogens has not been carried out on these 
extracts, levels of some chemicals with estrogenic potency, such as polybrominated 
diphenylethers and polycyclic aromatic hydrocarbons (PAHs) have been measured in these 
sediments (De Boer et al., 2000). The highest concentrations of PAHs and PBDEs at the 
twelve sediment locations were found in Rotterdam Harbour sediments (De Boer et al., 2000). 
Some chemicals in these groups have previously been shown to be estrogenic in the ER-
CALUX assay, such as the PAH benzo[a]pyrene (Legler et al., 2000c) and some PBDEs 
(Meerts et al., 2000). Other evidence of the presence and effects of (xeno-)estrogenic 
compounds in Rotterdam Harbour sediments was found in mesocosm experiments in which 
female flounder exposed for three years in tanks containing harbour sediment showed 
premature vitellogenesis (Janssen et al, 1997). These results demonstrate that (xeno-
)estrogenic substances are not only of importance in the water phase, but may also accumulate 
in sediments in the aquatic environment. Therefore, more attention should be given to the 
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estrogenic effects of compounds that may be available to aquatic organisms via food and 
through contact with particulate matter and sediment. 
Estrogenic activity of environmentally relevant xeno-estrogens 
Recent studies have shown that akylphenol ethoxylates and phthalates are commonly 
detected in sediments in The Netherlands (Belfroid et al., 2000). Some of these substances are 
also estrogenic in the ER-CALUX assay. The degradation products of the alkylphenols with 
no (nonylphenol) or short sidechain ethoxylates (NP1E0 and NP2EO) show elevated 
estrogenic potency. Previous studies by Jobling and Sumpter (1993) and White and 
colleagues (1994) also demonstrated that NP and NP2EO could stimulate the estrogen-
responsive vitellogenin gene in trout hepatocytes at concentrations of 1000 nM and above. 
These compounds also increased breast cancer cell growth and stimulated ER transcriptional 
activity by transient transfections of an ERE reporter gene construct in MCF-7 breast cancer 
cells (White et al., 1994). Interestingly, the carboxylate acid derivatives of NPEOs (NP1EC 
and NP2EC) tested failed to induce estrogenic activity in the ER-CALUX assay (Table 3). 
However, White et al. (1994) showed NP1EC to be slightly more potent than NP or NP2EO 
in the cell-based assays described above. NP1EC and NP2EC have also been shown to induce 
reporter gene activity in a recombinant yeast estrogen screen at concentrations above 1 mg/1 
(Routledge and Sumpter, 1996). It is possible that the concentrations tested in this study (max. 
10 u,g/l) may have been too low to elicit luciferase induction. Though 4-octylphenol 
demonstrated estrogenic potency in the ER-CALUX, the OP ethoxylates tested (OP 8/9EO) 
were not estrogenic (Table 3). To our knowledge, these OP ethoxylates have not been tested 
earlier for estrogenic effects. 
Of the phthalate plasticizers tested in ER-CALUX, only butylbenzylphthalate (BBP) 
demonstrated full estrogen agonism (Figure 2). BBP has been previously shown to be 
estrogenic, both in stimulating breast cancer cell growth (Jobling et al, 1995; Soto et al., 
1995) and inducing ER transcriptional activity in both transiently transfected MCF-7 cells 
(Jobling et al, 1995) and in the recombinant yeast screen (Harris et al, 1997). Importantly, 
the high-volume use phthalate DEHP was not estrogenic in the ER-CALUX (Figure 2) or 
other in vitro estrogenicity assays (Harris et al, 1997). 
The commonly used chloro-s-triazine-derived herbicides triazine and atrazine, as well 
as the atrazine degradation products desethylatrazine, and deisopropylatrazine were not 
estrogenic in the ER-CALUX assay (Table 3). Accordingly, a recent study showed the failure 
of atrazine and simazine to elicit estrogenic effects using in vivo (uterine wet weight) and in 
vitro (breast cancer cell growth and ER-mediated reporter gene induction) assays (Connor et 
al. 1995). 
Prediction of in vivo effects using in vitro biotransformation 
Chemicals may be converted to active estrogens following in vivo metabolism. For 
some sediment-associated compounds such as PAH benzo[a]pyrene, as well as some PBDEs, 
it has been previously shown that metabolites are responsible for in vitro estrogenic activity 
(Charles et al, 2000a, Meerts et al, 2000). In order to provide an even more realistic 
screening tool, a biotransformation step was included in the ER-CALUX assay. Methoxychlor 
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was chosen as a model compound because it is a known pro-estrogen that must undergo 
hydroxylation to produce its estrogenic metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1 -
trichloroethane (HPTE) (Bulger et al, 1978). Pre-incubation of methoxychlor with Aroclor-
induced liver microsomes resulted in higher estrogenic activity of the metabolites in the ER-
CALUX assay than the parent compound (Figure 4b). Accordingly, other studies have shown 
that methyoxychlor is metabolised in vivo or using liver microsomes to produce the active 
estrogenic HPTE form (reviewed by Cummings, 1997). Estradiol, on the other hand, showed 
weaker estrogenic metabolites following pre-incubation with induced micrsomes. This is 
consequent with in vivo studies in which the stimulatory effect of liver microsomal enzymes 
on steroid metabolism is paralleled by a decreased action of estradiol (reviewed by Zhu and 
Conney, 1998). However, chemical analysis of the extracts obtained following microsomal 
incubations would be useful to identify which metabolites are responsible for activation or 
inactivation of a (xeno-)estrogen. In a recent study, Charles and colleagues (2000b) incubated 
methoxychlor with Aroclor 1254-induced liver microsomes directly with transiently 
transfected MCF-7 cells in a recombinant ERcc transactivation assay. Incubation with 
microsomes increased the estrogenic potency of methoxchlor in this study, and HPTE was 
identified by HPLC as one of three main metabolites formed. The inclusion of an incubation 
step with liver microsomes could provide a simple addition to a sensitive in vitro screen such 
as the ER-CALUX assay to provide more insight in the in vivo estrogenic potency of a 
suspected (xeno-)estrogen. 
In conclusion, the ER-CALUX assay is a very useful tool to rapidly characterize the 
(anti-)estrogenic potency of mixtures of compounds in small amounts of environmental 
matrices, such as sediment extracts. This assay appears to be more sensitive to both estrogens 
and anti-estrogens than the widely used recombinant yeast screen. The value of this assay is 
becoming increasing apparent through its current use in ongoing large-scale baseline studies 
to determine the exposure and effects of (xeno-)estrogens in The Netherlands (Vethaak et al, 
2000b). Addition of a metabolic transformation step, such as pre-incubation of test 
compounds with P450-induced rat liver microsomes, can provide valuable information 
regarding the potential estrogenic effects of metabolites of (xeno-)estrogenic compounds. 
Further research is underway to determine if in vitro estrogenic activity can predict in vivo 
events using a novel test system with transgenic zebrafish expressing the same recombinant 
luciferase gene as in the ER-CALUX assay (Legler et al, 2000a). 
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Abstract 
Estrogens are mainly excreted from humans and animals in a conjugated, biologically inactive 
form. Detection of "free" estrogens in the environment suggests that these conjugates are re-
converted to an active form. One possibility for this conversion is that bacteria in the 
environment can deconjugate estrogen metabolites through enzymatic hydrolysis. We have 
developed a simple method to determine if estrogen metabolites present in human urine and 
fish bile can be deconjugated by enzymatic hydrolysis into active estrogens. Estrogen 
glucuronides in human urine samples were subjected to enzymatic hydrolysis via incubation 
with 6-glucuronidase or live E. coli cells. Bile from male bream and flounder sampled from 
various freshwater and marine locations were also deconjugated. Deconjugated glucuronides 
were tested for estrogenic activity in a recently developed estrogen receptor-mediated 
luciferase reporter gene (ER-CALUX) assay in stably transfected T47D human breast cancer 
cells. Estrogen glucuronides in urine obtained from human males and females, as well as in 
male fish bile, were indeed converted to active forms following incubation with B-
glucuronidase or E. coli, indicating that bacterial hydrolysis may form a major contribution to 
the levels of estrogenic substances found in the environment. The highest estrogenic activity 
was found in deconjugated metabolites from urine of a pregnant woman, in which levels up to 
3000 nmol estradiol equivalents per liter urine were found following overnight incubation of 
urine with E. coli. In fish bile, high estrogenic activity of deconjugated bile metabolites 
correlated with elevated levels of (xeno-)estrogens in water as well as vitellogenin induction. 
Measurement of (deconjugated) bile and urine metabolites could form a useful biomarker for 
internal dose of (xeno-)estrogens in males. 
Introduction 
In mammals, estrogens are eliminated by metabolic conversion to less active or 
inactive water-soluble metabolites that are excreted via the urine and/or faeces. Oxidative 
metabolism of estrogens occurs mainly via hydroxylation in the liver (reviewed by Martucci 
and Fishman, 1993). Conjugation of hydroxylated metabolites occurs by glucuronidation, 
sulfonation and/or O-methylation (reviewed by Zhu and Conney, 1998). Conjugation is an 
essential step for excretion of waste products. In human urine, estrogens are excreted mainly 
as estrogen glucuronide conjugates, though minute quantities of parent form 17 P-estradiol 
(E2), as well as the metabolites estriol (E3) and estrone (El) are also excreted. For example, 
women can excrete around 2.4 ng E2, 4.6 (xg E2 and 7 ug El daily (Aldercreutz et al., 1986). 
Estrogens may also be excreted with the faeces, as small quantities of E2, E3 and El have 
been found in the faeces of females (Aldercreutz et al., 1994). Estrogens in the bile are 
excreted into the intestines, where they may be broken down by intestinal bacteria, thereby 
forming a de novo source of the active parent compound (Klaassen and Watkins, 1981). 
Ethinylestradiol (EE2), the widely used synthetic estrogen for contraception, can be excreted 
in higher amounts in the unchanged form in urine and faeces. In a study in which EE2 was 
administered orally, a total of 18.5% of the dose was excreted as unconjugated free EE2 
(Reed et al., 1972). In the urine, about 64% of the dose of EE2 was conjugated, compared to 
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70% in the faeces (Reed et al., 1972). In fish, glucuronidation is the dominant conjugation 
reaction for biliary excretion of steroids as well as xenobiotic compounds (Truscott, 1979, 
Truscott, 1983). In rainbow trout, estrogens are excreted for over 90% in the bile as E2-
glucuronides (Forlin and Haux, 1985). 
Despite the fact that estrogens are mostly excreted in conjugated, biologically inactive 
forms, many recent studies have reported the presence of parent forms of natural and 
synthetic estrogens in the environment (Shore et al, 1993; Arcand-Hoy et al., 1998, Desbrow 
et al., 1998, Belfroid et al., 1999a). It is possible that conjugated estrogens become 
deconjugated as they pass through the sewage process, or even before reaching the sewage 
treatment works. Several enzymes produced by bacteria are capable of transforming steroids. 
For example, P-glucuronidase is capable of hydrolysing acid glucuronides back to their 
primary compounds (Ralovich, 1991). This enzyme is present in various micro-organisms, 
such as E. coli, in faeces and sewage treatment works. Recent studies with the fathead 
minnow (Pimephales promelas) exposed to the conjugated E2 metabolite estradiol 3-
glucuronide in the presence of laboratory simulated sewage treatment processes showed 
estrogenic effects (i.e. the induction of plasma vitellogenin) not seen in fish exposed to E2 3-
glucuronide alone (Panter et al., 1999). 
The objective of this study is to develop and apply a simple method to measure the 
bacterial deglucuronidation of (xeno-)estrogens glucuronides present in urine and fish bile in 
order to determine if transformation of metabolites by bacteria can form a major source of the 
high levels (xeno-)estrogens both in the environment and internally in fish. Incubation of 
human urine and male fish bile samples with P-glucuronidase from E. coli and the mollusc H. 
pomatia, as well as live E. coli cells, was used. The estrogenic activity of deconjugated (xeno-
)estrogens was quantified using the in vitro estrogen receptor (ER)-mediated Chemical 
Activated Luciferase gene expression (ER-CALUX) assay with stably transfected T47D 
breast cancer cells. To determine if estrogenic activity in deglucuronidated fish bile samples 
could provide an indication of internal dose of (xeno-)estrogens, comparison with induction 
of plasma vitellogenin in the same fish was performed. In addition, the estrogenic potency of 
a number of (xeno-)estrogens that may be present in urine and bile was determined using the 
ER-CALUX assay. 
Materials and Methods 
Chemicals 
17P-estradiol (E2, 99%), estradiol 3(B-D-glucuronide (E2-glucuronide, 99%), estriol 
(E3, 99%), benzo[a]pyrene and ethanol (100%, p.a.) were purchased from Sigma Chemicals. 
Estrone (El, p.a.) and 17a-estradiol (E2-17a, p.a.) were from Brunschwig. Ethinylestradiol 
(EE2, 98%) was purchased from Aldrich. Dimethyl sulfoxide (DMSO, 99.9%, spectrop-
hotometric grade) was purchased from Acros. 
ER-CAL UK assay procedure 
The ER-CALUX assay procedure and cell culture is described in detail elsewhere 
(Legler et al., 1999). Briefly, stably transfected T47D cells were plated in clear plastic 96 well 
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plates (Nucleon, Denmark) at a density of 5000 cells in 0.1 ml DMEM-F12 without phenol 
red supplemented with 5% dextran-coated charcoal treated fetal bovine serum (DCC-FBS) 
per well. Following 24 hours incubation, medium was renewed and the cells incubated for 
another 24 hours. The medium was then removed and the cells were dosed in triplicate by 
addition of the dosing medium containing the chemical or extract to be tested dissolved in 
ethanol or DMSO (max. 0.2%). Control wells, solvent control wells and E2 calibration points 
(6 pM and 30 pM) were included in triplicate on each plate. Following 24 hours treatment, 
medium was removed and cells were lysed in 50 ul triton-lysis buffer, pH 7.8 (containing 1% 
triton X-100, 25 mM glycylglycin, 15 mM MgS04, 4 mM EGTA and 1 mM DTT) for a 
minimum of 1 hour with gentle shaking at 4°C. A sample of 25 ul lysate was then transferred 
to a black 96 well plate (Costar) and 25 ul of luciferin solution (Luclite, Packard) was added 
per well. Luciferase activity was assayed in a scintillation counter (Top Count, Hewlett-
Packard) for 0.1 minute per well. 
Extraction of estrogen conjugates from urine 
For all extraction procedures, glassware was pre-rinsed with ethyl acetate (p.a., 
Merck). 
First morning urine was collected from males and females and aliquoted in 2 ml 
portions over 4 glass test tubes. Concentrated hydrochloric acid (HC1) was added with a 
pasteur pipette, one drop per ml urine, and the tubes vortexed. Ethyl acetate (2 ml) was added 
to each test tube, the tubes vortexed for one minute, and centrifuged 5 minutes at 3800 rpm. 
The ethyl acetate fraction was removed with a pasteur pipette and transferred to a clean test 
tube. Because of protein formation in between the water/solvent phases, 500 ul isopropanol 
was added once after centrifugation. The extraction was repeated a total of 3 times, after 
which the collected ethyl acetate extract was carefully evaporated to a small drop under a 
gentle N2 gas flow at 37°C. The extract was transferred to a glass conical vial and the test 
tube rinsed 3 times with ethyl acetate, and transferred to the conical vial. The remaining ethyl 
acetate was evaporated at 37 °C under N2 gas. The extract was then taken up in 100 ul 
ethanol. 
Deconjugation of urinary and biliary estrogen conjugates 
As a positive control of the deconjugation reactions in all experiments, 1 nmol 17 |3-
estradiol 3(B)-D-glucuronide per ml urine was included in the procedures described below. 
i) Incubation of urine with B-glucuronidase preparations 
B-glucuronidase purified from E. coli or B-glucuronidase/arylsulfatase from H. 
pomatia (Sigma) were compared. For reactions with fi-glucuronidase purified from E. coli, 
885 ul distilled water was added to a test tube, followed by 500 ul of a 75 mM potassium 
phosphate buffer ((KH2P04), pH 6.8 with 1% (w/v) bovine serum albumin). Urine extract 
(15 ul) then added to the tube. The solutions were mixed and equilibrated at 37°C. 100 ul (J-
glucuronidase (400 U/ml in cold KH2P04 buffer) was added, mixed by inversion, and 
incubated for 30 minutes, 3 hours or 18 hours at 37°C. For incubations with B-
glucuronidase/arylsulfatase enzymes purified from H. pomatia, the incubation mixture was 
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composed of 700 ul buffer (100 mM sodium acetate buffer (NaAc), pH5.0), 685 ul distilled 
water, 15 ul urine extract, and 100 ul enzyme (400 U/ml NaAc buffer). 
In addition to deconjugation using urine extracts, pure urine was also used. First 
morning urine was collected from a man, woman and pregnant woman. Distilled water (1 ml) 
was used as a control. For reactions with B-glucuronidase purified from E. coli, 1 ml urine 
was mixed with 555 ul KH2P04 buffer and 40 U B-glucuronidase. For reactions with B-
glucuronidase/arylsulfatase enzymes purified from H. pomatia, 1 ml urine was mixed with 1 
ml NaAc buffer and 40 U enzyme. Incubations with pure urine were carried out for 18 hours 
at 37°C. 
it) Incubation of urine with live E. coli culture 
Urine estrogen conjugates in pure urine from male, female, 6-month pregnant female 
and control (water only) were also deconjugated using wild type E. coli cells. E. coli cells 
were cultured overnight in a 37°C water bath with gentle shaking in tubes containing 10 ml 
growth medium (10 g/1 bacto-tryptone, 5 g/1 yeast extract and 10 g/1 NaCl). First morning 
urine (1 ml) was added to duplicate tubes, followed by 1 ml growth medium. A 10 ul sample 
of the overnight E. coli culture (OD 1) was transferred to the tubes, and left overnight to grow 
in a 37°C water bath. 
Hi) Fish bile incubation with /^-glucuronidase preparations 
The freshwater and marine sampling locations for bream (Abramis brama) and 
flounder (Platichthys flesus) in The Netherlands are described elsewhere (Vethaak et al., 
2000c). Bile samples were frozen and stored at -20°C. Bile samples were thawed on ice, and 
samples of 100 ul bile were transferred to glass test tubes. Sodium acetate-3H20 buffer (100 
mM, pH 5.0 at 37°C) was added at a volume of 700 ul. Distilled water (600 ul) and 100 ul of 
400 U/ml (3-glucuronidase/arylsulfatase (from H. pomatia) was added. Tubes were incubated 
overnight (17-18 hrs) in a 37°C water bath with gentle shaking. 
Extraction of deconjugation products 
Following incubation of urine (extracts) and fish bile with P-glucuronidase enzyme 
preparations or E. coli cells, deconjugations products were extracted with ethyl acetate. For 
samples with E. coli cells, tubes were first centrifuged at 3800 rpm for 20 minutes to pellet 
the cells. The supernatant was then transferred to a fresh tube. For the extraction of urine and 
bile, 2 drops of HC1 (1 N) were added to each tube and vortexed. Ethyl acetate (2 ml) was 
then added, and the samples vortexed for 1 minute and centrifuged at 3800 rpm for 5 minutes. 
The overlying ethyl acetate fraction was transferred to a clean tube, and the extraction 
procedure repeated a total of three times. The collected ethyl acetate extract at 37°C was 
carefully evaporated to a small drop under a gentle N2 gas flow. The extract was transferred 
to a glass conical vial and the test tube rinsed 3 times with ethyl acetate, and transferred to the 
conical vial. The remaining ethyl acetate was evaporated at 37 °C under N2 gas. The extract 
was then taken up in 50 ul DMSO and tested in the ER-CALUX assay as described above. 
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Extraction efficiency 
The efficiency of extracting deconjugation products was determined using 3H-labelled 
estradiol (3H-E2). The radiolabeled E2 was added to 2 ml of buffer reagent from the reactions 
with B-glucuronidase, or 2 ml of E. coli growth medium in glass tubes. The samples were 
vortexed and left to stand for 15 minutes. The extraction was carried out as described above 
using four extraction solvents: dichlormethane, ethyl acetate, diisopropylether and 
hexane:dietylether (97:3). After each extraction step (three in total), the extract was 
transferred to a plastic counting tube. To each tube, 9 ml of counting fluid (Ultima Gold, 
Packard) was added and the tubes are shaken well. The amount of 3H was measured in a 
liquid scintillation analyzer (Packard). 
Estrogenic activity in environmental samples 
Samples of water, particulate matter, sediment and biota (fish and mussels) were 
sampled from the same location as the fish sampled for the bile studies. The extraction of 
these samples is described elsewhere (Vethaak et al., 2000c). These extracts were dissolved in 
DMSO and tested in the ER-CALUX assay as described above. 
Vitellogenin induction 
Vitellogenin (VTG) was measured in plasma in the same male bream and flounder in 
which bile estrogenic activity was determined. VTG was measured using a 96-wells 
competitive ELISA method adapted from Smeets et al (1999). The primary antibody, raised 
against goldfish by the Michigan State University, showed good cross-reactivity with bream 
VTG. 
Data analysis 
For quantification in the ER-CALUX assay, data shown are representative of a minimum 
of three independent assays. Extraction with urine and bile were carried out in a minimum of 
two independent experiments. For quantification of the estrogenic potency of an 
environmental sample, urine or bile extract, the response of the extract is interpolated in a 
dose-response curve of the standard E2. For this the curve-fitter of Slide Write 4.0 was used 
(cumulative fit). The R of the fit of the standard curve was above 0.98. The extracts were 
diluted so that the response used for interpolation was between the signal of 1 and 6 pM 
(linear portion of curve) only. The estrogenic potency of the extract is expressed as EEQ 
(estradiol equivalents) per volume of material. 
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Results and Discussion 
Estrogenic potency of natural, synthetic and xeno-estrogens in ER-CALUX assay 
In order to determine the sensitivity of the ER-CALUX assay to natural, synthetic and 
xenobiotic estrogens that may be present in urine, we exposed cells to parent compounds 
(estradiol, E2), metabolites (17a-estradiol (E2-17a), estrone (El) and estriol (E3)) and one 
E2-glucuronide conjugate, as well as ethinylestradiol (EE2) and benzo(a)pyrene (BAP). 
Exposure of T47D.Luc cells to E2 for 24 hours resulted in a detection limit of 0.5 pM and an 
EC50 of 6 pM (Figure 1). Maximum induction at 30 pM E2 relative to control was about 100 
fold. El and 17a-E2 were about 5-500x less potent than E2 (Figure 1), with an EC50 of 27 
and 530 pM, respectively. Interestingly, E3 was as potent in the ER-CALUX assay as E2 
(Figure 1), with an EC50 of 6 pM. E3 has been previously shown to have about 10 times less 
binding affinity to rat ER (Blair et al., 2000), as well as 10 times less ER transactivational 
activity (Melamed et al., 1997) than E2. The mechanism underlying the equal potency of E3 
and E2 in the ER-CALUX assay are unclear, though tissue specific effects of E3 are possible, 
as E3 was also shown to be a full agonist in breast cancer cell proliferation (Soto et al., 1995). 
The synthetic estrogen EE2 was slightly more potent than E2, with an EC50 of 5 pM (Figure 
1). The higher potency of EE2 compared to E2 is due its higher binding affinity to the ER 
(Blair et al., 2000), as well as its stability and resistance to metabolisation (Guengerich, 
1990). T47D.Luc cells possess minimal intrinsic deconjugation activity, as exposure to 
increasing concentrations of P-estradiol 3-(B-D)-glucuronide (E2-gluc) did not result in 
increased luciferase activity (Figure 1). 
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Figure 1: Estrogenic activity (fold induction relative to solvent control) of various 
estrogens, including natural estrogens (estradiol (E2); estrone (E1) 17a-estradiol (E2-17a) 
and estriol (E3)), estrogen metabolites (P-estradiol 3-(B-D)-glucuronide (E2-gluc)), synthetic 
estrogens (ethynylestradiol (EE2)) as well as benzo[a]pyrene (BaP) in the ER-CALUX assay. 
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In addition to the natural and synthetic estrogens, BaP was tested for estrogenic 
potency because its hydroxylated metabolites are widely detected in human urine (reviewed 
by Angerer et ah, 1997) and fish bile (Leadly et al., 1999 and references therein) as a 
biomarker of exposure to aromatic hydrocarbons. BaP demonstrated weak estrogenic activity 
in the ER-CALUX assay, with an EC50 of 3200 nM (Figure 1). Charles and colleagues 
(2000) also recently demonstrated the estrogenic activity of BaP in an ER-a mediated reporter 
gene assay, and provided evidence that estrogenic activity was predominantly produced by 
hydroxylated metabolites of BaP. 
Enzymatic deconjligation of estrogen glucuronides in urine 
Extraction of deconjugated estrogens was performed with ethyl acetate because this 
solvent resulted in the highest recovery (98% recovery, data not shown) of the solvents tested 
using 3H-E2 spiked reaction buffer. Enzymatic deconjugation of estrogen glucuronides in 
(extracts of) male and female urine samples resulted in increased estrogenic activity as 
measured in the ER-CALUX assay (Table 1). These results indicate that inactive metabolites 
in urine can be readily converted to biologically active estrogens by bacterial enzymes. Urine 
spiked with (3-estradiol 3-(B-D)-glucuronide (E2-gluc) was efficiently converted to active E2 
by (3-glucuronidase from both E. coli and H. pomatia (Table 1). Of the 1 nmol/ml E2-gluc 
spiked urine, 1 to 1.4 nmol/ml EEQ was found following 18 hour incubation with both 
enzyme preparations (Table 1), indicating complete enzyme hydrolysis. In general, longer 
incubation times with p-glucuronidase preparations (up to 18 hours) increased the activation 
factor (Table 1). Higher (about 2-3 times) deglucuronidation of estrogen glucuronides was 
found pure urine samples than in urine extracts when incubated for 18 hours (Table 1). This 
difference is likely due to the loss of glucuronides during the first extraction step of urine. 
Although H. pomatia has both glucuronidase and sulfatase activity so estrogen sulfates may 
be also hydrolysed, little difference was found in the estrogenic activity in urine metabolites 
conjugated with (3-glucuronidase purified from E. coli and H. pomatia. Previous studies have 
also shown little difference in these 2 enzyme preparations to hydrolyse estriol glucuronides 
in urine (Graef et al, 1977). Interestingly, in both pure urine and urine extracts, the difference 
in deconjugated estrogens between female male and urine is about a factor of 4 (Table 1). 
This corresponds to reports of estrone excreted by women (3-20 ug/person/day) and men (5 
ug/person/day) (Gower, 1975). 
Hydrolysis of estrogen glucuronides using E. coli cells 
Incubation of pure male and female urine with E. coli cells resulted in an efficient 
conversion of estrogen conjugates to active estrogens that could be easily measured in the ER-
CALUX (Table 2). Extraction efficiency of 3H-E2 from E. coli growth medium was about 
98% using ethyl acetate (data not shown). Urine sampled from the pregnant female contained 
the most estrogen conjugates, as conversion by E. coli resulted in extremely high estradiol 
equivalents (2800 nmol EEQ/1 urine), about 150 times more than a non-pregnant female. 
During pregnancy, estriol is the most abundant estrogen, and E3 levels rise to about ten times 
that of estradiol and estrone (De Hertogh et al., 1975). In this study, E3 was as active as E2 in 
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the ER-CALUX assay (Figure 1). Assuming a production of 2 liters of urine per day, the EEQ 
level found in the pregnant woman in this study would be the equivalent to about 5 umol 
estrogens/day. Accordingly, Fostis (1987) reported excretion of up to 10 p.mol/day of 
estrogens by pregnant women. These results provide clear evidence that E. coli can convert 
metabolites present in urine into biologically active estrogens. This efficient conversion of 
glucuronides to active estrogens forms a major source of estrogens in the aquatic 
environment. In a recent study in The Netherlands, elevated estrogenic activity was measured 
using the ER-CALUX assay in influent and effluent samples from treatment plants receiving 
domestic wastewater (Murk et al., 2000). The highest contribution to the estrogenic activity 
measured in these samples was the natural estrogens E2 and El, as well as EE2 (Murk et al., 
2000). 
Enzymatic hydrolysis of estrogen glucuronides in fish bile 
Bile samples from male bream and flounder collected from 5 locations within The 
Netherlands contained metabolites that could be converted to active estrogens via enzymatic 
hydrolysis (Table 3). Activation factors following deglucuronidation of bile samples ranged 
from 17-590 (data not shown). Male bream sampled from a small freshwater river (The 
Dommel) showed high levels of biliary (xeno-)estrogens (up to 8700 pmol EEQ/ml) in 
comparison to the freshwater reference site Vrouwenzand (up to 65 pmol EEQ/ml) (Table 3). 
Accordingly, elevated EEQs were found in the surface water of this river (8.5 pmol EEQ/1), as 
well as in freshwater mussels (145 pmol EEQ/1) (Table 3). Additional evidence of exposure to 
(xeno-)estrogens at this location was found in the extremely high plasma vitellogenin levels in 
the same bream (Table 3). Recent studies have shown that the wastewater treatment plant 
effluent released in this river contains high levels of compounds that are estrogenic in the ER-
CALUX as well as a novel in vivo assay using estrogen-sensitive transgenic zebrafish (Legler 
et al., 2000d). In partial life cycle studies with zebrafish, chronic exposure to this effluent has 
been found to influence sexual differentiation (Bulder et al, 2000). In addition, wild 
populations of bream sampled from this river showed increased number of hermaphroditic 
fish compared to other locations in The Netherlands (Vethaak et al, 2000b and 2000c). 
Interestingly, bile sampled from male flounder showed relatively little difference in 
estrogenic activity in between reference areas (Eastern Scheldt) and relatively polluted areas 
(Amsterdam) (Table 3). Plasma vitellogenin levels in these flounder were also not elevated 
(Table 3). As the flounder is a benthic species, it is likely that it is mainly exposed to (xeno-
)estrogens through contact with the sediment. Estrogenic activity in the sediment was low in 
all three locations (Table 3), suggesting that the flounder were not exposed to elevated levels 
of (xeno-)estrogens. In addition, flounder may not be as sensitive to estrogenic compounds as 
other fish species, as laboratory exposure of flounder to EE2 showed a threshold value for 
vitellogenin induction about 10 times higher than rainbow trout (Allen et al., 1999). 
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Table 1: Estrogenic activity of deglucuronidated estrogen glucuronides in male and 
female urine (nmol estradiol equivalents EEQ/L urine), ^-glucuronidase ((3-glucuron) 
purified from H. pomatia (also containing arylsulfatase activity) and E. coli was incubated 
with pure urine or urine extracts for various incubation periods (inc. time). 
Matrix 
Urine (pure) 
Male 
Female 
Male, spiked6 
E2-gluc. 
Urine (extract) 
Male 
Female 
Male, spiked 
E2-gluc. 
Source 
(3-glucuron. 
H. pomatia 
E. coli 
H. pomatia 
E. coli 
H. pomatia 
E. coli 
H. pomatia 
H. pomatia 
E. coli 
H. pomatia 
Inc. time 
(hours) 
0 (control) 
18 
18 
0 (control) 
3 
18 
3 
18 
0 (control) 
3 
18 
3 
18 
0 (control) 
3 
18 
0 (control) 
3 
18 
3 
18 
0 (control) 
0.5 
3 
18 
nmol EEQ/L 
urine 
0.2 
16 
21 
0.9 
26 
71 
82 
69 
22 
299 
1042 
1109 
1422 
0.2 
4.0 
6.6 
0.6 
22 
25 
22 
26 
0.9 
347 
1753 
1082 
Activation 
Factor" 
77 
101 
28 
77 
89 
75 
14 
47 
50 
65 
20 
33 
37 
42 
37 
43 
386 
1948 
1202 
"Activation factor represents the factor increase in estrogenic activity relative to control. 
b
 Male urine was spiked with 1 nmol P-estradiol 3-(B-D)-glucuronide (E2-gluc)/ml urine. 
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Table 2: Estrogenic activity of deglucuronidated estrogen glucuronides in male and 
female urine (nmol estradiol equivalents EEQ/L urine). Pure urine was incubated 
overnight with live E. coli cells and hydrolysed estrogens were extracted and tested in the ER-
CALUX assay. 
Matrix 
Urine (pure) 
Male 
Female 
Pregnant 
Female 
male, spiked b 
E2-gluc. 
Conversion 
- E. coli 
+ E. coli 
- E. coli 
+ E. coli 
- E. coli 
+ E. coli 
- E. coli 
+ E. coli 
nmol EEQ/L 
urine 
2 
20 
8 
19 
34 
2825 
2 
2635 
Activation 
Factor3 
10 
2 
83 
1318 
"Activation factor represents the factor increase in estrogenic activity relative to control. 
b
 Male urine was spiked with 1 nmol P-estradiol 3-(B-D)-glucuronide (E2-gluc)/ml urine. 
Comparison of the results of biliary (xeno-)estrogenic activity and VTG induction in 
male bream in a polluted system suggests that measurement of estrogenic activity in bile may 
provide a useful indication of internal dose of (xeno-)estrogens for this fish species. Because 
the sample size in this study was small, results from a previous study were also analysed. 
Male bream were sampled from 8 different locations in the spring of 1999 in the Netherlands, 
and bile estrogenic activity measured in the ER-CALUX assay following deglucuronidation. 
A good correlation (coefficient of determination = 0.81) was found between bile EEQs and 
plasma vitellogenin induction in these fish (Figure 2). Of course, chemical analysis of bile 
samples is necessary to determine the identity of (xeno-)estrogens that may contribute to 
internal levels. In addition to estrogen glucuronides, BaP and nonylphenol are two examples 
of xeno-estrogens that are present in fish bile mainly as glucuronides (James et al., 1991; 
Arukwe et al., 2000). In this study, BaP and in a previous study, nonylphenol (Legler et al, 
1999) were demonstrated to be estrogenic in the ER-CALUX assay. 
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Table 3: Estrogenic activity of deglucuronidated estrogen glucuronides in male fish bile 
(pmol estradiol equivalents EEQ/ml bile). Deglucuronidated (xeno-)estrogens were 
extracted and tested in the ER-CALUX assay. EEQs in extracts of water (pmol/1), particulate 
matter and sediment (pmol/g) and biota (fish and mussels) (pmol/kg) taken from the same 
location. Vitellogenin (VTG, ng/ml) was measured in plasma of same fish. 
Fish 
# Location 
Estradiol equivalents (EEQ) 
Bile3 water 
part, 
mat. sed. fish mussels VTG 
Bream 
1 
2 
4 
5 
3 
4 
9 
13 
Vrouwen-
zand 
Dommel 
Flounder 
37 
9 
27 
3 
1 
9 
16 
34 
4 
16 
14 
21 
Eastern 
Scheldt 
Amsterdam 
North Sea 
Canal 
Den Oever 
65 
58 
34 
51 
2265 
8670 
3865 
1150 
92 
61 
281 
38 
166 
164 
115 
59 
328 
54 
76 
56 
0.0 0.2 2.3 34.2C 
8.5" 1.0 11.8 145.4C 
0.1 0.1 1.8 0.9" 
0.6 0.1 0.0 21.6 23.9C 
0.0 0.1 0.0 1.5 
51 
143 
141 
54 
26E6 
25E6 
15E6 
3.0E6 
511 
<d.l" 
<d.l. 
1095 
888 
1287 
242 
<d.l. 
330 
<d.l. 
<d.l. 
<d.l. 
ap-glucuronidase purified from H. pomatia was incubated with bile for 18 hours. 
bsample taken from receiving waters of waste water treatment plant effluent (Legler et al., 2000d) 
'freshwater mussels, n=400 
dsaltwater mussels, n=200 
n.m.: not measured 
<d.l.: below detection limit 
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Figure 2: Estrogenic activity (EEQ, pmol/ml) in bile and vitellogenin (ng/ml plasma) in 
male bream from 8 different locations in The Netherlands. 
In conclusion, we have developed a method to rapidly test if estrogenic metabolites 
present in small samples of urine and bile can be transformed to active estrogens through 
enzymatic hydrolysis using a rapid and sensitive in vitro reporter gene assay. Indeed, 
enzymatic hydrolysis by E. colt is very effective in transforming conjugated metabolites to 
active parent compounds. We propose that this effective transformation of metabolites by 
bacteria can form a major source of the high levels of natural and xenobiotic estrogens found 
in environmental compartments. Though chemical validation is needed, the use of the ER-
CALUX assay with deconjugated bile and urine estrogen metabolites may form a promising 
biomarker of internal exposure. 
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Abstract 
Adverse trends in the reproductive health of male fish, including testis abnormalities and 
intersex gonads, have been increasingly reported over recent years. These effects have been 
associated with the exposure of fish to natural, synthetic and xenobiotic estrogens present in 
the aquatic environment. A novel in vivo test system using transgenic zebrafish has been 
developed to rapidly determine the effects of estrogenic chemicals on critical life stages and 
sensitive target organs in the fish. In the transgenic zebrafish, an estrogen binding sequence 
linked to a TATA box and luciferase reporter gene was stably introduced. Binding of a 
substance to endogenous estrogen receptors (ER) and the subsequent transactivation of the ER 
result in luciferase gene induction that is easily measured in tissue lysates. Exposure to 
estradiol (E2) during juvenile stages of the transgenic zebrafish revealed the period of gonad 
differentiation to be the most responsive early life stage. In adult male transgenic zebrafish, 
the testis was the most sensitive and responsive target tissue to estrogens. Partial sequences of 
zebrafish estrogen receptor subtypes a and (3 were cloned for the first time and were found to 
be differentially expressed in developing fish and tissues of adult male zebrafish. The 
transgenic zebrafish assay is a promising new tool to rapidly determine the estrogenic potency 
of chemicals in vivo. 
Introduction 
Endocrine disruption is an issue that has raised public concern and is on the political 
and research agenda of governments worldwide. Reports of chemicals in the environment that 
can mimic the actions of endogenous estrogens, thereby disturbing normal endocrine 
functions and causing male reproductive dysfunction in humans and wildlife (reviewed in 
Colburn et al., 1993; Golden et al., 1998, Sumpter, 1998), are increasing. In wild fish 
populations, intersex (the simultaneous presence of both male and female gonadal 
characteristics) and testis abnormalities have been found in a high proportion of male fish 
sampled in rivers, estuaries and coastal waters (Jobling et al., 1998, Lye et al., 1997, Allen et 
al, 1999). These feminizing effects have been associated with exposure to environmental 
levels of natural, synthetic and xenobiotic chemicals (xeno-estrogens) in the aquatic 
environment. Natural estrogens include the female hormones estradiol, estrone and estriol. 
Synthetic estrogens are pharmaceutical chemicals designed to mimic the action of natural 
estrogens, such as the birth control pill component ethinylestradiol as well as 
diethylstilbestrol. Xeno-estrogens can be defined as environmental and industrial pollutants 
that are not designed to be used as estrogens, but nevertheless can evoke effects via the 
estrogen receptor signal transduction pathway. Laboratory exposure of male fish to (xeno-
)estrogens has resulted in the synthesis of high levels of the estrogen-inducible yolk precursor 
protein vitellogenin (VTG) as well as inhibited testicular growth, testis abnormalities and 
formation of intersex gonads (reviewed in Tyler et al., 1998). 
Regulations aimed at determining a substance's potential to disrupt endocrine systems 
have proven to be extremely difficult because estrogenic substances often have very different 
chemical structures, hampering their analysis and risk assessment on a structural basis. Tests 
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to determine estrogenic effects on laboratory animals are available but are laborious, time-
consuming, costly, and may require large amounts of animals. As an alternative, simpler 
screening methods such as in vitro reporter gene assays have been developed, allowing large-
scale screening of chemicals (reviewed in Zacharewski, 1997). These assays make use of the 
fact that the receptor for estrogens is a transcription factor that induces transcription of target 
genes after binding to specific DNA sequences in their promoter. However, major drawbacks 
of such cell lines are, compared to in vivo measurements in animals, that important aspects of 
in vivo functioning such as metabolic conversion and breakdown can be missed. Moreover, no 
assessment can be made of the vulnerability of critical life stages, such as developing 
embryos, to the hormonal disrupting compounds. 
With this in mind, we have developed a novel test system for (xeno-) estrogens using 
zebrafish in which an estrogen responsive reporter gene has been stably introduced. Using 
transgenic reporter zebrafish, the direct effects of estrogenic chemicals on estrogen-sensitive 
tissues can be readily determined during various stages of sexual development. Because of the 
large number and rapid development of offspring, transgenic zebrafish can combine the 
advantages of in vitro and in vivo systems to provide a rapid and simple in vivo model to 
screen for hormonally active substances. In addition, zebrafish genetics and early 
development have been widely studied (Haffter and Nusslein-Volhard, 1996) and it is a 
recommended freshwater fish species for toxicity testing (OECD, 1992). Using these 
transgenic fish, we show reporter gene induction in vivo by (xeno-) estrogens following short 
term exposure, demonstrating the presence of highly responsive estrogen receptors in sexually 
differentiating juvenile fish. Of the wide range of organs tested in adult male fish, the 
reproductive organs appear to be the main target tissue for estrogens. 
Experimental section 
Generation of transgenic zebrafish 
Zebrafish were maintained at 27°C on a 14 hours light/10 hours dark photoperiod and 
were fed brine shrimp Artemia salinas four times daily. To generate transgenic zebrafish, 
zebrafish embryos were microinjected with 15 pg of the supercoiled DNA construct 
pEREtata-Luc (Legler et al., 1999) prior to first cleavage essentially according to Stuart et al, 
1988. In total, about 1600 embryos were injected. At 24 hours post fertilization (h.p.f), 940 
(56%) of embryos survived and were individually tested for luciferase expression by 
immersion in 200 (il of a non-toxic luciferin substrate solution (20 mM tricine, 1 mM 
(MgCO)4MgOH2-5H20, 2.67 mM MgS04, 0.1 mM EDTA, 270 uM coenzyme A, 470 uM 
luciferin, 530 uM ATP, pH 7.8)) in 96-well plates. Embryos were assayed for luciferase 
activity in a scintillation counter (Top Count, Packard). Embryos with luciferase expression 
(about 500 embryos or 55% of the survivors) were selected and reared to sexual maturity 
(approx. 3 months). Potential founder transgenic fish were crossed with wild type zebrafish. 
Fi offspring at 24-48 h.p.f. were pooled in eppendorf tubes (about 60 embryos per tube) and 
lysed overnight at 55°C in 500 uj lysis buffer containing 100 mM Tris.HCl (pH 8.5), 5 mM 
EDTA, 0.2% SDS, 200 mM NaCl and 100 ng/ml proteinase K. Genomic DNA was extracted 
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each of dATP, dCTP, dGTP and dTTP (Gibco B.R.L.) and 1.5 units of TAQ polymerase 
(Eurogentec). Primers for zfERa, zfER-P and GAPDH were used a concentration of 20 pmol 
per reaction. PCR reactions were carried out in a Biometra PCR using 35 cycles of 
amplification for each reaction. The following conditions were used: denaturation at 95CC for 
5 min., annealing at 53°C (zfERa), 68 °C (zfERP) or 58°C (GAPDH) and extention at 72°C 
for 1 min. As a positive control, a sample of 10000 copies of zebrafish liver cDNA was 
included in the amplification reaction. No PCR products were found in RNA or water 
controls. 
Immunohistochemistty 
Adult male transgenic and wild type fish were fixed in 4% paraformaldehyde 
containing 10% EDTA and embedded in paraffin. Immunohistochemistry was performed on 5 
|im sections following antigen retrieval by heating sections four times for 5 minutes in 10 mM 
citrate buffer, pH 6. Following blocking with 20% swine serum, sections were incubated with 
a 1:200 dilution of an affinity purified rabbit polyclonal anti-luciferase (Promega), followed 
by avidin-conjugated swine anti-rabbit Ig, and avidin-peroxidase with a biotin bridge. 
Reactivity was visualized using diaminobenzidine + H2O2 (Sigma). 
Results and Discussion 
We developed transgenic zebrafish stably expressing pEREtata-Luc an estrogen 
responsive luciferase reporter gene regulated by three estrogen response elements (ERE) 
upstream from a TATA box. The pEREtata-Luc construct and activation by estradiol in vitro 
have been described elsewhere (Legler et al., 1999). Since enhancer and promoter regions 
other than the ERE are absent in this construct, it very specifically responds to estrogen 
receptor (ER) activation. Compounds activating endogenous estrogen receptors in target cells 
lead to receptor binding to the EREs and consequently activate transcription of the luciferase 
gene. Following short term exposure of transgenic zebrafish to (xeno-) estrogens, the 
production of luciferase protein can be easily assayed by preparing tissue lysates, and 
measuring light activity following addition of the enzyme substrate luciferin. 
Estrogen receptor gene activity is developmental^ regulated in transgenic zebrafish 
Expression of luciferase in transgenic zebrafish was determined in developing life 
stages following 48 hours exposure in water to 1000 nM E2 (Fig. la). Range finding toxicity 
tests carried out prior to these experiments under the same exposure periods established that 
this concentration did not cause acute toxicity (data not shown). In embryos less than 28 days 
post fertilization (d.p.f.), luciferase activity could be easily assayed in lysates of pooled 
embryos. In fry between 28 and 35 d.p.f. of approximately 1 cm length, luciferase activity 
was assayed in lysates of individual embryos. Luciferase induction increased with age and 
stage of gonad differentiation, ranging from 4-fold in 1 day old embryos (1 d.p.f.) to 100 to 
300-fold induction in 35 d.p.f. juvenile transgenic fry relative to vehicle-exposed controls 
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(Fig. la). Gonad differentiation in the zebrafish commences at about 2 weeks of age in 
zebrafish (Takahashi, 1977). Clear evidence of female ovarian and male testicular gonad 
differentiation has been observed in fry at about 28 d.p.f. (Wester, unpublished results). Our 
results indicate that transgene induction correlates with the sexual development of the 
zebrafish. 
As transgene expression is regulated by the ER, we determined the timing of 
expression and distribution of the zebrafish ER (zfER). We isolated specific fragments of ER 
subtypes a and (3 in zebrafish ovarian cDNA and designed specific primers for semi-
quantitative PCR (see Experimental Section). It should be noted that the PCR reactions with 
primers for zfER-p were more efficient than with the zfER-a primers (Fig. lb, control), 
indicating that the absolute levels of zfER-a mRNA may be underestimated. zfER-a mRNA 
was detected at all stages tested in the developing embryo and fry, though the expression is 
highest late in sexual differentiating stages (35 d.p.f.) (Fig. lb). zfER-P mRNA was also 
detected at all stages, though was low at 14 d.p.f, the stage of the onset of gonad 
differentiation. From 28 to 35 d.p.f, ERP mRNA expression increased, coinciding with high 
luciferase induction (Fig. la). Our results suggest that estrogen receptors are very active 
during sexual development. Therefore, the period of gonad differentiation may be very 
sensitive to disruption by estrogenic compounds. 
Ligand sensitivity of reporter gene induction in juvenile fish 
In order to determine the sensitivity of juvenile fish to E2, dose-response studies were carried 
out with transgenic 35 d.p.f. fry (Fig. 2a). A nominal concentration of 0.1 nM E2 resulted in 7 
+ 4-fold induction following 96 hours exposure (Fig. 2a), indicating that the juvenile fish 
undergoing sexual differentiation may be sensitive to E2. The concentration of 0.1 nM E2 is a 
realistic concentration that may be encountered in aquatic systems in the environment 
(Desbrow et al., 1998). Some natural, synthetic and xenobiotic estrogens were also tested for 
their potential to induce luciferase in juvenile transgenic zebrafish. Following 48 hour 
exposure to a nominal concentration of 1000 nM, the natural estrogens 17oc-estradiol and 
estrone, as well as the synthetic estrogens diethylstilbestrol and ethinylestradiol, induced 
luciferase at levels ranging from 70 to 300 times that of non-exposed controls (Fig. 2b). 
Importantly, the principle DDT isomer o,p'DDT, a known environmental estrogen in 
mammals (Bitman et al., 1969) and fish (Denison et al, 1981), also induced luciferase 
activity to a level around 40 times that of the solvent control (Fig. 2b). It should be noted that 
relatively high variation was found in the response of individual transgenic fish to estrogens. 
The outbred genetic background of these heterozygous transgenic fish may contribute to the 
variation in estrogenic response observed since differences in genetic background may greatly 
influence the response to estrogens (Spearow et al, 1999). In addition, both males and 
females undergoing gonad differentiation were assayed together at this stage, as their 
phenotypic sex is not yet apparent. It was found that males and females respond differently to 
exogenous estrogens (see below). 
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Figure 1: (A) Luciferase activity in developing life stages of transgenic zebrafish 
exposed for 48 hours to 1000 nM 17(3-estradiol (fold induction in light units/fxg protein 
relative to vehicle exposed controls) and (B) stage-related expression of zebrafish 
estrogen receptor type ER-a and ER-p mRNA in non-exposed developing life stages 
(dpf=days post fertilization). "Control" lane shows PCR product from liver cDNA (10000 
copies) amplified under the same conditions. In Figure 1 (A), age given indicates age at 
initiation of exposure. Bars show the luciferase induction in pools of embryos from 1 to 21 dpf: 
1 dpf: n=20; 7 dpf: n= 10,14 dpf: n=10; 21 dpf: n=5. For embryos of 28 and 35 dpf, bars show 
mean luciferase induction in individual fry (n=4); error bars show standard error of the mean. 
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Estrogen reporter gene induction is highly tissue specific 
To determine the tissue distribution of transgene expression, we studied the response 
of adult, sexually mature, male transgenic zebrafish to estrogen treatment (Fig. 3a). 
Surprisingly, dramatically high transgene expression of up to 1000-fold was observed in the 
testis following 48 hours exposure to 1000 nM E2 (Fig. 3a). In addition, luciferase activity 
was also prominent in liver (30-fold) and slightly induced in the scales (4-fold) and muscle 
(3.6-fold). Slight or no significant luciferase induction was found in heart, brain, eye or bone 
tissue. In control males exposed to vehicle (DMSO or ethanol) alone, luciferase was not 
induced, indicating extremely low levels of endogenous estrogens. In control adult transgenic 
females of 3-6 months of age, however, background levels of luciferase in liver and ovaries 
were high, reaching approximately the same level as liver in E2 exposed males. High 
background levels of luciferase in transgenic females are likely due to high levels of 
circulating endogenous estrogens. Exposure to E2 in adult females did not result in luciferase 
induction above this elevated background level (data not shown). 
Analysis of the zfER mRNA expression pattern in various tissues of the adult male 
zebrafish confirmed the presence of both zfER-a and ER-(3 (Fig. 3b) in tissues showing high 
luciferase induction such as testis and liver (Fig. 3a). Tissues that did not show high luciferase 
induction such as brain, bone, digestive tract and eyes, however, expressed varying amounts 
of both receptors (Fig. 3b). Differences in the expression of the internal control GAPDH do 
not reflect differences in the amount of tissue amplified per reaction. GAPDH is differentially 
expressed in various organs, with lower expression in the brain. We therefore did not correct 
for GAPDH variation throughout the samples. The differences in ER mRNA expression and 
activation of luciferase between various tissues may be explained by differences in levels of 
receptor protein or co-activators necessary for ER-mediated transcriptional activation. It is 
also possible that the luciferase response to E2 in some tissues was limited due to the tissue-
specific bioavailability of the ligand, perhaps partly due to the short exposure period. 
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Figure 2: Luciferase activity (fold induction in light units/jug protein relative to vehicle 
exposed controls) in juvenile (35 days post fertilization) transgenic zebrafish exposed 
for 96 hours to (A) increasing doses of 17/3-estradiol (E2) and (B) 1000 nM of the 
estrogenic compounds 17a-estradiol (E2-17A), estrone (E1), diethylstilbestrol (DES), 
ethinylestradiol (EE2) and o,p' DDT (DDT). Bars show mean luciferase induction in 
individual fry (n=3-4); error bars show standard error of the mean. 
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Ligand specificity and tissue distribution of testicular reporter gene induction 
To gain further insight in the possible significance of the testicular estrogen receptors, 
we characterised the sensitivity of the transgenic testis to estradiol. A dose-response related 
luciferase induction to E2 was measured in testis of adults exposed to nominal concentrations 
of 0.1 to 1000 nM for 96 hours (Fig. 4a). During this short exposure period, 1 nM E2 already 
resulted in induced luciferase activity in the adult testis. To localize luciferase-producing cells 
in the testis, we incubated sectioned tissues of E2-exposed transgenic zebrafish with a 
polyclonal antibody against luciferase (Fig. 4b). Immunohistochemistry of the testis revealed 
positive staining in the Sertoli cells and early spermatogonia (germ cells), but not in the 
differentiated spermatocytes and spermatids (Fig. 4b-a,b). No staining was found in non-
induced transgenic or wild type controls (Fig. 4b-c, 4b-e), as well as transgenic controls 
without luciferase antibody (Fig. 4b-d). Though little is known about the cellular localization 
of ER subtypes in fish testis, ER has been detected in the testis of goldfish (Tchoudakova et 
al., 1999) and channel catfish (Xia et al., 1999). Localization of luciferase-producing cells in 
the E2-induced transgenic testis is consistent with the ER distribution found in rodent testis, 
in which differential expression of ER-a and p has been found in various cell types, including 
Sertoli cells and spermatogonia (Van Pelt et al., 1999, Saunders et al., 1998). At the moment, 
the functional significance of highly responsive estrogen receptors in male reproductive 
tissues in unclear. However, luciferase induction in the spermatogonia suggests that estrogens 
may play a role in the maturation of germ cells. Induction of luciferase in the Sertoli cells may 
also be consistent with a role in testis size and sperm production. 
Our results demonstrate that the testis may be the one of the most sensitive direct 
target organs for estrogenic pollutants. Although more detailed dose-response studies are 
necessary, our results with the transgenic zebrafish also suggest that the liver was two orders 
of magnitude less sensitive to exogenous estrogens than the gonads. Recent studies have 
demonstrated an estrogen receptor in cytosolic and nuclear fractions of the testis of the marine 
teleost Atlantic croaker (Micropogonias imdulatus) which binds estrogens and xeno-estrogens 
with higher affinity than the hepatic ER (Loomis and Thomas, 1999). The occurrence of 
intersex gonads in wild populations of fish, which is associated with exposure to (xeno-
)estrogens (Jobling et al., 1998), also suggests the sensitivity of the gonads to environmental 
estrogens. We favour the hypothesis that estrogens can directly influence testicular 
functioning, and may even directly regulate the occurrence of intersex. Our future studies aim 
at testing this hypothesis, thereby testing the validity of the transgenic zebrafish model. 
Further studies will also be carried out to compare the usefulness of the transgenic zebrafish 
assay with another widely used biomarker for estrogenic effects in fish, namely the induction 
of the estrogen-regulated liver protein vitellogenin (Sumpter and Jobling, 1995). 
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Figure 3: (A) Luciferase activity in tissues of adult male transgenic zebrafish exposed 
for 48 hours to 1000 nM E2 (fold induction in light units/u.g protein relative to vehicle exposed 
controls) and (B) tissue-related expression of zebrafish estrogen receptor type ER-a and 
ER-/3 mRNA in non-exposed adult male zebrafish. "Control" lane shows PCR product from 
liver cDNA (10000 copies) amplified under the same conditions. 
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Figure 4: (A) Luciferase activity (fold induction in light units//ug protein relative 
to vehicle exposed controls) in testis of adult transgenic zebrafish exposed for 96 hours 
to increasing doses of E2. (B) Luciferase protein expression in testis of adult transgenic 
zebrafish exposed for 48 hours to 1,000 nM E2. Immunohistochemical staining of paraffin-
embedded sections using polyclonal anti-luciferase antibody, showing (a, b) expression of 
luciferase localized in clusters of primary spermatogonia and Sertoli cells (brown stained 
cells). No background staining is found in: (c) non E2-induced transgenic testis; (d) negative 
controls without primary antibody; and (e) wild type non-transgenic testis (Bar = 50 u,M). 
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In conclusion, we have developed a new in vivo model that has the potential to 
rapidly determine the estrogenic mode of action of chemicals during development and further 
throughout sexual differentiation in fish. In addition, we can determine whether these 
chemicals exert their effects directly on the testis or other tissues during adult stages. Thus the 
magnitude, tissue distribution and sensitive period of estrogenic effects can be determined in 
situ. As a complement to the wide variety of in vitro assays currently available to screen 
compounds for estrogenic activity (Zacharewski, 1997; Legler et ah, 1999), this transgenic 
model more realistically reflects the availability, kinetics, and metabolism of compounds in 
vivo. In comparison to long term reproduction tests, the transgenic zebrafish model may also 
offer a more rapid and specific means for screening substances with a suspected estrogenic 
mode of action. The transgenic zebrafish bioassay is a promising new tool in the field of 
environmental contaminant monitoring and risk assessment of new and existing chemicals. 
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Abstract 
Functional in vitro and in vivo reporter gene assays have recently been developed to measure 
biological exposure to (xeno-)estrogens. The in vitro estrogen receptor (ER)-mediated 
chemical activated luciferase gene expression (ER-CALUX) assay uses T47D human breast 
cancer cells stably transfected with an ER-mediated luciferase gene construct. In the in vivo 
assay, transgenic zebrafish are used in which the same luciferase construct has been stably 
introduced. The transgenic zebrafish assay ensures that environmental chemistry and 
toxicokinetics of a substance in vivo are taken into account. Considerable differences were 
found in the relative potencies of the (xeno-)estrogens estradiol (E2), estrone, ethyny [estradiol 
(EE2), o,p-DDT, nonylphenol (NP), bisphenol A (BPA) and di-(2-ethylhexyl)phthalate 
(DEHP) in vitro and in vivo. EE2 was the most potent of the (xeno-)estrogens tested and was 
100 times more potent than E2 in the transgenic zebrafish assay whereas in the ER-CALUX 
assay, EE2 was only slightly (1.2 times) more potent than E2. Although the xeno-estrogens 
o,p'DDT, NP and BPA were full estrogen agonists in the ER-CALUX assay, only o,p'DDT 
demonstrated dose-related estrogenic activity in vivo. DEHP was only weakly estrogenic in 
both assays at concentrations above 1 |aM. Estrogenic potency was determined in mixtures of 
(xeno-)estrogenic compounds in wastewater treatment plant (WTP) effluent as well as WTP 
effluent extracts and revealed levels of (xeno-)estrogens that exceed threshold values for 
negative effects in fish. Our results demonstrate that the transgenic zebrafish assay can 
provide a rapid and valuable tool to complement in vitro screening of estrogenic substances as 
well as indicating if substances may be estrogenic in fish. 
Introduction 
The presence of hermaphrodite fish has been increasingly reported in wild fish 
populations in rivers, estuaries and coastal waters (Lye et al., 1997; Jobling et al., 1998; Allen 
et al., 1999; Vethaak et al., 2000). These effects have been associated with exposure offish in 
the aquatic environment to natural and xenobiotic chemicals with the same mode of action as 
the estrogen steroid hormones (the so-called "(xeno-)estrogens") (reviewed in Tyler et al, 
1998). The focus on (xeno-)estrogens in the aquatic environment can be largely attributed to 
the finding that effluents from wastewater treatment plants (WTP) contain (xeno-)estrogenic 
chemicals at levels sufficient to invoke biological effects in fish in laboratory studies. 
Exposure of fish to WTP effluent has resulted in synthesis of the estrogen-inducible yolk 
precursor protein vitellogenin in male fish (Folmar et al., 1996; Harries et al., 1997, Rodgers-
Gray, et al., 2000) as well as changes in sexual differentiation of juvenile fish (Bulder et al., 
2000). The natural estrogens 17P-estradiol and estrone have been detected in WTP effluent at 
levels up to 80 ng/1 (Desbrow et al., 1998). These levels have been shown to stimulate 
vitellogenin synthesis in laboratory fish (Routledge et al., 1998, Panter et al., 1998). The 
synthetic estrogen 17a-ethynylestradiol (EE2) used in the contraceptive pill has also been 
detected in WTP effluents, at levels up to 7 ng/1 (Desbrow et al., 1998; Belfroid et al., 1999a). 
Exposure of EE2 at concentrations of above 1 ng/1 can stimulate synthesis of vitellogenin 
(Purdom et al., 1994, Sheahan et al., 1994) as well as retard growth and development of testes 
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in maturing male trout (Jobling et al., 1996). Xeno-estrogens such as the alkylphenol 
surfactants have also been found in WTP effluent (reviewed in Nimrod and Benson, 1996). 
Nonylphenol, one of the microbial breakdown products of alkylphenol ethoxylates, has been 
detected in WTP effluent at levels that induce vitellogenin synthesis and decrease growth rate 
of testis (Jobling et al, 1996). Laboratory exposure to nonylphenol has also shown 
development of intersex conditions in male fish (Gray and Metcalfe, 1997). 
Wastewater treatment plant effluent is a complex mixture of many (unknown) 
chemicals and routine chemical analysis of (xeno-)estrogens in effluent is hampered by high 
costs. Only known compounds can be analyzed and no account is taken of the biological 
effects of mixtures of chemicals. The use of bioassays to rapidly screen the exposure and 
demonstrate potential effects of (xeno-)estrogens can be an ideal means to determine the total 
estrogenic potency of mixtures of substances. Recently, extensive efforts to develop screening 
assays to detect exposure of (xeno-)estrogenic compounds on wildlife have been undertaken 
(Zacharewski, 1997; Ankley et al, 1998, Andersen et al., 1999). In our laboratories, two new 
assays for estrogenic activity have been recently developed: the in vitro Estrogen Receptor-
mediated Chemical Activated LUciferase gene expression (ER-CALUX) assay using human 
T47D breast cancer cells (Legler et al., 1999), and the in vivo transgenic zebrafish assay 
(Legler et al., 2000a). In both assays, an ER-mediated luciferase reporter gene construct 
containing 3 estrogen response elements (ERE) has been stably introduced and integrated in 
the genome of the T47D cells and transgenic zebrafish. In the ER-CALUX assay, exposure of 
cells to (xeno-)estrogens results in diffusion of chemicals through the cell membrane, binding 
to the endogenous ER, activation of the receptor, and consequently, binding of the ligand-
receptor complex to EREs present in the promoter region of the luciferase gene (Figure 1). 
Luciferase protein is then induced, and is easily measured by lysing the cells, adding luciferin 
substrate, and measuring light photon production. In the transgenic zebrafish assay, luciferase 
is induced according to the same principle, but exposure to test substances takes place via the 
water phase. Therefore the environmental chemistry, bioavailability and toxicokinetics of the 
test substance in vivo determine ultimate exposure of target cells in the transgenic fish (Figure 
1). Luciferase protein will only be induced in target cells in which the test substance is 
bioavailable, and active endogenous ER's and co-factors necessary for ER transcription are 
present. Therefore, in the transgenic zebrafish, tissue and life stage-specific effects of (xeno-
)estrogens can be determined. 
In this study, the ER-CALUX and transgenic zebrafish assays were applied to 
determine the in vitro and in vivo estrogenic potency of mixtures of (xeno-)estrogens in a 
domestic WTP effluent. For this purpose, individual (xeno-)estrogens that have been 
measured in WTP effluent were tested in both assays to determine the differences in relative 
potencies of these substances, and to determine if the mixture effects could be predicted by 
knowledge of the individual components of a mixture. The ability of the in vitro ER-CALUX 
assay to predict estrogenic effects in vivo is discussed. 
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Exposure in transgenic zebrafish assay 
fate in aquarium 
m (xeno-)estrogens 
bioavailability 
(xeno-)estrogens 
• • 
TARGET CELL 
Exposure in 
ER-CALUX assay 
Figure 1: Principle of reporter gene (luciferase) induction in the in vivo transgenic 
zebrafish assay and the in vitro ER-CALUX assay in T47D cells. Differences in exposure 
routes in the two assays are illustrated. In the transgenic zebrafish assay, zebrafish are 
exposed to (xeno-)estrogens via the water phase. Bioavailability of (xeno-)estrogens depends 
on environmental chemistry and fate of the (xeno-)estrogen in the aquarium. In the fish, the 
compound may be metabolized, accumulated, eliminated and transported to target cells 
according to the toxicokinetics of the (xeno-)estrogen. In the ER-CALUX assay, cells are 
exposed directly to (xeno-)estrogens. Luciferase induction in target cells depends on the 
binding of xeno-estrogens to endogenous estrogen receptors which are then activated and 
bind to estrogen response elements (ERE) in the promoter regions of genes, finally resulting 
in production of luciferase. Luciferase will emit light photons when the substrate luciferin is 
added to cell homogenates. 
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Materials and Methods 
Test substances 
17p-estradiol (E2, 99%) and ethanol (100%, p.a.) were purchased from Sigma 
Chemicals Co. Estrone (El, p.a.) was from Brunschwig. Ethinylestradiol (EE2, 98%) and 
Bisphenol A (BPA, 99%) were purchased from Aldrich. 4-n-nonylphenol (NP, 91%) and di-
(2-ethylhexyl)phthalate (DEHP, 98% purity) were from TCI, Japan. o,p'-dichlorodiphenyl 
trichloroethane (o,p'DDT) was kindly provided by the Dutch State Institute for Quality 
Control of Agricultural Products (RIKILT-DLO). Nonylphenol ethoxylates (NP-4-E, average 
ethoxylate chain length of 4 units) and octylphenol ethoxylates (OP-8/9-E, average 8 to 9 
ethoxylate units) were gifts from Shell. Dimethyl sulfoxide (DMSO, 99.9%, spectrophotome-
tric grade) was purchased from Acros. 
Synthetic WTP mix and WTP extracts 
The levels of a number of known (xeno-)estrogens in the domestic effluent of a 
wastewater treatment plant (WTP) in a large city in the Netherlands were analyzed in a 
previous study (Belfroid et al., 1999). Based on this information on concentrations of(xeno-
)estrogens in the effluent, a synthetic mix of (xeno-)estrogens was made, consisting of three 
groups of compounds: 1) estrogens and bisphenol A; 2) nonylphenol and alkylphenol 
ethoxylates and 3) the phthalate DEHP. All compounds were dissolved in ethanol (p.a.). 
Group 1 consisted of 1.99 mg/1 El, 1.13 mg/1 EE2 and 1.6 g/1 BPA, dissolved in ethanol 
(p.a.). Group 2 consisted of 0.8 g/1 NP, 3.71 g/1 NP-4-ethoxylates (NP-4-E) and 0.2 g/1 
octylphenol-8/9-ethoxylates (OP-8/9-E). Group 3 consisted of 1.064 g/1 DEHP. The three 
concentrated stocks were further diluted in ethanol in order to reach levels based on previous 
analysis of the actual effluent (Belfroid et al, 1999a and 1999b). 
In addition to the synthetic mix, extracts were made of the same WTP effluent as well 
as the receiving surface waters of the river at the WTP outfall, though at different sampling 
periods. Effluent samples (200 ml) were collected twice weekly in the period of September to 
November 1999, and frozen in glass bottles at -20°C. A 10 L sample WTP effluent-receiving 
waters was taken in April, 2000, stored at 4°C, and extracted within 3 days. Prior to 
extraction, effluent samples were thawed and mixed well and extracted using a previously 
described solid phase extraction method (Struijs et al., 1998). Briefly, effluent and effluent-
receiving water samples of 6 liters were mixed for 24 hours with macro-reticular resins 
(XAD). The XAD was then sieved and dried at room temperature for 12 hours. (Xeno-
)estrogens were extracted by elution with acetone. The acetone fraction was evaporated under 
a gentle N2 gas flow at room temperature, and taken up in 60 u.1 DMSO. The DMSO fraction 
was further diluted for testing in the ER-CALUX and transgenic zebrafish assays. 
ER-CALUX assay 
The ER-CALUX assay procedure is described in detail elsewhere (Legler, et al., 
1999). Briefly, T47D.Luc cells stably transfected with pEREtata-Luc were plated in clear 
plastic 96 well plates (Nucleon, Denmark) at a density of 5000 cells in 0.1 ml DMEM-F12 
without phenol red + 5% DCC-FBS per well. Following 24 hours incubation, medium was 
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renewed and the cells incubated for another 24 hours. The medium was then removed and the 
cells were dosed in triplicate by addition of the dosing medium containing the chemical or 
extract to be tested dissolved in ethanol or DMSO (max. 0.2%). Control wells, solvent control 
wells and E2 calibration points (6 pM and 30 pM) were included in triplicate on each plate. 
Following 24 hours treatment, cells were lysed in 50 |il triton-lysis buffer, pH. 7.8 (containing 
1% triton X-100, 25 mM glycylglycin, 15 mM MgS04, 4 mM EGTA and 1 mM DTT) for a 
minimum of 1 hour with gentle shaking at 4°C. A sample of 25 |il lysate was then transferred 
to a black 96 well plate (Costar) and 25 uJ of luciferin solution (Luclite, Packard) was added 
per well. Luciferase activity was assayed in a scintillation counter (Top Count, Hewlett-
Packard) for 0.1 minute per well. 
Transgenic zebrqfish assay 
The recent development of the transgenic zebrafish is described elsewhere (Legler et 
al, 2000a). For the assays, heterozygous transgenic juveniles of the F4 generation of the age 
of 4-5 weeks were used. Juvenile transgenic zebrafish undergoing gonad differentiation were 
used because this period was previously shown to be the most responsive to estrogens during 
development (Legler et al., 2000a). Juvenile fish (n=5-6) were exposed for 96 hours in 150 ml 
acclimated tap water (26-27°C) in all-glass aquaria. The chemical or extracts to be tested was 
added to the water at volumes not exceeding 0.01% ethanol. Fish were fed once daily with 
live brine shrimp (Artemia salinas). Test medium was renewed for 50% daily. After 
termination of the exposure, fish were sacrificed in ice water, transferred to eppendorf vials, 
and immediately frozen at -80°C. To assay luciferase, eppendorf vials containing fish were 
transferred to ice, 500 u.1 of cold triton-lysis buffer added, and the fish homogenised using a 
micro-pestle (Eppendorf). Following centrifugation at 12.000 rpm for 15 minutes at 4°C, 
duplicate samples of 25 fxl supernatant were assayed in a luminometer (LUMAC) with 
automatic injection of 100 u,l luciferin substrate, pH 7.8 (containing 20 mM tricine, 1 mM 
(MgC03)Mg(OH)25H20, 2.67 mM MgS04, 0.1 mM EDTA, 33.7 mM DTT, 270 uM 
coenzyme A, 470 uM luciferin and 530 uM ATP). Light units measured by the luminometer 
were normalized for protein content, which was measured according to Bradford, 1976. 
Analysis of actual exposure concentrations 
The hormones E2, El and EE2 as well as the xeno-estrogens NP and o,p'DDT were 
measured in test medium at the start (t=0) of an exposure experiment, prior to introducing the 
transgenic zebrafish, as well as at the end (t=96 hrs) of the experiment. Test medium samples 
were approx. 100 ml. NP and o,p'DDT levels were also analyzed in whole fish homogenates 
(n=5, total weight about 100 mg) at the start and termination of the experiment. 
E2, El and EE2 analysis in water was carried out as described in Belfroid et al. 
(1999), with the exception that the quantification of the chromatograms was done with the 
internal deuterated standard of «W-17(3-estradiol. For NP analysis in test medium, water was 
extracted according to the method described by De Voogt et al (1997). Analysis of NP in 
zebrafish following 96 hour exposure was done according to Zhao et al. (1999). Extracts were 
analysed by reversed-phase HPLC with fluorescence detection. For o.p'DDT analysis, test 
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medium samples from the were extracted three times with n-hexane. The extracts were dried 
over anhydrous Na2S03 and analyzed by GC-ECD. Zebrafish were mixed with anhydrous 
Na2S03 and then extracted three times with acetone:n-hexane (1:3 v:v). The extract was then 
filtered and analysed with GC-ECD. Extraction efficiency of o,p'DDT was 90-100%. 
Data analysis 
The EC50 values for both the ER-CALUX and transgenic zebrafish assay were calculated 
from dose-response curves using the curve-fitter of SlideWrite 4.0 (cumulative fit). The R of 
the fit of the curves was above 0.99 for the ER-CALUX assay, and above 0.9 for the 
transgenic zebrafish assay. EC50 values were calculated by determining the concentration at 
which 50% of the maximum luciferase activity was reached. For quantification of the 
estrogenic potency of an extract or component of the synthetic mix, the response of the 
extract was interpolated in the dose-response curve of the standard E2 curve. The extracts 
were diluted (for the ER-CALUX assay) or concentrated (for the transgenic zebrafish assay) 
to ensure that the responses could be interpolated within the linear portion of the curve. For 
the ER-CALUX, this was between the signal of 1 and 6 pM E2, and for the transgenic 
zebrafish assay, between 1 and 10 nM E2. The estrogenic potency of the extract is expressed 
as EEQ (estradiol equivalents) per volume of material. Estradiol equivalent factors (EEF) 
were determined as the ratio EC50 E2: EC50 test compound. EEQ and EEF values were 
calculated based on an average of 3 to 5 independent experiments. 
Results and Discussion 
Assay characteristics 
The in vitro ER-CALUX assay using stably transfected T47D cells can detect 
estradiol (E2) at concentrations as low as 0.5 pM and is highly reproducible, with a 
coefficient of variation of about 5%. Maximal induction (about 100 fold relative to solvent 
controls) is reached at 30 pM E2. The in vivo transgenic zebrafish assay using 96-hour 
exposed juvenile transgenics has a detection limit of about 300 pM E2 and exhibits higher 
variation (CV=20-30%). Maximal fold induction of 1000-3000 fold relative to solvent 
controls is reached at 100 nM E2. The high biological variation is a reflection of individual 
fish differences in uptake and metabolism of substances, as well as differences in (gonad) 
developmental stage and sex. As the phenotypic sex of the transgenic zebrafish is not 
apparent at the age of fish used, both males and females are assayed together, thereby 
contributing to the variation in response. Previous studies have shown that male and female 
transgenics respond differently to E2 exposure (Legler et al., 2000a). Interestingly, a decrease 
of luciferase induction by high concentrations of estrogens can be seen in both assays, 
particularly in the transgenic zebrafish assay (Figure 2). Down-regulation of ERs or other 
mechanisms of negative feedback to high dosages may cause this decrease. 
91 
Chapter 6 
Relative responses of the assays to estrogens 
The ER-CALUX and transgenic zebrafish reporter gene assays demonstrate a dose-
response-related increase in luciferase induction following exposure to estradiol, estrone (El) 
and ethynylestradiol (EE2) (Figure 2). However, the sensitivities of the response of the two 
assays differ as well as the relative potencies of (xeno-)estrogens vary according to the assay 
used (Table 1). In the ER-CALUX assay, the EC50 of E2 and El were two to three orders of 
magnitude lower than in the transgenic zebrafish (Table 1). There may be several reasons for 
this difference in sensitivity. In the transgenic zebrafish assay, actual target cell exposure will 
likely be much lower than in the ER-CALUX assay, depending on the fate of the compound 
in the aquarium and its toxicokinetics in the fish. Chemical analysis of actual E2 and El 
levels in exposure water revealed that though actual concentrations were similar to nominal 
concentrations at the beginning of the experiment, very low amounts of these estrogens were 
present after 96 hours of exposure (Table 2) despite the fact that half of the exposure water 
was renewed daily. The disappearance of E2 and El from the water column is likely due to 
rapid uptake by the fish over the gills. In vivo, E2 and El can be extensively transformed to 
less potent metabolites by fish (Bone et al., 1995). Therefore, in the transgenic zebrafish, 
higher concentrations of E2 or El are required to induce luciferase in target cells. In the ER-
CALUX assay, the extent metabolism during the 24-hour exposure period is only slight. An 
additional reason for the difference in response to E2 and El can be found at the level of the 
ER. Fish ER's may have a lower affinity for E2 than mammalian ER's. Rainbow trout ER has 
been shown to require 10 times higher E2 concentration than the human ER for 
transactivation (Petit etal., 1995; Le Drean etal, 1995). 
Interestingly, El induced luciferase in the transgenic zebrafish at similar 
concentrations as E2 (EEF=1, Table 1). In the ER-CALUX assay, however, El demonstrated 
an EEF of 0.23 (Table 1). These results indicate that El may be a more potent estrogen in 
fish than in mammals. While El binds with only 10% affinity to the rat ER relative to E2 
(Blair et al, 2000), no difference was found in the ability of El and E2 to transactivate two 
rainbow trout ER isoforms of the trout ER gene (Pakdel et al, 2000). Accordingly, a recent 
study by Panter and colleagues demonstrated that El induced vitellogenin at concentrations 
similar to E2 in male fathead minnows (Panter et al., 1998). Routledge and colleagues (1998) 
also showed that El was only slightly less potent than E2 in inducing vitellogenin in rainbow 
trout. 
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Figure 2: Estrogenic potency of (a) estradiol, (b) estrone, and (c) ethinyl-estradiol in in 
vitro ER-CALUX and in vivo transgenic zebrafish reporter gene assays. Data are 
representative of 3 independent assays. Values given are averages, error bars represent 
standard error of the mean (ER-CALUX: n=3; transgenic zebrafish: n=5-6). 
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In both assays, ethynylestradiol (EE2) was the most potent (xeno-)estrogen tested 
with only a 20-fold difference in EC50 between the ER-CALUX (0.005 nM) and transgenic 
zebrafish (0.1 nM) assays (Table 2, Figure lc). Interestingly, in the transgenic fish, EE2 was 
100 times more potent than E2 while in the ER-CALUX EE2 was 1.2 times more potent 
(Table 2). The high potency of EE2 in both assays can be explained partly by the high ER 
binding affinity of EE2. In rat uterus, EE2 exhibits over 2 times higher binding affinity to the 
ER than E2 (Blair et ah, 2000). In binding studies with channel catfish ER, EE2 was found to 
be five times more potent than E2 (Nimrod and Benson, 1997). Importantly, because EE2 is 
poorly metabolized by the liver and subject to intensive enterohepatic recycling (Guengerich, 
1990), it is more resistant to metabolism in vivo than E2 and El. Chemical analysis of the 
actual EE2 concentrations in the exposure water of the assay revealed that although EE2 was 
present at the nominal concentration at the beginning of the experiment, no EE2 was 
measured above the detection limit (20 ng/1) at the end of exposure (Table 2). This indicates 
that EE2 may be highly taken up by transgenic fish and is persistent in vivo where it exerts 
estrogenic activity to a higher degree than E2. 
Table 1: Estrogenic potency of (xeno-)estrogens in in vitro ER-CALUX and in vivo 
transgenic zebrafish assays. 
compound 
E2 
EE2 
El 
o,p'DDT 
NP 
BPA 
DEHP 
ER-CALUX 
EC50 (nM)' 
0.006 
0.005 
0.026 
390 
110 
770 
0 
EEF" 
1 
1.2 
0.2 
1.5E-05 
5.5E-05 
7.8E-6 
0 
Transgenic zebrafish 
EC50(nM)* 
10 
0.1 
10 
450 
0 
0 
0 
EEF" 
1 
100 
1 
0.02 
0 
0 
0 
EC50 is nominal concentration at which 50% of maximal response is reached. 
**EEF is ratio EC50E2:EC50compound. 
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Different responses of the assays to xeno-estrogens 
The most dramatic difference in response between the ER-CALUX and transgenic 
zebrafish assay was found with exposure to xeno-estrogenic chemicals. Of the small panel of 
xeno-estrogens tested, only o.p'DDT induced luciferase activity in a full dose-dependent 
manner in both assays, and at similar nominal concentrations (Figure 3a, Table 1). Previous 
studies have also demonstrated the estrogenic activity of o,p'DDT in both fish and mammals 
(reviewed by Tyler et al, 1998). Chemical analysis of the exposure water and transgenic 
zebrafish (Table 2) revealed that actual o.p'DDT concentrations at the start and end of the 
experiment reflected nominal concentrations, and that o,p'DDT bioaccumulated in the fish. It 
should be noted that nominal and measured concentrations of o,p'DDT seemed to exceed the 
water solubility of this compound (about 250 nM). Because total extraction was carried out, 
DDT adsorption to particulates in the water was also measured. 
In contrast to o.p'DDT, exposure to 4-nonylphenol only slightly induced luciferase in 
transgenic zebrafish (13 fold induction at 1000 nM or 1% of the response of 10 nM E2) while 
it was a full agonist in the ER-CALUX assay (Figure 3b). Nominal test concentrations above 
1000 nM caused mortality of transgenic zebrafish. Chemical analysis of actual nonylphenol 
concentrations in exposure water revealed that only about 60% of the nominal concentration 
of NP was found at the start of the exposure period, prior to addition of the fish (Table 2), 
likely due to adsorption to glass walls. Following 96-hour exposure, only 7 u,g/l NP of the 
nominal 220 ug/1 NP was detected. Analysis of the fish following exposure revealed that NP 
was accumulated, though less than o,p'DDT. The low estrogenic potency of NP in the 
transgenic zebrafish is unexpected, considering the number of documented reports on the in 
vivo estrogenicity of nonylphenol (reviewed in Tyler et al., 1998). NP has been shown to 
induce vitellogenesis and inhibition of testicular growth in male rainbow trout exposed under 
continous flow conditions for 3 weeks (Jobling et al, 1996) as well as induce feminized 
gonads in male Japanese medaka exposed during a full life cycle (3 months) (Gray and 
Metcalfe, 1997). It is possible that the 96-hour exposure duration of the transgenic zebrafish 
was too short to achieve an internal dose that could induce luciferase. NP has been shown to 
be readily metabolised in the liver of rainbow trout, with a half-life of 6 hours (Lewis and 
Lech, 1996). Recent studies in our lab have demonstrated that prolonged (3-week) exposure 
of adult male transgenic zebrafish to 100 u.g/1 NP resulted in elevated luciferase activity in the 
liver (Legler, unpublished results), suggesting that the short incubation period rather than the 
insensitivity of the transgenic fish caused the absence of a response to NP. 
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Figure 3: Estrogenic potency of xeno-estrogens (a) o.p'DDT, (b) 4-nonylphenol, (c) 
bisphenol A (BPA) and (d) DEHP in in vitro ER-CALUX and in vivo transgenic zebrafish 
reporter gene assays. Data are representative of 3 independent assays. Values given are 
averages, error bars represent standard error of the mean (ER-CALUX: n=3; transgenic 
zebrafish: n=5-6). 
Bisphenol A provided an example of a xeno-estrogen that was not estrogenic at all in 
the transgenic zebrafish assay, though it induced dose-response mediated induction in the ER-
CALUX assay (Figure 3c). Though chemical analyses of the actual concentrations of BPA in 
the water and fish were not performed, both short (96-hour) and prolonged 3-week exposure 
(Legler et cd., unpublished results) did not induce luciferase in the transgenic zebrafish. 
Though BPA has been previously shown to be estrogenic using mammalian in vitro and in 
vivo assays (Krishnan et ah, 1993; Steinmetz et cd., 1997), little has been reported regarding 
its estrogenic potency following waterborne exposure in fish. However, because a low 
bioaccumulation potential has been reported for BPA in the aquatic environment (Staples et 
ai, 1998), it is likely that target cell exposure in the transgenic zebrafish can not become high 
enough to induce estrogenic effects. 
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Table 2: Concentrations of (xeno-)estrogens determined in test water and fish taken 
during exposure experiments with transgenic zebrafish. Samples were taken at the start 
(T=0) and end (T=96hr) of the experiment. 
Comp. 
E2 
EE2 
El 
NP 
o,p'DDT 
Nominal cone. 
Water 
nM 
100 
1 
100 
1000 
1000 
ns/i 
27 
0.3 
27 
220 
346 
Water 
(ng/i) 
T=0 
20.3 
0.4 
30 
133 
340 
Measured concentrations 
T= =96hr 
1 
<d.l" 
0.2 
7 
850 
Zebrafish 
Og/kg) 
T=0 
n.m. 
n.m. 
n.m. 
<d.\" 
<d.f 
T=96 hr 
8940 
685000 
n.m.: not measured 
<d.l.: below detection limit 
The phthalate DEHP demonstrated very weak estrogenic potency in both the ER-
CALUX and the transgenic zebrafish assay (Figure 3d). In the ER-CALUX assay, 10 jiM 
DEHP induced luciferase about 13 times above solvent controls (or about 13% of maximal E2 
levels). In the transgenic zebrafish assay, 1000 and 5000 nM (nominal) DEHP induced 
luciferase about 10 times above solvent controls (or less than 1% luciferase induction relative 
to 10 nM E2). In both assays, no complete dose-response curves could be performed as 
concentrations above 10 |aM resulted in cell toxicity in the ER-CALUX assay, and 
concentrations tested above 5 uM were toxic to the transgenic zebrafish. To our knowledge, 
specific estrogenic effects of DEHP in fish in vivo have not been demonstrated previously. 
The rapid metabolism of DEHP in rainbow trout has been demonstated (Barron etal., 1987). 
In mammals, a recent study has shown the inability of DEHP to induce estrogenic activity 
(i.e. increase uterine wet weight) in rats in vivo (Zacharewski et ah, 1998). Earlier reports 
have demonstrated the potential of DEHP to induce reproductive organ toxicity in rats at high 
dosages only (Ganogolli, 1982; Davis et al., 1994). These studies, taken together with our 
results, suggest that DEHP may not exert estrogenic effects at levels found in the 
environment. 
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Environmentally realistic mixtures of (xeno-)estrogens 
The estrogenic potency of a synthetic mix composed of (xeno-)estrogens at 
concentrations found in a domestic WTP effluent was tested, as well as an extracts of total 
effluent and receiving surface waters (Table 3). This particular WTP effluent was chosen as a 
model effluent for estrogenic effects because wild male bream sampled from the river 
receiving this WTP effluent showed elevated vitellogenin levels (Legler et al., 2000c) as well 
as a high incidence of intersex gonads (Vethaak et al, 2000). The synthetic mix was 
composed of three sub-groups: estrogens (El, EE2) and bisphenol A; alkyphenols (NP and 
NP/OP ethoxylates); and the phthalate DEHP. The presence of free E2 itself was not detected 
in this WTP sample. The total theoretical estrogenic potency (EEQ) of this mix was 
calculated by summing the products of the EEF of the (xeno-)estrogens in the synthetic mix 
and their molar concentration (Table 3). In the ER-CALUX assay, the theoretical EEQs in the 
hormone and BPA group (15 pM) correlated well with the measured EEQs (11 pM), as did 
the alkylphenol group (theoretical EEQ 0.5 pM vs measured EEQ 0.4 pM) (Table 3). DEHP 
did not induce luciferase activity in the ER-CALUX assay. The measured EEQ (10 pM) in the 
total mix was in the same order of magnitude as the theoretical EEQ (16 pM) based on the 
EEF approach. These results on the total in vitro estrogenic potency of the mixture indicate 
that the individual estrogenic compounds behaved in an additive manner. 
Higher estrogenic activity was found when testing the synthetic mix in the transgenic 
zebrafish assay than in the ER-CALUX assay (Table 3). The major reason for the relatively 
high estrogenic activity in the zebrafish is the probably the presence of EE2 in the mix, which 
is 100 times more potent than E2 and El in the transgenic fish (Table 1). The group composed 
of El, EE2 and BPA contributed most to the total estrogenic activity measured (Table 3). 
Both the alkylphenol group and DEHP were slightly estrogenic in the transgenic fish assay 
(Table 3). Comparison of the total theoretical estrogenic activity of the synthetic mixture (960 
pM EEQ) based on the zebrafish-EEFs of the individual compounds resulted in a value 
comparable to the actual measured activity (570±140 pM EEQ). 
In addition to the synthetic mix, extracts were made from the actual effluent from the 
same WTP, as well as the WTP effluent-receiving surface waters. In the ER-CALUX assay, 
little difference was found in estrogenic activity between the whole effluent extract and the 
synthetic mix (12 and 10 pmol EEQ/1, respectively). Extracts of the WTP receiving surface 
water showed elevated EEQs in the ER-CALUX (9 pM) suggesting a minimal effect of 
dilution by surface waters. When tested in the transgenic zebrafish assay, both the whole 
effluent extract and the receiving waters extract showed about the same estrogenic activity 
(189 and 237 pM EEQ, respectively, Table 3), also suggesting that dilution by river water did 
not affect the levels of potent (xeno-)estrogens. However, in the transgenic zebrafish, the 
estrogenic activity in the whole effluent extract was about two to three times lower than 
estrogenic activity in the synthetic mix. Because this effluent was sampled at a different time 
period, it is possible that levels of potent (xeno-)estrogens in the fish, such as EE2, were 
different from those in the synthetic mix. Unfortunately, estrogen concentrations in the total 
effluent extracts were not measured, though temporal fluctuations in estrogen content in 
effluents have been shown previously (Rodgers-Gray et al, 2000, Belfroid et al., 2000). The 
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in vivo estrogenic activity found in the WTP effluent is at a level in which negative effects on 
fish reproduction may be expected by exposure to this WTP effluent. EEQ values in the WTP 
effluent extracts exceed the threshold values of E2 and EE2 required to induce vitellogenin 
induction (Routledge et al., 1998; Sheahan et al., 1994), reduce testicular growth (Jobling et 
al., 1996) as well as inhibit egg production (Kramer et al., 1998) and development (Kime and 
Nash, 1999). 
Use of in vitro and in vivo reporter gene assays for assessing estrogenic activity 
Both the in vitro ER-CALUX assay and the in vivo transgenic zebrafish assay have a 
number of characteristics that make them useful screening tools. The ER-CALUX assay is 
extremely sensitive, rapid and can be used to screen many chemicals in a high-throughput 
manner. However, an in vitro assay can not predict the uptake and toxicokinetics of a 
substance in vivo. For this reason, the in vivo transgenic zebrafish assay forms an excellent 
complement to the ER-CALUX assay. The assay is rapid (96 hours), easy to perform, and the 
measured endpoint (luciferase activity) is simple and cost effective when compared to long-
term exposure studies in which reproductive and histological parameters are analysed. The 
value of the transgenic zebrafish assay is that it can predict if estrogenic activity measured 
with an in vitro assay actually may affect fish during a critical life stage, e.g. the stage of 
gonad differentiation. When adult transgenic fish are used, it is possible to determine the 
tissue specific effects of (xeno-)estrogens (Legler et al., 2000a). 
In this study, the transgenic zebrafish assay demonstrated that less readily 
metabolized (xeno-)estrogens such as EE2 and o.p'DDT were more potent in vivo than would 
be expected based on their in vitro estrogenic activity. Xeno-estrogenic chemicals which are 
metabolized in vivo such as NP and BPA, were estrogenic in the mammalian cell in vitro but 
did not induce reporter gene expression in vivo. These results indicate that the ER-CALUX 
assay may predict the potency of a xeno-estrogen once it has reached the target cell, but it can 
not predict the bioavailability of the substance to the cell. However, caution should be 
exercised when assessing the apparent lack of estrogenic effects of some xeno-estrogens in 
the transgenic fish. Estrogenic activity in vivo depends on a number of factors including 
exposure duration and exposure route. More research is necessary to determine if the in vivo 
transgenic zebrafish assay may prove more responsive to xeno-estrogens by testing prolonged 
exposure duration under continuous flow conditions. In addition, some differences in 
response between the two assays may be explained by differences in mammalian and fish ER 
activation. Comparing the transgenic zebrafish assay with an in vitro reporter gene assay 
using zebrafish ERs would be more appropriate to exclude these differences. 
In testing complex mixtures, the exquisite sensitivity of the ER-CALUX assay system 
makes it possible to detect estrogenic activity in extracts of small samples. The ER-CALUX 
assay is a suitable choice for screening complex environmental samples for unexpected 
estrogenic activity that could be further identified by chemical analysis, as well as further 
tested in the transgenic zebrafish assay to determine in vivo estrogenic potency. Knowledge of 
the chemical composition of (xeno-)estrogens in an environmental mixture, and the relative 
potencies (EEFs) of the identified (xeno-)estrogens in the transgenic zebrafish assay, can be 
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valuable to predict the possible effects of the mixture in fish without the need for long-term 
studies with many experimental animals. Ultimately, it is essential to determine what level of 
exposure to (xeno-)estrogens will result in reproductive problems in aquatic organisms that 
may eventually affect the survival of the population. Ideally, biological validation of the ER-
CALUX and transgenic zebrafish assays will reveal critical levels of reporter gene induction 
which correspond with estrogenic effects on gonad differentiation and reproduction in the 
zebrafish. 
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General Discussion 
In recent years, both scientific and public concern about the possible threat of estrogenic 
compounds in the environment which may impact the reproduction of humans and wildlife 
has increased. Many substances have been demonstrated to possess estrogenic potency using 
in vitro test systems, and these compounds have been identified in the environment using 
chemical analysis. However, up until now, it has been difficult to rapidly estimate the total 
biologically active estrogenic potency in environmental mixtures, as well as predict the 
exposure of and possible effects on organisms. The research presented in this thesis describes 
the development and application of two new bioassays to determine the biologically active 
exposure of natural and xenobiotic estrogens (xeno-estrogens) in the environment and predict 
the estrogenic effects of such exposure on fish. These new bioassays may help to determine if 
organisms are exposed to levels of (xeno-)estrogens which may impact their reproduction or 
endocrine functioning. 
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Summary of results 
In vitro ER-CALUX reporter gene assay 
The estrogen receptor (ER)-mediated chemical activated luciferase reporter gene 
expression (ER-CALUX) assay was developed by stable transfection of an ER-regulated 
luciferase reporter gene in the T47D breast cancer cell line (Chapter 2). The ER-CALUX is 
the most sensitive and highly responsive stably transfected vertebrate cell reporter gene assay 
for estrogens reported to date. Exposure (24-hour) to estradiol (E2) demonstrated a detection 
limit of 0.5 pM, an EC50 of 6 pM and a maximum induction of 100-fold at 30 pM relative to 
solvent controls. The presence of anti-estrogenic activity can be determined by co-incubation 
with E2, and was demonstrated for ICI 182,780, TCDD and tamoxifen. A variety of xeno-
estrogenic compounds were shown to be estrogenic in the ER-CALUX assay, including 
pesticides, alkylphenols, phtalates and phytoestrogens, though with a potency 10,000 to 
100,000 times less than E2 (Chapter 2 and 3). Interactive effects of the mixtures of xeno-
estrogens were tested, and in general, additive effects were found (Chapter 2). 
The response of the ER-CALUX assay was compared with the widely used recombinant 
yeast screen (Routledge and Sumpter, 1996) for determining estrogenic potency. The ER-
CALUX assay is 10 to 100 times more sensitive to E2, nonylphenol and o,p'DDT. Unlike the 
ER-CALUX, yeast cells were unable to demonstrate the anti-estrogenic effects of ICI 182,780 
and tamoxifen, as these compounds were agonistic in the yeast (Chapter 3). Because of these 
differences, the ER-CALUX assay may be more suitable for screening environmental samples 
in which the amount of material available for extraction is limited, or levels of (xeno-
)estrogens are very low. 
The inclusion of an in vitro biotransformation step in the ER-CALUX assay may assist in 
predicting the in vivo activity of (xeno-)estrogens. Pre-incubation of E2 and methoxychlor 
with liver microsomes obtained from PCB-treated rats demonstrated that metabolites of 
methoxychlor were more estrogenic than the parent compound (Chapter 3). 
Given the exquisite sensitivity of the ER-CALUX assay, it can be an ideal screening 
tool for determining estrogenic activity in complex mixtures from various environmental 
matrices. Extracts of sediments were tested in the ER-CALUX assay for estrogenic potency. 
A number of sediment extracts obtained from industrialized areas such as the Port of 
Rotterdam showed high estrogenic potency (up to 40 pmol estradiol equivalents per gram 
sediment) (Chapter 3). 
A simple method to determine if estrogen metabolites present in human urine and fish 
bile can be reactivated into active estrogens was developed (Chapter 4). Estrogen 
glucuronides in urine obtained from human males and females were deconjugated by 
enzymatic hydrolysis following incubation with B-glucuronidase or live E. coli cells, 
indicating that bacterial hydrolysis as is present in wastewater treatment plants may form a 
secundary source of estrogenic substances in the environment. Also, glucuronides in bile 
samples from male fish showed estrogenic activity following deconjugation. These 
conjugated metabolites could also form a secondary source of estrogen exposure in fish due to 
enterohepatic recycling. High estrogenic activity of deconjugated bile metabolites from male 
bream correlated with elevated estrogenic potency in water extracts as well as vitellogenin 
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induction in blood of the same fish. Estrogenic potency of (deconjugated) bile and urine 
metabolites could form a useful biomarker for internal dose of (xeno-)estrogens in males 
(Chapter 4). 
In vivo reporter gene assay using transgenic zebraflsh 
Transgenic zebrafish were developed by stably introducing an estrogen binding 
sequence linked to a TATA box and luciferase reporter gene into the genome. This is the first 
report of an in vivo reporter gene assay to assess exposure to estrogen modulating substances 
(Chapter 5). Exposure of the transgenic zebrafish to E2 during juvenile stages revealed the 
period of gonad differentiation to be the most responsive early life stage. In this juvenile 
period, E2 induced luciferase activity in a dose-dependent manner. Also the natural estrogens 
estrone and 17a-estradiol, as well as the synthetic estrogens diethystilbestrol and 
ethinylestradiol, and the organochlorine pesticide o,p'DDT demonstrated estrogenic activity 
in vivo in this test system. In adult male transgenic zebrafish, short-term exposure to E2 
revealed a number of tissues such as liver, bone, muscle and scales to be a potential target 
organ for E2. However, the testis was the most sensitive and responsive target tissue to 
estrogens. Exposure to E2 resulted in dose-response related luciferase induction in the testis. 
Immunohistochemistry revealed the Sertoli and germ cells to be the main target cells of E2 in 
the zebrafish testis. ER a and p mRNA was detected already in young embryos (24 hours post 
fertilization) and both subtypes were highly expressed during the period of gonad 
differentiation. In adult male transgenics, tissues with the highest luciferase activity (testis and 
liver) expressed both ER a and (3 mRNA (Chapter 5). 
Exposure of ER-CALUX cells is very direct without interaction with environmental 
factors influencing bioavailability and accumulation and without the toxicokinetics of an 
intact organism. In the transgenic fish assay, however, these factors do play a role, resulting in 
concentrations target cells that are sometimes difficult to predict using an in vitro system. 
Both assays exhibited high responsiveness to natural and synthetic estrogens such as E2, El 
and EE2, though differences in their relative potencies to E2 were found. EE2 was 100 times 
more potent than E2 in the transgenic fish, whereas it was only slightly (1.2 times) more 
potent than E2 in the ER-CALUX assay. The highly accumulating xeno-estrogen o,p'DDT 
was estrogenic in both assays, with similar potencies relative to E2. On the other hand, xeno-
estrogenic chemicals with which are readily metabolized in vivo such as NP and BPA were 
estrogenic in vitro but did not induce reporter gene expression in vivo in short-term exposures 
(Chapter 6). 
Estrogenic activity was detected in mixtures reflecting concentrations of (xeno-
)estroens found in a domestic wastewater treatment plant effluent (WTP) as well as extracts 
from WTP effluent, using both the ER-CALUX and transgenic zebrafish assay (Chapter 6). 
Estrogenic potency in WTP effluent was higher in the transgenic zebrafish assay than in the 
ER-CALUX assay. This may have been due to the presence of individual estrogens such as 
EE2 which are more potent estrogens in the fish than in the in vitro system. 
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Perspectives for the use of in vitro and in vivo reporter gene assays in environmental 
toxicological research 
The ER-CALUX and transgenic zebrafish assay are very promising complementary in 
vitro and in vivo biomarkers of exposure to and potential effects of substances with an 
estrogenic mode of action. The ER-CALUX assay is rapid and simple, and detection in 
microtiter volumes is possible, allowing for qualitative and quantitative assessment of 
luciferase induction in a high throughput setup. The assay can be used as a biomarker of 
internal exposure to (xeno-)estrogens as demonstrated for male fish bile samples. The ER-
CALUX assay is a suitable choice for screening complex environmental samples for 
unexpected estrogenic activity that could be further identified by chemical analysis. This in 
vitro assay has proven to be very effective in detecting estrogenic activity in complex 
environmental mixtures, such as extracts of sediments (Chapter 3), water and biota (Chapter 
4), and effluents (Chapter 6). For these reasons, the ER-CALUX assay is being implemented 
in various field surveys in The Netherlands to determine estrogenic activity in a wide variety 
of environmental matrices from various freshwater and marine locations (Murk et al., 2000, 
Vethaak et al., 2000). It is important to note, however, that when using extracts of 
environmental matrices, more chemicals will be extracted from an environmental matrix than 
may be realistically bioavailable to an aquatic organism, or there may be loss of compounds 
during the extraction procedure. Therefore, extraction methods used require further chemical 
and biological validation to identify which substances are responsible for estrogenic activity 
and to determine if these substances are bioavailable in aquatic systems. 
Despite the many advantages of using in vitro assays to determine biological potency of 
(mixtures of) substances, one of the main disadvantages is their simplification of the in vivo 
situation. The in vitro ER-CALUX assay cannot completely reflect complex in vivo events, 
such as bioavailability and toxicokinetics, of a compound. The ER-CALUX assay may 
predict the potency of a (xeno-)estrogen once it has reached the target cell, but it can not 
predict the final bioavailability of the substance to the cell. Cross-talk with other mechanisms 
not directly related to the interaction of substances with the ER signal transduction pathway 
are not included in the ER-CALUX assay. The breast cancer cell line used in the ER-CALUX 
assay expresses both ERa and ER(3 subtypes, which may be problematic for the prediction of 
tissue-specific effects. Tissues such as prostate and ovary have been found to contain 
prominent ER|3 expression (Kuiper et al., 1997). Differences in the binding affinities of 
compounds, such as phytoestrogens, as well as in the transcriptional activity for both ER 
subtypes have been demonstrated (Kuiper et al., 1998). In addition, the possibility of 
extrapolating the estrogenic potency predicted in the ER-CALUX assay using human cells to 
other species, such as fish, birds and reptiles, requires further study. For example, differential 
binding affinities of polychlorinated biphenyls using human, rainbow trout and reptilian ERs 
have been recently demonstrated (Matthews and Zacharewski, 2000). Development of 
reporter gene assays using ERs in estrogen-sensitive cell lines from various species may be 
needed to better predict species-specific estrogenic effects in a particular species. 
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The in vivo reporter gene assay using transgenic zebrafish addresses many of the 
disadvantages associated with in vitro assays. In addition to being rapid and easy to perform, 
reporter gene induction in this assay is a reflection of the bioavailability and toxicokinetics of 
a substance in vivo. This assay provides a unique means to determine the effects of (xeno-
)estrogens on target tissues, as well as critical life stages for estrogen exposure in the 
development of the zebrafish. Even with short-term exposure of juvenile transgenic zebrafish, 
considerable differences were found in relative estrogenic potency of compounds in the 
zebrafish in vivo than would be predicted according to in vitro estrogenic activity. In 
particular, substances that were resistant to metabolism in vivo, such as ethinynlestradiol, or 
highly accumulating, such as o,p'DDT, were more estrogenic in the zebrafish than would be 
predicted based on their in vitro estrogenic activity. This type of information increases insight 
in mechanisms underlying differences between in vitro and in vivo potencies needed to 
determine the potential risk of complex mixtures of chemicals to fish. If the principal 
differences between in vitro and in vivo estrogenic potencies are known for a well studied 
matrix, it may be possible to rely more on the fast, cheap and animal-friendly in vitro assay 
for large scale monitoring for this type of matrix. One example of a such as matrix are 
domestic wastewater treatment plant effluents in which natural and synthetic estrogens are the 
main source of estrogenic activity and their relative potency in the transgenic zebrafish is 
known. For environmental matrices in which the chemical composition is unknown or 
estrogenic potency in vitro is higher than expected, more research should be conducted on 
determining the estrogenic potency of individual compounds in the transgenic zebrafish. 
A number of aspects require further study to realize the full potential of the transgenic 
zebrafish assay. As of yet, only a small panel of xeno-estrogens have been tested in the 
zebrafish. As some xeno-estrogens did not induce reporter gene activity under short-term 
static renewal regimes (Chapter 6), use of longer exposure periods under continous flow 
conditions may be useful. Parental transfer of (xeno-)estrogens could be studied by 
determining luciferase induction in offspring. The tissue-specific anti-estrogenic working of 
compounds could be determined by co-administration of estrogen with suspected anti-
estrogens, or investigation in adult female transgenics, where luciferase levels by endogenous 
estrogens are elevated. In addition, a detailed comparison of the transgenic zebrafish assay 
with another widely used biomarker for estrogen exposure, namely vitellogenin induction, 
would shed light on the advantages and disadvantages of both test systems. 
Possible impact of current levels of (xeno-)estrogens on fish 
The final challenge for an environmental toxicologist is to determine whether the 
exposure of aquatic organisms to (xeno-)estrogens results in reproductive problems which 
affect the survival of wild populations. The presence of highly responsive ERs in the testis of 
adult transgenic zebrafish as well as in juveniles undergoing sexual differentiation (Chapter 5) 
suggests the sensitivity of the gonads to realistic estrogen exposure. Studies are ongoing to 
determine if reporter gene activity in adult males and sexually differentiating juvenile 
transgenic zebrafish can predict reproductive and gonad morphological effects. Preliminary 
studies have demonstrated that exposure to estradiol during juvenile life stages in which 
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luciferase reporter gene induction is highly elevated results in reduced fertilization success of 
adult male fish (Legler et al, manuscript in preparation). 
In this study, elevated in vitro and in vivo estrogenic activity was found in extracts 
from domestic effluent of a wastewater treatment plant in The Netherlands, as well as in the 
effluent-receiving surface waters (Chapter 6). Male fish sampled from the river receiving this 
effluent demonstrated both elevated biliary estradiol equivalents (EEQ) and plasma 
vitellogenin levels compared to reference sites (Chapter 4). In the transgenic zebrafish, 
approximately 200 pmol EEQ/1 was measured following 96-hour exposure to these extracts. 
This level of EEQ far exceeds levels reported in the literature necessary to induce vitellogenin 
induction (Sheahan et al, 1994, Routledge et al, 1998) and inhibit testicular growth (Jobling 
et al. 1996, Panter et al. 1998) in other fish species. This indicates that fish at this particular 
location may be exposed to (xeno-)estrogens at levels that may impact their reproductive 
success. Accordingly, wild populations of bream sampled from the river receiving this WTP 
effluent showed high numbers of male fish with hermaphroditic gonads compared to 
reference locations (Vethaak et al, 2000). Exposure of F0 and Fl generations of zebrafish to 
this effluent in partial life cycle studies also demonstrated adverse effects on sexual 
differentiation of juvenile zebrafish (Bulder et al, 2000). 
Elevated estrogenic activity was found not only in water and effluent sample extracts 
using the ER-CALUX assay, but also in extracts of sediments from various locations in the 
Netherlands (Chapter 3). This demonstrates that (xeno-)estrogenic substances may also 
accumulate in sediments in the aquatic environment. The lipophilic pesticide o,p'DDT, which 
would be found more in sediment than the water phase in the aquatic environment, was the 
most potent xeno-estrogen of the compounds tested in the transgenic zebrafish assay so far. 
Therefore, more attention should be given to the estrogenic effects of hydrophobic 
compounds that may be available to aquatic organisms via food and through contact with 
particulate matter and sediment. 
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Concluding Remarks 
This study resulted in the development of two important new biological tools to identify 
estrogenic compounds. These tools are very valuable in determining if substances in the 
environment are present at levels that may interfere with reproduction or endocrine 
functioning in organisms. The in vitro ER-CALUX assay with T47D cells is the most 
sensitive and responsive stably transfected reporter gene assay reported to date and has 
already proven indispensable in rapidly and cost-effectively determining total biological 
potency of estrogenic chemicals in complex environmental mixtures. The in vivo transgenic 
zebrafish assay is the ideal complement to the ER-CALUX assay because environmental 
chemistry and toxicokinetics of compounds are taken into account. This assay is important for 
predicting the estrogenic effects of chemicals on fish. The surprising result that the male 
testis, and not the liver, is the most sensitive and responsive target tissue to estrogens 
underlines the vulnerability of the male reproductive organs and provides a mechanistic basis 
for the worldwide observance of male gonad abnormalities in wild populations of fish. In 
addition to identifying sensitive target tissues, the transgenic zebrafish assay has been pivotal 
in demonstrating the period of gonad development in juvenile life stages to be the most 
responsive to exogenous estrogen treatment. 
The possible applications of the ER-CALUX and transgenic zebrafish assay in the 
fields of mechanistic and environmental toxicology are numerous. For example, in 
environmental toxicology, the ER-CALUX assay can be a useful biomarker for internal dose 
of (xeno-)estrogens by determination of the estrogenic potency of (deconjugated) bile and 
urine metabolites of males. For mechanistic research, comparison of in vitro and in vivo 
bioassay responses can shed light on bioavailability, toxicokinetices and tissue-specific 
effects of (xeno-)estrogens. Of course, the route of exposure of (xeno-)estrogens and 
concentrations used in the transgenic zebrafish assay should be realistic. Injection of (xeno-
)estrogens, as opposed to exposure via the water or particulate (food) phase, is not a realistic 
exposure route for fish and will overestimate the bioavailability of chemicals in vivo. 
Unfortunately few well-validated in vitro test systems exist, and for this reason, the 
use of in vivo test systems has been widely promoted by regulatory agencies for endocrine 
disruption research. The result is that many experimental animals are sacrificed for what are 
generally labour intensive and expensive experiments. The use of the ER-CALUX assay and 
the transgenic zebrafish assay can drastically fine-tune and further direct complex in vivo 
studies. Pre-screening with the ER-CALUX assay will determine if a substance is a potential 
estrogen. Further testing in the transgenic zebrafish assay at concentrations not exceeding 5 
uM (due to possible toxicity and exceeding water solubility levels) will determine if the 
substance is also estrogenic in fish. Determination of estrogenic effects of a substances in 
long-term reproductive studies would only be warranted if the estradiol equivalency factor 
(EEF) of the substance in the transgenic fish is greater than 10"6. Ideally, future studies to 
biologically validate the transgenic zebrafish assay will determine critical levels of reporter 
gene induction in the zebrafish which correspond with effects on gonad differentiation and 
reproduction, thereby further reducing the need for chronic studies with large numbers of 
experimental animals. 
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In response to the question "can estrogenic effects be expected in aquatic organisms 
exposed to (xeno-)estrogenic compounds in the Dutch environment?", the answer is yes. 
Though probably not widespread, there are some localized areas of concern. In this study we 
showed that domestic wastewater treatment plant effluent is estrogenic in both the ER-
CALUX and transgenic zebrafish assay. Natural and synthetic hormones contributed most to 
this estrogenic activity, in particular the contraceptive pill component ethynylestradiol (EE2). 
Importantly, EE2 was one hundred times more potent than the natural hormone estradiol in 
the transgenic zebrafish, demonstrating that only small amounts of this compound in the 
environment can have dramatic effects on fish. EE2 is definitely a priority estrogenic 
contaminant in the environment and measures should be taken to limit its release in domestic 
sewage effluent. In addition, another source of estrogenic activity in the environment that may 
be underestimated is sediment. Persistent compounds that likely enter the environment via 
industrial effluents or runoff from pesticide use are accumulated in sediments. Extracts from 
contaminated sediments, such as from Rotterdam Harbour, showed elevated estrogenic 
activity in the ER-CALUX assay. Aquatic organisms and their eggs can be exposed to 
sediment-associated (xeno-)estrogens through contact or ingestion of sediments. In this 
study, the organochlorine pesticide o,p'DDT which is mainly found accumulated in sediments 
and not in the water phase, was the most potent xeno-estrogenic chemical in the transgenic 
fish. More attention in terms of regulation should be given to identification of estrogenic 
potency of (unknown) compounds in sediments, in contrast to the possibly unwarranted 
widespread focus on the estrogenic effects of compounds such as phthalates which 
demonstrated minimal estrogenic potency in vitro and in vivo. 
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Samenvatting 
Sinds het begin van de jaren 1990 is in toenemende mate melding gemaakt van endocriene 
stoornissen bij zowel de mens als organismen in het natuurlijke milieu. Geconstateerde 
verschijnselen omvatten o.a. verminderde spermakwaliteit bij mannen en misvormingen van de 
geslachtsorganen en seksuele gedragsstoornissen bij dieren in het wild. Deze verontrustende 
effecten zouden mogelijk te wijten zijn aan de aanwezigheid van stoffen in het milieu die o.a. de 
werking van oestrogenen, vrouwelijke geslachtshormonen, mogelijk kunnen nabootsen of 
remmen. Deze meldingen hebben aanleiding gegeven tot veel wetenschappelijke onderzoek om 
het verband te zoeken tussen negatieve reproductie effecten bij mannelijke organismen en 
blootstelling aan (xeno-)oestrogene stoffen. Bovendien werd geadviseerd door nationale en 
internationale beleidsorganen om nieuwe en bestaande chemicalien te testen op oestrogene 
werking. Omdat stoffen met (anti-)oestrogene activiteit uiteenlopende chemische structuren 
hebben, is identificatie op basis van de chemische structuur moeilijk. Bestaande biologische 
testmethoden, zogenoemde "bioassays" bleken onvoldoende om snel specifieke effecten van 
(xeno-)oestrogenen te bepalen. Het werd duidelijk dat het ontwikkelen van snelle bioassays om 
stoffen te testen op oestrogeen verstorende potentie noodzakelijk was. 
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Het doel van het in dit proefschrift beschreven onderzoek was om nieuwe in vitro en in vivo 
bioassays te ontwikkelen om (xeno-)oestrogene stoffen te detecteren op basis van hun 
biologisch werkingsmechanisme. Dit werkingsmechanisme berust op het binden van 
oestrogenen aan oestrogeen receptoren (ER) in de eel en het induceren van ER-gemedieerde gen 
transcriptie en translatie. Deze nieuwe bioassays beoogen om op gevoelige wijze de 
blootstelling van biologisch actieve (xeno-)oestrogene stoffen in het aquatische milieu in 
Nederland te bepalen, en bovendien de mogelijke effecten van blootstelling aan deze stoffen op 
de reproductie of endocriene nineties van vissen te voorspellen. 
Er zijn twee nieuwe testsystemen ontwikkeld die gebruik maken van een reporter gen, in 
dit geval coderend voor het lichtproducerende luciferase afkomstig van het vuurvliegje. 
Allereerst is een in vitro reporter gen assay ontwikkeld. Deze assay gebruikt een menselijke 
borst kanker cellijn waarin een oestrogeen-induceerbaar luciferase reporter gen op stabiele wijze 
tot expressie komt. Op basis van deze cellijn is de zogenaamde ER-CALUX (Estrogen 
Receptor-mediated Chemical Activated LUciferase gene expression) assay ontwikkeld om snel 
(mengsels van) stoffen uit waterige en vaste milieufracties te kunnen testen op (anti-)oestrogene 
potentie. Naast de ER-CALUX assay is een tweede biologisch testsysteem ontwikkeld dat 
gebruik maakt van transgene zebravissen. In deze in vivo reporter gen bioassay kan de expressie 
van hetzelfde oestrogeen gereguleerde luciferase reporter gen in doelorganen bepaald worden. 
Tevens kunnen de kritieke levensstadia van de zebravis bepaald worden voor blootstelling aan 
vermoede (xeno-)oestrogene stoffen. Hieronder worden de resultaten behaald met beide assays 
samengevat. 
In vitro reporter gen assay (ER-CALUX) 
De ER-CALUX assay maakt gebruik van de T47D menselijke borst kanker cellijn 
stabiel voorzien van een recombinant gen coderend voor het luciferase eiwit. Het ontwikkelen 
van deze cellijn wordt in Hoofdstuk 2 beschreven. De ER-CALUX methode is gebaseerd op het 
werkingmechanisme van oestrogenen in levende cellen: oestrogenen binden aan de endogene 
ER's in de T47D eel, waardoor de receptor wordt geactiveerd en bindt aan specifiek DNA 
sequenties (de 'estrogen response elements' of ER's) op het luciferase gen. Blootstelling van 
deze cellen aan (xeno-)oestrogenen resulteert in de vorming van luciferase. Luciferase is heel 
gevoelig in eel lysaten te meten omdat het na toevoegen van het substraat luciferine, licht wordt 
geproduceerd. 
De respons van de ER-CALUX assay is gekarakteriseerd met diverse (mengsels van) 
oestrogene en anti-oestrogene stoffen (Hoofdstukken 2 en 3). De assay blijkt uiterst gevoelig 
en heeft in microtiter platen voor het natuurlijke oestradiol (E2) een detectie limiet van 0.5 
pM, een EC50 van 6 pM en maximale inductie van ca. 75-voud bij 30 pM E2. Anti-
oestrogenen zoals ICI 182,780, tamoxifen en TCDD kunnen in de ER-CALUX gedetecteerd 
worden door co-administratie met E2. Een scala aan xeno-oestrogenen waaronder 
alkylfenolen en alkylfenol-ethoxylaten, organochloor pesticiden, ftalaten en fyto-oestrogenen 
zijn getest in de ER-CALUX en bleken 1000-100000 maal minder potent dan E2. Genisteine, 
nonylfenol en o,p'DDT waren van de geteste stoffen de meest potente xeno-oestrogenen 
(EC50 100, 260 en 620 nM, resp.). De ER-CALUX assay is ook gebruikt om de interactie 
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tussen verschillende combinaties van stoffen te onderzoeken. Over het algemeen bleken 
combinaties van organochloor pesticiden additiviteit te vertonen (Hoofdstuk 2). Om na te 
gaan of metabolieten van (xeno-)estrogene stoffen zelf ook een oestrogene werking konden 
vertonen, is een in vitro biotransformatie stap aan de ER-CALUX assay procedure 
toegevoegd. Hiertoe zijn uitgangstoffen vooraf gei'ncubeerd met microsomen van P450 
gei'nduceerde rattenlevers. De metabolieten van de xeno-oestrogeen methoxychloor bleken 
een hogere oestrogene activiteit te vertonen dan de uitgangsstof (Hoofdstuk 3). 
De respons in de ER-CALUX assay is vergeleken met een andere veel gebruikte 
reporter gen assay voor oestrogene werking, de zogenoemde "recombinant yeast screen". 
Deze assay maakt gebruik van gist-cellen die voorzien zijn van een recombinante menselijke 
oestrogeen receptor en een ER-gemedieerd p-galactosidase reporter gen. Vergelijking tussen 
de ER-CALUX assay en de gist assay laat zien dat de ER-CALUX assay E2, nonylfenol en 
o,p'DDT detecteert bij een 10-100 keer lagere concentratie dan de gist assay (Hoofdstuk 3). 
Experimenten met anti-oestrogenen laten zien, dat de ER-CALUX assay ook veel gevoeliger 
is voor anti-oestrogenen dan de gist assay (Hoofdstuk 3). 
De hoge gevoeligheid van de ER-CALUX assay en mogelijkheid om een relatief hoge 
aantal monsters op een snelle manier te testen maakt het een ideale methode om oestrogene 
activiteit aan te tonen in milieumonsters. Onderzoek naar de optimale extractie methode voor 
waterbodems liet zien dat relatief polaire componenten in hexaan:aceton extracten hogere 
oestrogene activiteit bevatten dan apolaire componenten (Hoofdstuk 3). Sediment extracten 
van ge'i'ndustrialiseerde locaties, zoals de haven van Rotterdam vertoonden een verhoogde 
oestrogene potentie vergeleken met referentie gebieden (Hoofdstuk 3). Naast sediment is in 
deze studie de oestrogene activiteit gemeten in oppervlaktewater, zwevend stof en biota 
(mosselen en vissen) in verschillende locaties in Nederland (Hoofdstuk 4), en van effluent van 
een huishoudelijke rioolwaterzuiveringsinstallatie (Hoofdstuk 6). 
Er is ook een methode ontwikkeld om te bepalen of biologische inactieve (xeno-) 
oestrogene metabolieten aanwezig in humane urine en vissengal opnieuw geactiveerd kunnen 
worden (Hoofdstuk 4). Urine bleek na voorbehandeling met het enzym (3-glucuronidase of E. 
coli cellen weer actieve uitgangsstoffen te bevatten waardoor ze een secundaire bron van 
oestrogene stoffen kunnen vormen in het milieu. Ook in galmonsters van vissen zijn 
geconjugeerde metabolieten aanwezig die na een dergelijke deconjugatie weer oestrogene 
potentie bevatten waardoor ze eveneens een secondaire bron van oestrogenen kunnen vormen 
in de vis. Hoge oestrogene activiteit van gedeconjugeerde gal monsters van mannelijke 
brasem van verschillende locaties in Nederland correleerde met verhoogde oestrogene 
activiteit in water en vitellogenine inductie in plasma van dezelfde vissen (Hoofdstuk 4). De 
oestrogene potentie in (gedeconjugeerde) metabolieten van gal en urine is een veelbelovende 
biomarker voor de interne dosis van (xeno-)oestrogenen in mannelijke organismen. 
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In vivo reporter gen assay (transgene zebravissen) 
Transgene zebravissen zijn ontwikkeld met hetzelfde oestrogeen-gevoelige luciferase 
reporter gen als de ER-CALUX assay stabiel gei'ntegreerd in hun genoom (Hoofdstuk 5). Dit 
is de eerste melding van een in vivo reporter gen assay om de blootstelling van (xeno-) 
oestrogenen te bepalen. Luciferase reporter gen expressie is in deze assay niet alleen 
afhankelijk van de bindingscapaciteit van oestrogenen aan endogene ER's maar ook van de 
biologische beschikbaarheid en in vivo toxicokinetiek van de stof. 
De transgene zebravissen zijn gegenereerd met een effectieve methode dat gebruik maakt 
van microinjectie van DNA constructen in eencellige embryo's. De ontwikkelde stabiele 
transgene lijn vertoont hoge luciferase expressie na blootstelling aan E2. Luciferase expressie 
is gevolgd tot de vijfde generatie van deze lijn, en is stabiel gebleven. De gevoeligheid van de 
transgene zebravissen voor E2 bleek sterk afhankelijk van het levensstadium. De hoogste 
luciferase inductie tijdens de juveniele ontwikkeling is gevonden in vissen van 4-5 weken 
oud, de periode waarin gonadendifferentiatie plaatsvindt. Interessant is dat ook zeer jonge 
embryo's (24 uur oud) al actieve oestrogeen receptoren bevatten. In transgene vissen van 4-5 
weken oud leidde blootstelling aan zowel natuurlijke oestrogenen (17a-oestradiol, oestron) 
als het synthetische oestrogeen ethinyloestradiol (EE2) en het xeno-oestrogeen o,p'DDT tot 
verhoogde luciferase activiteit. In volwassen transgenen bleken bij kortstondige blootstelling 
aan E2 lever, spier, schubben en botten potentiele doelorganen voor oestrogenen. In de testes 
van volwassen mannetjes vertoonden de hoogste waargenomen luciferase activiteit van 
minimaal 1000 maal na 48 uur blootstelling aan 1 uM E2. Immunohistochemie op testis 
coupes liet zien dat luciferase expressie gelokaliseerd is in vroege kiemcellen en Sertoli cellen 
(Hoofdstuk 5). 
Omdat luciferase expressie in de transgene vissen afhankelijk is van endogene ER 
niveaus, is van twee ER-vormen de expressie in de zebravis bestudeerd. De ER-vormen a en 
(3 zijn gedetecteerd in zeer jonge embryos (24 uur oud) en komen sterk tot expressie in de 
periode van geslachtsdifferentiatie. In volwassen vissen bleken weefsels met hoge luciferase 
activiteit (testis, lever) zowel ER-a als ER-p te bevatten (Hoofdstuk 5). 
De responsen in de in vitro ER-CALUX assay en de in vivo transgene zebravis assay 
zijn vergeleken na blootstelling aan (mengsels van) (xeno-)oestrogenen (Hoofdstuk 6). Beide 
assays zijn gevoelig voor natuurlijke (E2 en oestron) en synthetische (ethinyloestradiol, EE2) 
oestrogenen, maar er waren duidelijke verschillen in relatieve potenties ten opzichte van E2 
zijn waargenomen. EE2 was 100 keer potenter dan E2 in de transgene vissen, maar heeft 
ongeveer dezelfde potentie als E2 in de ER-CALUX assay. De bioaccumulerende xeno-
oestrogeen o,p'DDT liet vergelijkbare relatieve potenties in beide assays zien. De snel 
metaboliseerbare xeno-oestrogenen nonylfenol en bisfenol A gaven echter verhoogde 
oestrogene activiteit in vitro, maar induceerden geen reporter gen activiteit in vivo (Hoofdstuk 
6). Deze resultaten tonen aan dat stabiele stoffen in vivo, zoals EE2 en o,p'DDT, hogere 
oestrogene activiteit kunnen vertonen dan voorspeld wordt met in vitro bioassays. Deze 
stoffen verdienen extra aandacht bij de risicobeoordeling van (xeno-)oestrogenen voor 
aquatische organismen terwijl snel metaboliseerbare stoffen wellicht een mindere bedreiging 
vormen dan gedacht. 
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In een vergelijkend onderzoek zijn beide assays toegepast op extracten van effluent 
van een Nederlandse zuiveringinstallatie voor huishoudelijke rioolwater. Dit effluent is in 
detail onderzocht omdat in eerdere studies in het ontvangende rivierwater en galmonsters van 
mannelijke vissen hoge oestrogene activiteit werd gemeten (Hoofdstuk 4). Bovendien 
bevatten deze vissen verhoogde plasma vitellogenine waarden (Hoofdstuk 4). De oestrogene 
potentie in dit effluent was hoger in de transgene zebravis assay dan de in vitro assay, 
waarschijnlijk door de aanwezigheid van het in vivo zeer potente EE2. Er werd ca. 200 pmol 
E2 equivalenten per liter effluent gemeten na 96-uur blootstelling van juveniele transgene 
zebravissen. Deze concentratie overschrijdt effectwaarden gerapporteerd in literatuur voor 
reproductie effecten in vissen. Dit betekent derhalve dat vissen in deze locatie mogelijk 
blootgesteld zijn aan niveaus van (xeno-)oestrogenen die hun reproductieve succes zouden 
kunnen bei'nvloeden. 
Het onderzoek beschreven in dit proefschrift leidt tot de conclusie dat de ER-CALUX 
en transgene zebravis assays veelbelovende in vitro en in vivo assays zijn voor blootstelling 
aan en potentiele effecten van stoffen met een oestrogene werking. De ER-CALUX assay is 
snel en makkelijk uit te voeren, en kan toegepast worden voor het kwantificeren van 
complexe milieumonsters voor oestrogene activiteit. De transgene zebravis assay is de ideale 
aanvulling voor de in vitro assay, omdat deze ook de beschikbaarheid en toxicokinetiek van 
stoffen in vivo integreert. Deze assay biedt een unieke, snelle methode om de effecten te 
bepalen van (xeno-)oestrogenen op doelorgangen en kritieke levensstadia in de ontwikkeling 
van de zebravis. Op basis van de nu bekende relatieve oestrogene potentie van stoffen in vivo 
is het mogelijk de voorspelende waarde van de in vitro assay te bepalen. Daardoor kunnen 
beide assays worden ingezet voor het determineren of stoffen in het milieu aanwezig zijn bij 
concentraties die kunnen leiden tot effecten op reproductie of endocriene nineties in 
aquatische organismen. Met behulp van deze technieken zijn in Nederland op enkele plaatsen 
al niveaus van biologische active (xeno-)oestrogenen gevonden die zeer waarschijnlijk 
ongewenste effecten op de voortplanting van vissen kunnen veroorzaken. 
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